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Abstract 
 
 Mitochondrial dysfunction is the cause of many diseases that vary in their 
complexity and clinical presentation. Flawed mitochondrial protein synthesis can 
disrupt the homeostasis of the whole cell and activate different stress responses, 
which are trying to outweigh the damage. Both the depletion of mitochondrial 
aspartyl-tRNA synthethase (Dars2) in a tissue-specific manner and ATP-dependent 
Clp protease (Clpp) in whole body, leads to the activation of versatile stress 
responses. Remarkably, in both mouse models, we observed a significant increase in 
the expression of a mitokine fibroblast growth factor 21 (Fgf21). This mitokine was 
shown to be upregulated in many different mouse models with mitochondrial 
dysfunction, however, its role has still not been clearly demonstrated. 
In this study, we generated different double-deficient mouse models, in order 
to access the role of FGF21 in mitochondrial dysfunction. The results have shown that 
the autocrine role of FGF21 in DARS2-deficient cardiomyocytes is dispensable and 
the non-cell autonomous effects of the topical DARS2 depletion are independent of 
FGF21. Furthermore, with the depletion of FGF21 in whole body, we have shown 
that DARS2-deficient animals are not affected, indicating that alternative signaling 
pathways might be activated. Remarkably, when FGF21 was depleted in CLPP 
deficient animals, we observed an increase in the markers of cardiomyopathy 
suggesting importance of this mitokine in cardiac physiology.  
In summary, these results have shown that FGF21 is not a key player 
mediating stress responses upon strong mitochondrial deficiency, as modeled in 
DARS2-deficient mice. However, this cytokine might have a more significant role in 
late-onset mitochondrial diseases that are modeled by the CLPP loss, which is 
featured by mild mitochondrial dysfunction. Moreover, the observed expression of 
Fgf21 might be dose-dependent and therefore mirroring the severity of mitochondrial 
dysfunction. In addition, there are possibly alternative players compensating for the 
lack of FGF21 in mouse models with mitochondrial disease. 
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Zusammenfassung 
 
Mitochondriale Dysfunktionen sind die Ursache vieler Erkrankungen, die sich 
in ihrer Komplexität und klinischen Repräsentation signifikant unterscheiden können. 
Eine defekte mitochondriale Protein-Synthese kann die Homöostase der gesamten 
Zelle beeinträchtigen und so verschiedene Stress-Reaktionen zur Schadensbegrenzung 
aktivieren. Sowohl der gewebe-spezifische Verlust der mitochondrialen Aspartyl-
tRNA-Synthethase (Dars2) als auch ein Defizit der ATP-abhängigen Clp-Protease 
(Clpp) im gesamten Körper führt zu vielfältigen Stress-Reaktionen. Beiden 
Mausmodellen gemeinsam ist jedoch ein signifikanter Anstieg in der Expression des 
Mitokins Fibroblast growth factor 21 (Fgf21). Eine Hochregulation dieses Proteins 
konnte zwar in vielen verschiedenen Mausmodellen mit mitochondrialen 
Dysfunktionen beobachtet werden, seine funktionale Rolle war bislang jedoch 
unbekannt.   
In der vorliegenden Studie haben wir verschiedene Doppel-Knockout-
Mausmodelle generiert, um die Rolle von FGF21 in mitochondrialen Dysfunktionen 
näher untersuchen zu können. Die Ergebnisse zeigen, dass FGF21 eine nur 
unwesentliche autokrine Funktion in Dars2-defizienten Kardiomyozyten hat und 
nicht-zell-autonomen Effekte einer Dars2-Depletion ebenso unabhängig von FGF21 
verlaufen. Eine Ganzkörper-Deletion von FGF21 beeinträchtigt zwar nicht zusätzlich 
den Phänotyp von Dars2-Knockout-Tieren, jedoch wurden Veränderungen im 
Phosphorylierungsstatus verschiedener Proteine festgestellt, was Hinweise auf 
alternative Signalmechanismen gibt. Interessanterweise führt einen Depletion von 
FGF21 in CLPP-Knockout-Tieren zu einem Anstieg von Markern, welche mit einer 
Kardiomyopathie in Verbindung stehen. 
Zusammenfassend zeigen die vorliegenden Ergebnisse, dass FGF21 kein 
entscheidender Faktor bei der Vermittlung der Stress-Reaktionen in Dars2-defizienten 
Tieren ist. Jedoch kann nicht ausgeschlossen werden, dass dieses Zytokin eine 
signifikantere Rolle bei spät auftretenden mitochondrialen Erkrankungen spielt, wie 
sie durch den Verlust von CLPP mit milder mitochondrialer Dysfunktion 
veranschaulicht werden. Zudem könnte die beobachtete Expression von Fgf21 dosis-
abhängig sein und somit den Schweregrad der mitochondrialen Dysfunktion 
wiederspiegeln. Darüberhinaus existieren mögliche alternative Spieler, die den 
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Verlust von FGF21 in Musmodellen mit mitochondrialen Dysfunktionen 
kompensieren könnten.  
 
		 				
 
1. Introduction 
 
Mitochondria are organelles, which make life possible by providing energy and many 
other functions necessary for cells’ balance and dynamic. The name of this organelle comes 
from the Greek language, where mitos means “thread” and chondrion represents “granules”. 
Interestingly, mitochondria were firstly described back in 1890, by the German scientist 
Richard Altmann. In his book “Die Elementarorganismen und ihre Beziehungen zu den 
Zellen”, Altmann named mitochondria bioblasts, referring to them as life germs. He believed 
that they were autonomous organelles important for cell metabolism and genetics, which had 
been proven to be true almost a century later (O'Rourke, 2010). 
 
1.1. Mitochondria structure and main functions 
 
The eukaryotic cell is a symbiotic community of two life forms, the nucleus-cytosol and 
the mitochondrion.  Mitochondria are not self-supporting entities, since they rely for their 
functions on nuclear gene products which are then imported into them. (Wallace, 1992). They 
have a double membrane, the outer that separates them from cytosol, and the inner membrane, 
which form the cristae that are defining the matrix of the organelle. (Taanman, 1999). The 
matrix contains the mitochondrial genome, ribosomes, transfer RNAs (tRNAs) and versatile 
proteins and enzymes needed for the function of the organelle.  
Mitochondria are thought to have originated two billion years ago from incorporated 
alpha-proteobacteria, introducing the oxidative respiratory system to the host cell in the times 
of the drastic changes in the earth’s atmosphere (Gray, Burger, & Lang, 1999). During the 
evolution, the endosymbiont transferred many of its essential genes to the nuclear genome, by 
which today’s mitochondria have a very efficient system of gene expression. The 
mitochondria still carry hallmarks of its bacterial ancestor, which are reflected on mtDNA 
expression machinery (Gray, 1989) . 
Mitochondria perform central functions in cells, most importantly they generate the 
cells’ main energy source – adenosine triphosphate (ATP). Moreover, they buffer cytosolic 
calcium levels, take part in programmed cell death, steroid synthesis, iron-sulfur cluster 
biosynthesis, reactive oxygen species (ROS) formation etc. (Wallace, 2009).  
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Mitochondrial energetics relies on the availability of reducing agents (hydrogen) that 
react with oxygen to generate water. Most of the usable energy comes from the breakdown of 
carbohydrates or fats. The outcome is the production of ATP molecules and electron donors, 
NADH and FADH2, through the process known as oxidative phosphorylation (OXPHOS).  
Electrons from the donors are then transferred to molecular oxygen and the energy released 
from these oxidation/reduction reactions is used to drive synthesis of ATP from ADP. This 
energy must be created successively, by the passage of electrons through versatile carriers, 
which are building up the electron transport chain (ETC). The ETC consists of four 
complexes which function as the carriers: complex I (CO I – NADH:ubiquinone 
oxidoreductase), complex II (C II – succinate dehydrogenase), complex III (C III – ubiquinol 
cytochrome c reductase) and complex IV (C IV – cytochrome c oxidase, COX). Complex V 
(C V – ATP synthase) serves to couple energy-yielding reactions of electron transport to ATP 
synthesis (Alberts et al., 1983).  Electrons are transported from NADH to C I and from 
succinate through FADH2 to C II. They are further passed down to C III by coenzyme Q 
(CoQ/ubiquinone). The electron transport from C III to C IV is resolved by soluble 
cytochrome c.  The free energy is produced by the passage of electrons through carriers, and 
the H+ transport through the inner mitochondrial membrane creates the proton gradient. This 
energy is harvested by being coupled to ATP synthesis, which is driven by CV. This is known 
as chemiosmotic coupling, and it was proposed by Peter Mitchell in 1961 (Mitchell, 1961).  
The organization of the OXPHOS system was modeled in different ways over time. 
Two main proposed models are the “fluid” and “solid” model.  The ‘solid’ model was 
firstproposed after a successful purification of functional respiratory complexes. Here 
complexes unit together in a rigid structure called respirasome (Hatefi, Haavik, Fowler, & 
Griffiths, 1962). Later on, with the increased knowledge of the properties of the inner 
mitochondrial membrane (IMM), the ‘fluid’ model was proposed (Hochli & Hackenbrock, 
1977). This model was later termed as the ‘random collision’ model, where it was suggested 
that all membrane complexes, proteins and redox components are in constant and independent 
diffusional motion. This model was generally accepted for a long time, until new experiments 
proved the existence of individual intact respiratory complexes with additional multiple 
comigrating respiratory complexes, known as supercomplexes. In contradiction to the ‘fluid’ 
model, most of the complex I appear to form associations with complex III, and some 
complex IV is retained in the form of I–III–IV supercomplexes. This model is a combination 
of both types, and represents the ‘plasticity’ model (Schagger & Pfeiffer, 2000). 
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Figure 1.1 Different models of mitochondrial respiratory chain organization. 
Schematic representation of the different models of the OXPHOS organization mentioned in the text. (A) 
‘random-collision’ model or ‘fluid model’, (B) ‘solid’ model, and (C) the plasticity model. The question mark 
indicates proposed associations or supercomplexes, which are not fully confirmed. (Acin Perez R. and Enriquez 
JA, 2014). 
 
It has been proposed that the benefits of supramolecular structures are enabling 
channeling of the substrates ubiquinone and cytochrome c or to catalytically enhance the 
reactions due to shorter diffusion times or stabilization of complex I (Schagger & Pfeiffer, 
2000). The existence of respiratory supercomplexes have been found in different kingdoms of 
eukaryotes. The abundance of the supercomplexes with different compositions varies from the 
organism to the organism. Thus, the supercomplex with composition I + III2 is the most 
abundant in plants, where most of the complex IV is found as monomer. I + III2 + IV1–4 
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supercomplex is highly present in mammals and III2 + IV2 in fungi (Chaban, Boekema, & 
Dudkina, 2014). 
1.2.  Mitochondrial gene expression 
 
Mammalian mitochondrial DNA (mtDNA) encodes 13 proteins that are essential for 
OXPHOS, but the full mtDNA expression and maintenance depends on the import of a large 
number of nuclear-encoded proteins. MtDNA is a double stranded molecule of 16.6 kb in 
mammals, encodes for 13 polypeptides, 22 tRNAs and two ribosomal RNAs (rRNAs). The 
OXPHOS system itself has a dual genetic origin, while its subunits are encoded both by 
mtDNA and nuclear genes, whose products are imported into mitochondria (Cann, Stoneking, 
& Wilson, 1987). MtDNA has some specific features, for instance, it is transmitted almost 
exclusively through the female germ line. Oocytes have extremely high mtDNA copy 
number, whereas sperm cell mtDNA count is very low. Paternal mtDNA is usually detected 
only in the early pronucleus stage and the mechanism by which sperm-derived mitochondria 
are being eliminated is still not well understood. However, a case report of a patient with 
mitochondrial myopathy with a deletion in the ND2 gene showed that the change in patient’s 
mtDNA was of paternal origin and accounted for 90% of patient’s muscle mtDNA (Schwartz 
& Vissing, 2002). One explanation of uniparental inheritance of mtDNA could be the 
selective pressure in order to decrease the deleterious mutations that are present in biparental 
inheritance of cytoplasmic genomes (Birky, 1995; Wallace, 2007). Maternal mtDNA 
mutations can be transmitted to the offspring, but the phenotype severity depends on mutation 
load. A pathogenic mutation could be present in all copies of mtDNA or in just a few. The 
presence of different populations of mtDNA in a single cell is called ‘heteroplasmy’ in 
contrast to ‘homoplasmy’ where all the mtDNA molecules are identical (Lightowlers, 
Chinnery, Turnbull, & Howell, 1997). Only a mutational load above certain level can trigger a 
pathogenic phenotype (threshold effect). The germ line has several mechanisms to counteract 
maternal transmission of mtDNA mutations. A bottleneck effect is present during 
development, since only a small number of mtDNA molecules will populate the primordial 
germ cells. Moreover, there is a purifying selection mechanism that prevents specific mtDNA 
mutations (Poulton, 1995). Nevertheless, mothers with high mutational load in their germ line 
have decreased fertility (Gustafsson, Falkenberg, & Larsson, 2016; Wallace, 1993).   
Mammalian mtDNA replication uses a set of different proteins in comparison to nuclear 
replication. At the core of the replisome is DNA polymerase-γ (POLγ), the only replicative 
polymerase in mitochondria. POLγ has a 3’ to 5’ exonuclease domain that provides a 
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proofreading with a low-error-frequency. This polymerase cannot use double strand DNA 
(dsDNA) as a template and therefore requires the DNA helicase TWINKLE. This helicase 
unwinds the mtDNA in 5’ to 3’ direction and with the help of the mitochondrial single strand 
DNA (ssDNA) – binding proteins (mtSSB) forms the replication fork (Clayton, 1983; Kaguni, 
2004). The two strand of mtDNA differ in their guanine base composition. The one rich in 
guanines is therefore named ‘heavy’ strand (H) and the other ‘light’ strand (L) (Berk & 
Clayton, 1974). MtDNA lacks introns and has a non-coding control region, which contains 
promoters needed for the transcription of both the H and L strands. The central mammalian 
mtDNA transcription machinery includes mitochondrial RNA polymerase (POLRMT), 
mitochondrial transcription factor A (TFAM) and mitochondrial transcription factor B2 
(TFB2M) (Peralta, Wang, & Moraes, 2012). TFAM is playing a key role in both mtDNA 
transcription and mtDNA maintenance, since it is helping the organization of mtDNA into 
nucleids (Ekstrand et al., 2004).  In mammalian mitochondria, POLRMT drives transcription 
either from the light-strand promotor or the heavy-strand promotor. The primary polycistronic  
transcripts are then processed to generate individual tRNAs, rRNAs and mRNAs. 5’ to 3’ 
processing is done by RNaseP and ELAC2 (Hallberg & Larsson, 2014).  
Apart from the cytoplasmic translation, mitochondria are capable of synthesizing 
proteins “in the house”, serving their own needs. These proteins are 13 subunits of OXPHOS 
system and essential for its full function. The whole system enables that energy needs are met 
in no time. Nevertheless, it requires a coordinated synchronization of nuclear and 
mitochondrial gene expression. Most of the proteins involved in mitochondrial translation are 
encoded by the nuclear DNA and they need to be imported into mitochondria. Those proteins 
are the factors of initiation, elongation and termination of translation. Moreover, 
mitochondrial translation requires mitoribosomal proteins and the assembly factors, and last 
but not least, aminoacyl-tRNA synthethases and different tRNA and rRNA modifying 
enzymes (Smits, Smeitink, & van den Heuvel, 2010).  
The mitochondrial translation machinery differs from the cytoplasmic one in many 
ways. The overall properties of mitochondrial ribosomes (mito-ribosomes) differ considerably 
from cytosolic and bacterial ones. The mammalian mito-ribosome has a low sedimentation 
coefficient of nearly 55S. Its body consists of a large ~39S and small ~28S subunit, which 
contains the mtDNA encoded 16S and 12S rRNA respectively (Taanman, 1999). Yet another 
difference is that mitochondrial mRNAs usually do not contain 5’ untranslated nucleotides, 
nor 5’ caps. Moreover, mitochondria have a simplified system for decoding, using only 22 
tRNAs unlike 31 predicted by the “Wobble hypothesis” (Anderson et al., 1981). In addition, 
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mammalian mitochondria use an unique tRNAMet for both initiation and elongation of 
translation, unlike most of the lower eukaryotes (Smits et al., 2010). Mitochondrial tRNAs 
differ in size and shape from cytoplasmic and bacterial ones and are recognized by 19 
mitochondrial aminoacyl-tRNA synthethases (ARS2-s). Two of the 19 ARS2-s are encoded 
by the same gene, as their corresponding cytoplasmic enzymes (Bonnefond et al., 2005).  
Mitochondrial translation is divided into three phases: initiation, elongation and 
termination. The initiation mechanism is poorly understood, while it is not completely known 
how ribosome binding is facilitated due to the lack of 7-methylguanine cap which is found in 
cytoplasmic mRNAs (O'Brien, 2003). The first step in the initiation complex is sequence-
independent binding of the small ribosomal subunit and mRNA. Mitochondrial initiation 
factor 3 (MtIF3) is assisting the right positioning of the start codon AUG at the peptidyl (P) 
site, prior to the ribosome-mRNA binding.  MtIF2 is required for binding of fMet-tRNAMet  to 
the small ribosomal subunit, which is followed by binding of the large ribosomal subunit to 
the complex and this is a GTP dependent process (Christian & Spremulli, 2009; Ma & 
Spremulli, 1995). The next step is elongation of translation, which requires 3 different 
elongation factors: mtEFTu, mtEFTs and mtEFG1. First, mtEFTu associates with an 
aminoacylated tRNA and GTP, carrying it to the acceptor (A) site at the small subunit where 
the decoding is taking place. GTP hydrolysis and releasing of mtEFTu occurs after the codon-
anticondon recognition has occurred (Nagao, Suzuki, & Suzuki, 2007). As the next step, the 
3’ end of the aminoacyl-tRNA translocates into the P center on the large ribosomal subunit 
where an amino-acid is added to the growing peptide chain. This step is enabled by mtEFG1-
GTP, which causes conformational changes in mitoribosome that facilitate translocation of 
tRNAs from A and P sites to P and exit (E) sites (Smits et al., 2010; Taanman, 1999). 
However, E site is actually one of the weaker tRNA-binding sites in the mammalian 
mitoribosome, contrasting the E site in the cytoplasmic ribosomes. Eventually, tRNAs 
disassociate from the mitoribosome, enabling the onset of a new cycle of elongation. The last 
step in mitochondrial protein synthesis is termination, which occurs when a stop codon 
(UAG, UAA, AGG or AGA) in the A site is recognized by a mitochondrial translation release 
factor (mtRF), which belongs to a larger family of mitochondrial release factors that display 
high conservation of a GGQ domain, which is crucial for catalyzing peptidyl-tRNA 
hydrolysis. In human mitochondria, mtRF1, mtRF1a, ICT1, and C12orf65 contain a GGQ 
domain (Wesolowska, Richter-Dennerlein, Lightowlers, & Chrzanowska-Lightowlers, 2014). 
The hydrolysis of the ester bond between the nascent polypeptide and tRNA is catalyzed by 
GTP. After this release, all the components of the machinery are available again for a new 
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round of translation (Bertram, Innes, Minella, Richardson, & Stansfield, 2001; Christian & 
Spremulli, 2012). 
 
1.3.  Mitochondrial stress signaling  
 
Mitochondria are an essential part of cells for energy production and numerous 
processes, therefore they had to adjust to different exogenous and endogenous stresses. The 
ability of mitochondria to adapt to the changing conditions by activating versatile signaling 
pathways is known as mitochondrial stress response. The source of the stress can be diverse – 
oxidative damage, changes in mtDNA, OXPHOS dysfunction, accumulation of 
unfolded/damaged proteins etc. Mitochondria use different tools according to the type of 
stress they are dealing with. On the other hand, mitochondria can communicate with the 
nucleus and release signals, which would activate transcription of specific sets of genes that 
will support the survival in difficult circumstances. This is known as mitochondrial retrograde 
signaling. 
 
Mitochondrial biogenesis 
 
The mitochondrial content is a highly variable feature in different tissues. For example, 
the heart is a muscle that is continuously being contracted and requires constant inflow of the 
energy, therefore cardiomyocytes are rich in mitochondria. On the other hand, in skeletal 
muscle, the abundance of mitochondria depends on the fibre type. Type I fibres are involved 
in locomotion and posture and they are known as slow-twitch muscle-fibers. They are much 
richer in mitochondria than type II fibers, which are used periodically for the movements that 
are explosive and require more strength (Hood, Tryon, Carter, Kim, & Chen, 2016). The 
mitochondria content is in the end a result of the organelle biogenesis and its breakdown, 
known as mitophagy. The biogenesis of mitochondria can be an attempt of compensation for 
a metabolic defect and the transcriptional regulation is mediated by specific transcriptional 
activators such as nuclear respiratory factors 1 and 2 (NRF1 and NRF2), cyclic AMP-
responsive element binding protein 1 (CREB1), steroid hormone receptor (ERRα), 
peroxisome proliferator-activated receptors (PPARs). Both NRF1 and NRF2 regulate the 
transcription of TFAM, where ERRα promotes mitochondrial biogenesis in response to 
hormonal signals. However, the master regulator of mitochondria biogenesis, peroxisome-
proliferator-activated receptor – coactivator – 1 alpha (PGC-1α), is the key player that is 
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activating transcriptional factors that are later leading to increased synthesis of key enzymes 
in mitochondria. Those enzymes interact with TFAM in favor to replicate more mtDNA 
(Arnould, Michel, & Renard, 2015). The PGC-1 family is made up of three members: PGC-
1α, PGC-1β and PGC-related co-activator (PRC). Interestingly, mice lacking PGC-1α show 
disturbances exclusively upon stress. They have reduced exercise tolerance and a decrease in 
muscle mitochondria content and function. Moreover, they are failing to maintain their body 
temperature when exposed to cold (Spiegelman, 2007) .  This suggests that PGC-1α is 
important for mitochondrial biogenesis on demand and its lack could be compensated with the 
help of the other two members of the PGC-1 family. 
 
mTOR 
 
One of the examples of retrograde signaling is the energy deprivation stress response. 
An increased ratio of AMP/ATP in cell triggers the activation of AMPK kinase by 
phosphorylation of a specific threonine (Thr 172) residue. AMPK tends to restore energy 
balance by activating alternative metabolic pathways that generate ATP and on the other 
hand, switching off anabolic processes and the ones that consume ATP (Lin & Hardie, 2017). 
AMPK regulates PGC-1α, which induces mitochondrial biogenesis and more ATP is 
produced. Moreover, AMPK regulates the serine/threonine-protein kinase mammalian target 
of rapamycin (mTOR). There are two different mTOR complexes in mammalas – mTORC1 
and mTORC2. These two complexes are involved in different processes. While mTORC1 
regulates autophagy, translation and transcription, mTORC2 is associated with cell survival 
and proliferation (Arnould et al., 2015).  The pivotal function of mTORC1 is to promote 
anabolic processes through protein, lipid and nucleotide synthesis and to suppress autophagy. 
This is possible due to its downstream effectors, such as ribosomal S6 kinase (S6K), 
eukaryotic translation initiation factor 4E-binding protein (4E-BP) and unc-51-like autophagy 
activating kinase (ULK-1) (Rabanal-Ruiz, Otten, & Korolchuk, 2017). Under nutrient-rich 
conditions, mTORC1 kinase promotes growth by phosphorylation of S6K and 4EBP1.  
 
Autophagy  
 
When energy conditions are low, inhibition of mTORC1 leads toward autophagy by 
activation of ULK1 and different autophagy related proteins. The main role of autophagy is to 
reduce energy consumption when the cell is under restricted conditions. It is a highly 
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conserved process, which can be found in three forms: macroauotophagy, microautophagy 
and chaperone assisted autophagy (subsequently macroautophagy is termed as autophagy). 
This process involves the formation of a double-membrane autophagasome, which is fused 
with lysosome. Autophagy through organelle recycling is a way of saving energy. There are 
some types of selective autophagy such as: ER-phagy, ribophagy, pexophagy etc. Specific 
degradation of mitochondria is called ‘mitophagy’ and it recently came into focus. It has been 
noted that autophagy and mitophagy can be activated independently in yeast cells. Many 
mitophagy-specific genes were identified in yeast, among them Atg32 which is localized 
around mitochondria (Kanki & Klionsky, 2009). However, mitophagy genes are not 
conserved in higher species, even though there are some ‘functional homologs’ such as 
PTEN-induced putative kinase 1 (PINK1) and Parkin (Narendra, Tanaka, Suen, & Youle, 
2008). Autophagy and mitophagy differ in the final destination where the autophagosome will 
be recruited, for whose formation the inhibition of mTORC1 is required. The coordination 
between opposing processes such as mitophagy and mitochondrial biogenesis is essential for 
the cell to adjust to changing metabolic states, stresses and signals from the environment. 
Still, In vivo studies are needed to draw a clearer picture of the mitophagy process in higher 
organisms.  
 
1.3.1 Mitochondrial unfolded protein response (UPRmt) 
 
Eukaryote mitochondria developed several mechanisms for quality control in order to 
keep mitochondrial homeostasis and prevent cell death. One of them is an internal proteolytic 
system, which degrades misfolded or unfolded proteins. In situations where proteins get 
damaged or misfolded, it is crucial that they are turned over and removed, in order to prevent 
deleterious consequences on the cell. Since majority of the mitochondrial proteins are coded 
by nuclear DNA, translated in the cytosol and imported into the mitochondria, a system that 
precisely monitors this translocation is needed. Mitochondrial precursor proteins are kept in 
an unfolded state so they can be easily translocated across the mitochondrial membranes. The 
main challenge here is that precursor proteins in unfolded state are more prone to make 
aggregates, since their hydrophobic regions are exposed and unwanted protein-protein 
interactions are very likely to occur. This can be overcome by the action of chaperones, which 
are able to guide those precursors to the mitochondrial surface. Moreover, there is a specific 
set of chaperones in mitochondria that takes action once the protein enters this organelle. One 
of them is mitochondrial heat shock protein 70 (mtHsp70), also known as GRP75, which has 
		
	 10	
been shown to help the import of proteins with mitochondrial targeting signal and later on it 
allows the protein to find its correct tertiary structure by keeping it in an unfolded 
conformation (Horwich, Weber-Ban, & Finley, 1999).  Once the protein has been imported 
and its targeting sequence is cleaved off, it is refolded by heat shock protein 60 (HSP60) and 
his co-chaperonin 10 (HSP10) (Bross et al., 2007). HSP10 acts as a lid and regulates the ATP-
dependent activity of HSP60. Moreover, it has been shown that GRP75 interacts with HSP10 
independently of HSP60, promoting the biogenesis of its heptameric rings (Bottinger et al., 
2015). Mitochondria tend to produce misfolded proteins at a low level, but in times of 
extensive stress those proteins might accumulate and endanger mitochondria health. 
Therefore, mitochondria developed a specific defense mechanism called mitochondrial 
unfolded protein response (UPRmt) in order to alleviate proteotoxic stress. UPRmt   was 
primarily investigated in C. elegans (Yoneda et al., 2004). It has been shown that UPRmt can 
also be induced in mammalian cells by expression of truncated ornithine transcarbamoylase 
(ΔOTC) in the mitochondrial matrix. As the ΔOTC cannot fold properly, it forms aggregates 
signaling to the nucleus to transcribe genes encoding HSP60, HSP10 and additionally some 
proteases (Zhao et al., 2002). In C. elegans UPRmt acts through upregulation of heatshock 
protein 60 (hsp-60) and 6 (hsp-6), which are homologs of mammalian HSP60 and GRP75 
respectively. It has been shown that treatment of worms with ethidium bromide upregulates 
the expression of hsp-60 and hsp-6. This was due to depletion of mtDNA and therefore loss of 
single subunits of the multimeric complexes, which further increased the number of 
unassembled nuclear-coded partner subunits (Yoneda et al., 2004). In line with the previous 
finding, it has also been shown that disruption of mitochondrial translation leads to the 
activation of UPRmt. Moreover, translation inhibitors such as doxycycline or knockdown of 
ribosomal proteins induce UPRmt (Houtkooper et al., 2013). Additionally, perturbations of 
ETC caused by toxins or mutations were also shown to induce UPRmt  signaling (Durieux, 
Wolff, & Dillin, 2012; Feng, Bussiere, & Hekimi, 2001; Runkel, Liu, Baumeister, & Schulze, 
2013). Accumulated unfolded proteins are degraded by the Clp protease proteolytic subunit 
(ClpP), which in worms leaves small peptides that are later transported to the outer 
mitochondrial membrane (OMM) with the help of HAF-1 exporter. Those peptides trigger the 
translocation of the transcription factor ATFS-1, which contains both a nuclear and 
mitochondrial localizing sequence. Under basal, physiological conditions, this factor is 
transported to mitochondria and degraded by the LONP1 protease. However, when there is 
stress, ATFS-1 is traveling to the nucleus where it activates the expression of chaperone 
genes, OXPHOS assembly factors and glycolysis genes (Nargund, Pellegrino, Fiorese, Baker, 
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& Haynes, 2012). Interestingly, the activation of UPRmt can occur in a cell non-autonomous 
manner. It has been shown that mitochondrial dysfunction in neuronal cells in C. elegans can 
activate UPRmt in intestinal cells (Durieux et al., 2012).  
In line with both C.elegans and mammalian research, the ATF5 transcription factor 
was suggested as a mammalian homolog of ATFS-1. It has been suggested that ATF5 is 
necessary for the UPRmt activation in mammalian cells during mitochondrial stress (Fiorese & 
Haynes, 2017). Moreover, ATF5 was found to be transcriptionally upregulated in several 
mouse models of mitochondrial dysfunction. ATF5 was induced in the Deletor mouse, that 
carries a dominant mutation in the replicative helicase Twinkle gene. This mouse model 
displays mild mitochondrial myopathy with unaffected lifespan (Tyynismaa et al., 2010). 
Additionally, in our lab we showed recently that Atf5 was upregulated already in a very early 
stage in the heart-specific DARS2-deficient mouse, with severe mitochondrial dysfunction 
and strongly activated mitochondrial stress response (Dogan et al., 2014a). We also have 
demonstrated in our lab that CLPP is dispensable for the activation of UPRmt in mice. 
Moreover, the lack of CLPP improved the OXPHOS deficiency in DARS2 deficient hearts 
and extended the lifespan of the mice (Seiferling et al., 2016). Apart from increased Atf5 
expression, we detected a significant Atf4 and Chop-10 upregulation in our DARS2-deficient 
mice. These transcription factors belong to another line of defense in mitochondrial stress 
signaling which is known as integrated stress response (ISR). The mammalian UPRmt is 
intimately associated with the integrated stress response, while UPRmt activation requires 
eIF2α phosphorylation. On the contrary, in C. elegans the UPRmt does not require eIF2α 
phosphorylation. The attenuation of protein synthesis possibly reduces the nascent protein 
load in the matrix, so that chaperones and proteases may better promote proteostasis in 
these mitochondria (Melber & Haynes, 2018).  
 
1.3.2 Integrated stress response (ISR) 
 
Cells deal with many different sources of stress and accordingly use different 
mechanisms to adapt to the current state. The integrated stress response (ISR) is a common 
adaptive pathway that eukaryotic cells can activate in response to different stress stimuli. The 
main factor in this pathway is eukaryotic translation initiation factor 2 alpha (eIF2α), which 
when phosphorylated impedes global translation and shifts it towards the protein synthesis of 
very important factors needed for cellular recovery (Pakos-Zebrucka et al., 2016). Different 
physiological states and pathological conditions can activate this signaling pathway. There are 
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four different kinases that are leading to the phosphorylation of eIF2α, which are all activated 
by different stimuli. PKR-like ER kinase (PERK) is activated by endoplasmatic reticulum 
(ER) stress, which can be due to accumulated proteins, defects in calcium homeostasis etc 
(Harding, Zhang, & Ron, 1999). Another kinase is general control non-derepressable 2 
(GCN2) and it is activated in response to amino acid deprivation. Although, it has been shown 
that GCN2 is activated as a result of glucose deprivation, this is probably an indirect effect of 
amino acid overconsumption as a result of the low glucose level (Ye et al., 2010). The next 
kinase in the pathway, PKR, is activated by double-stranded-RNA (dsRNA), as a result of a 
viral infection (Lemaire, Anderson, Lary, & Cole, 2008).  The last kinase in ISR is heme-
regulated eIF2α kinase (HRI), which is mainly expressed in erythroid cells, unlike the other 3 
kinases, which are broadly distributed. This kinase is activated by heme-deficiency and it 
protects erythroid cells from toxic globin aggregates, which are accumulated in iron 
deficiency (Han et al., 2001). As a response to ISR activation, those kinases lead to 
phosphorylation of eIF2α, which results in the global attenuation of 5’-cap-dependent protein 
synthesis and preferentially translation of specific mRNAs that have an upstream open 
reading frame (uORF) within their 5’ untranslated region (5’ UTR). Those mRNAs contain 
internal ribosome entry sites (IRES) and the 40S ribosomal subunit can be directly recruited 
in the vicinity of the start codon, independently of 5’-cap recognition (Komar & Hatzoglou, 
2011).  One of those preferentially translated mRNAs is the ATF4 transcription factor, which 
belongs to the family of basic leucine zippers (bZIP) activating transcription factors 
(ATF/CREB family) (Ameri & Harris, 2008).  ATF4 is a master regulator of ISR, involved in 
many different functions such as energy expenditure, thermogenesis, glucose homeostasis, 
lipid metabolism, bone development and obesity regulation (C. Wang et al., 2010). ATF4 is 
upregulated upon stress and it is further activating the expression of stress-responsive genes. 
It can form homodimers and heterodimers with different transcription factors providing the 
further complexity of ISR regulation. One of those factors is CHOP, which together with 
ATF4 can induce autophagy upon starvation (B'Chir et al., 2013). The ISR must have its 
duration precisely controlled, and this is possible through the phosphatase GADD34, which 
dephosphorylates eIF2α (Novoa, Zeng, Harding, & Ron, 2001).  The scheme of ISR is 
presented in Figure 1.2.  
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Figure 2.2 Integrated stress response. 
Different stress stimuli are sensed through four different kinases that lead to phosphorylation of eIF2α. This 
leads to the repression of global protein synthesis and preferential translation of mRNA needed for the cell 
survival or cell apoptosis. ATF4 is the master transcription factor, which leads to the gene expression of pro-
survival genes (Pakos-Zebrucka et al., 2016).  
 
Cytosolic translation can be modulated during mitochondrial stress by the GCN2 
kinase, which can be stimulated by increased ROS, amino acid reduction or ribosome stalling 
(B. M. Baker, Nargund, Sun, & Haynes, 2012). The phosphorylation of eIF2α will follow and 
subsequently activation of ATF4, ATF5 and CHOP10. The functional relationship between 
those three proteins in mitochondrial stress is still unclear, even though it was shown before 
that transcription of Atf5 is controlled by ATF4 and CHOP10 out of the context of 
mitochondrial stress (Teske et al., 2013). ATF5 that is localized in the nucleus is able to 
activate mitochondrial-stress-response genes (Fiorese et al., 2016). A recent study 
demonstrated that none of the individual eIF2α –kinase knockdowns abolished ATF4 
induction in HeLa cells treated with FCCP (Quiros et al., 2017). Surprisingly, recent data 
from the Deletor mouse showed that mTORC1 activation stimulates ATF4 activity and 
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therefore it is implicated in ISR and furthermore, in UPRmt regulation (Khan et al., 2017). 
Mammalian models of mitochondrial dysfunction showed in addition that ATF4 promotes 
one-carbon metabolism, which is crucial for biosynthetic processes of nucleotides and amino 
acids (Bao et al., 2016). However, it is still not sure if the ATF4 response is adaptive or 
maladaptive. ATF4-dependent serine biosynthesis in respiratory chain deficiency might 
suggest an adaptive response by helping the cellular one-carbon availability. Also, 
transsulfuration represents another potential adaptive ATF4-response, since it promotes 
gluthathione synthesis, necessary for ROS scavenging (Bao et al., 2016; Nikkanen et al., 
2016). On the contrary, a recent study showed that inhibition of ATF4 is protective in rodents 
with intracerebral hemorrhage, pointing out possible maladaptive aspects of this transcription 
factor (Karuppagounder et al., 2016).  
The ISR pathway was shown to stimulate FGF21 expression. The activation of the 
eIF2α/ATF4 axis stimulates FGF21 transcription as a response to amino-acid deprivation, ER 
stress or mitochondrial dysfunction (De Sousa-Coelho, Marrero, & Haro, 2012; Keipert et al., 
2014; Schaap, Kremer, Lamers, Jansen, & Gaemers, 2013). Moreover, it was observed that 
the the muscle-specific overexpression of dynamin related protein 1 (DRP1) can activate the 
eIF2α/ATF4/FGF21 axis, which results in inhibition of muscle growth (Touvier et al., 2015). 
However, further studies are needed in order to decipher the precise role of FGF21 in 
mitochondrial dysfunction induced ISR.  
 
1.3.3 Quality control of mitochondrial proteostasis 
 
When chaperones fail to promote refolding of unfolded proteins, the proteases have 
the task to turn over the unfolded proteins in order to prevent the greater damage. The 
problem in mitochondria appears when there is an imbalance in the nuclear and mitochondrial 
encoded subunits of the respiratory chain (Reinecke, Smeitink, & van der Westhuizen, 2009). 
Furthermore, proteins can be damaged by reactive oxygen species (ROS), which can lead to 
loss of their function. Even though mitochondria have a specific system to alleviate ROS 
production by hosting a manganese superoxide dismutase (MnSOD) in their matrix, ROS can  
still cause protein modifications and consequently wrong folding. These proteins must be 
turned over by mitochondria’s proteolytic machinery (Wei, Miao, Yang, & Luo, 2008) .  
One of the proteases residing in the mitochondrial matrix is the LONP1 protease, 
which is conserved among prokaryotes and eukaryotes. It comprises three domains, an N-
terminal domain, central ATPase domain, and a C-terminal protease domain. The N-terminal 
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domain serves for oligomerization and protein substrate binding. The AAA+ domain is in the 
central part and it is involved in ATP binding and hydrolysis. The C-terminal domain owns 
the protease domain, which contains a serine and lysine dyad in the active site (Matsushima & 
Kaguni, 2012). LONP1 is in charge of elimination of oxidatively damaged or denaturated 
proteins (C. K. Suzuki, Suda, Wang, & Schatz, 1994). Moreover, mammalian LONP1 has 
been shown to degrade TFAM, aconitase and Fe/S protein (Bota & Davies, 2002). The 
findings have shown that Lon reduces TFAM and mtDNA levels and selectively degrades 
TFAM in order to regulate the levels of mitochondria transcription (Matsushima, Goto, & 
Kaguni, 2010). In humans, LONP1 was found to be involved in the regulation of respiration, 
removal of the oxidized proteins and protein quality control, since it cooperates with 
chaperones in order to keep the proteins unfolded prior to proteolysis (Bender, Lewrenz, 
Franken, Baitzel, & Voos, 2011). It has been demonstrated that levels of LONP1 decline in 
mice skeletal muscles with age (Bota, Van Remmen, & Davies, 2002). However, constitutive 
expression of Lon in the fungus Podospora anserine results in an increased life span without 
affecting growth and fertility (Luce & Osiewacz, 2009). 
Another protease present in the mitochondrial matrix is CLPP, which is also 
conserved from bacteria to higher organisms. This protease is part of larger complex together 
with CLPX, which is a chaperone necessary for substrate recognition. Together they form a 
CLPXP complex, whose homolog is absent in fermenting yeasts S. cervisae and S. pombe (Yu 
& Houry, 2007). In order to exert its role, CLPXP uses the energy of ATP hydrolysis. 
Therefore, it belongs to the special group of AAA+ proteases, which means it contains a 
conserved hetero-hexameric domain associated with the ATPase activity (Tatsuta & Langer, 
2009). After CLPX has recognized, bound and unfolded the substrate, it translocates it to the 
chamber where CLPP cleaves it. The proteolytic sites of CLPP are placed inside the barrel-
shaped-chamber, which is formed by two heptameric rings (Lee, Baker, & Sauer, 2010).  
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Figure 1.3 Mitochondrial proteases. 
Unassembled subunits and unfolded or damaged proteins are turned over by either i- or m-AAA proteases. 
Proteins that become damaged or unfolded in the mitochondrial matrix are degraded by Lon or ClpXP. OM – 
outer membrane; IMS – intermembrane space; IM – inner membrane (M. J. Baker, Tatsuta, & Langer, 2011). 
 
Apart from the soluble matrix proteases, mitochondria harbor special proteolytic 
machineries for membrane-integrated proteins. The inner mitochondria membrane is 
immensely rich in proteins and moreover, it houses the respiratory chain. Those proteins are 
prone to damage caused by ROS and therefore the system, which can regulate the degradation 
and turnover of the proteins, is highly in demand. The integrity of the inner membrane is 
controlled by the members of the FtsH / AAA family of proteases (filament-forming 
temperature-sensitive). They are building homo- or hetero-oligomeric complexes, which 
contain highly conserved subunits. Bacterial FtsH proteases are hexameric, barrel-like 
structures with an internal cavity containing proteolytic sites. Based on their topology, there 
are two classes of AAA complexes: i-AAA proteases, which are exposed to the 
intermembrane space, and m-AAA proteases, which are facing the matrix space (Tatsuta & 
Langer, 2009). This protease group builds homo-oligomeric structure anchored in membrane 
and facing the intermembrane space, comprising of Yme1 and YME1L subunits in yeast and 
mammalian mitochondria, repectively (Langer, Kaser, Klanner, & Leonhard, 2001). The i-
AAA proteases have been implicated to have a role in many processes, such as: mitochondrial 
fusion/fission (Rainbolt, Saunders, & Wiseman, 2015), quality control and transport of 
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intermembrane proteins and respiratory chain (Rainey et al., 2006), and UPRmt (Zhao et al., 
2002). The m-AAA protease in yeast exists as hetero-oligomeric structure comprising of 
Yta10 and Yta12 subunits (paraplegin and AFG3L2 in humans). Moreover, in human 
mitochondria, both homo-oligomeric (AFG3L2) and hetero-oligomeric (AFG3L2 and 
paraplegin) assemblies were found (Koppen, Metodiev, Casari, Rugarli, & Langer, 2007). 
AAA proteases defects are associated with different diseases. Mutations in the Spg7 gene, 
encoding paraplegin, cause neurodegenerative disorder – an autosomal recessive form of 
hereditary spastic paraplegia and mutations of Afg3l2 cause a dominant form of 
spinocerebellar ataxia (Casari et al., 1998; Di Bella et al., 2010). The clinical picture in the 
patients with Afg3l2 mutations is much more severe when compared to the patients with 
mutations in Spg7. This is due to the fact that Afg3l2 mutations affect both homo- and hetero-
oligomeric structures. Moreover AFG3L2 is more abundant than paraplegin (Koppen et al., 
2007). The m-AAA protease regulates mitochondrial calcium uniporter (MCU) assembly and 
mitochondrial calcium homeostasis (Konig et al., 2016). Additionally, it has been 
demonstrated that the m-AAA protease is responsible for the maturation of MRPL32, which is 
a mitochondrial ribosomal protein required for the assembly of ribosomes. A constitutive 
Purkinje cells Afg3l2 KO mouse in revealed a decrease in the rate of mitochondrial translation 
associated with deregulated ribosomal assembly. This later led to early-onset fragmentation of 
the mitochondrial network, which resulted in neurodegeneration (Almajan et al., 2012).  
 
1.3.4 Mitokines 
 
In C. elegans, induction of UPRmt in the nervous system can induce the same stress 
response in the distal tissue, such as intestine and prolonging the lifespan in that manner. 
Correspondingly, it has been hypothesized that this extension of the response to the distal 
tissues is due to specific soluble factors, which were named “mitokines”, diffusible 
moleculeas released from one tissue and inducing mitochondrial pro-longevity signals in 
distal tissues (Durieux et al., 2012). Later on, numerous factors were described as mitokines, 
since they were found produced and secreted in response to mitochondrial stress. The most 
prominent ones are Fibroblast Growth Factor 21 (FGF21) and Growth Differentiation Factor 
15 (GDF15) (Rose, Santoro, & Salvioli, 2017). The accent here is on the possibility of this 
proteins to function in a non-cell-autonomous manner, meaning that they could be produced 
in one tissue which is affected by stress and later on have an effect on another tissue, by 
improving its adaptive stress response.  
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Therefore, these factors can act in autocrine, paracrine and endocrine manner. 
However, it is still unknown if these soluble factors have exclusively beneficial effects or also 
detrimental ones. From previous data, one could hypothesize that mild mitochondrial 
dysfunction could have positive effects on longevity in animals as in humans, which is known 
as ‘mitohormesis’. The main idea behind mitohormesis is that the variety of mild stresses 
could be beneficial for an organism by making it less susceptible to detrimental effects of 
larger stresses thereby leading to increased longevity. (Yun & Finkel, 2014). Moreover, it is 
very interesting to note that in C.elegans activated stress responses, such as chaperone 
activation, xenobiotic detoxification or oxidative stress, are all coupled to increased longevity 
(Shore, Carr, & Ruvkun, 2012). The main question that remains is if that mitohormetic 
principle can be used for finding treatments for diseases.  
  
1.3.4.1 Growth differentiation factor 15 (GFD15) 
 
GDF15 is a member of the transforming growth factor beta (TGF β) family and 
recently it has been considered as a diagnostic marker for mitochondrial diseases. It is 
synthesized as a propeptide, which is later cleaved in ER and secreted as a mature protein. 
The secreted mature GDF15 is present in blood and cerebrospinal fluid, however the 
unprocessed forms were reported to be found in stroma (Bauskin et al., 2010).  The 
expression of this mitokine is upregulated by different stresses and stimuli. For instance, 
hypoxia was shown to activate the expression of GDF15 in different types of cancer (Krieg et 
al., 2010). Moreover, exposure to pro-inflammatory cytokines increased the expression of 
GDF15 in macrophages (Bottner, Suter-Crazzolara, Schober, & Unsicker, 1999). GDF15 
knockout mice have an increase in food intake and consequentially weigh more (Macia et al., 
2012). On the other hand, overexpression of GDF15 leads to decreased appetite by direct 
action on feeding centers in the brainstem and hypothalamus (Johnen et al., 2007). Moreover, 
it has been shown that GDF15 has cardioprotective effects. Under pathological conditions 
transgenic GDF15 mice deal partially better with cardiac stress. Furthermore, recombinant 
GDF15 treatment has beneficial effects on apoptosis in cultured cardiomyocytes (Kempf et 
al., 2006). Interestingly, different mouse models with mitochondrial dysfunction in skeletal 
muscle were shown to be protected from diet-induced obesity and they were more insulin 
sensitive. This suggested the existence of specific factors, which enables dysfunctional 
mitochondria in a given tissue to communicate with other tissues (Kim et al., 2013). In the 
Crif1 muscle-specific knockout mouse, GDF15 was found to be elevated and suggested to be 
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responsible for decrease of fat mass, improved insulin sensitivity and resistance to obesity 
(Chung et al., 2017). This suggested GDF15 as a potentially promising therapeutic agent for 
the obesity, caused by insulin resistance.   
A couple of studies have shown that GDF15 could be a good diagnostic marker for 
mitochondrial diseases. In a study where enucleated cells from patients carrying MELAS 
mtDNA mutation fused with cultureable cells, also known as cybrid cells, were used, 
expression levels of GDF15 were shown to be increased compared to control (Fujita et al., 
2015). Additionally, analysis of skeletal muscle of patients carrying a mutation in the 
thymidine kinase 2 gene, which causes mitochondrial myopathy, showed an increase in 
GDF15 (Kalko et al., 2014). Mitochondrial myopathy is one of the most common 
manifestations of mitochondrial disease in adulthood. The Deletor mice showed a plethora of 
robust transcriptional and metabolic stress responses, among which is also GDF15. The 
upregulation of GDF15 in Deletor mouse is a result of mTORC1 activation of ATF4, which 
leads to the increased expression of cytokines (Khan et al., 2017).   
 
1.3.4.2 Fibroblast growth factor 21 (FGF21) 
 
The second identified mitokine, FGF21, belongs to the family of fibroblast growth 
factors (FGFs), which have diverse role in signaling and development in many tissues. In 
mammals, there are 22 different FGFs, which can be autocrine, paracrine or endocrine. 
FGF21, together with FGF15/19 and FGF23 belongs to the endocrine family of FGFs, since 
they have a reduced affinity to heparin sulfate glycosaminoglycans (HSGAGs), which are 
sequestering the proteins to the extracellular matrix (BonDurant & Potthoff, 2018). FGF21 
binds a tyrosine kinase receptor FGFR, which, in mammals, exists in different isoforms (1b, 
1c, 2b, 2c, 3b, 3c, 4), that are tissue-specific (Kurosu et al., 2007). For the activation of FGFR 
by FGF21, the presence of a co-receptor β-Klotho (KLB) is necessary. KLB is a FGFR-
binding single-pass transmembrane protein and essential for endocrine effects of FGF21 (M. 
Suzuki et al., 2008). FGF19 and FGF21 both require KLB for their action, however, FGF19 
has more preferences for the FGFR4 isoform, while FGF21 preferentially binds FGFR1c and 
FGFR3c (X. Zhang et al., 2006). Concerning tissue specificity, FGF21 is predominantly 
expressed in liver, but its mRNA is also found in the other organs – thymus, pancreas, brain, 
white (WAT) and brown adipose tissue (BAT), skeletal muscle, testes, gastrointestinal tract 
and recently its expression in heart was detected (Fon Tacer et al., 2010). The expression 
levels in liver are impacted by many different factors, such as nutritional status, stress levels, 
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temperature etc. During fasting, fuel utilization is shifted from carbohydrates to ketone 
bodies. This involves other tissues, such as WAT, which is activating lipolysis and releasing 
free fatty acids (FFA) and glycerol into blood that enables ketogenesis and gluconeogenesis. 
On the other hand, lipid intake via suckling or consuming high-fat diet in mice, stimulates a 
raise of FGF21 in serum, which appears to be a result of increased blood concentrations of 
FFAs. Those FFAs activate PPAR α – dependent induction of FGF21 in liver (Inagaki et al., 
2007). It is interesting to note that in humans the elevation of plasma FFAs has a completely 
opposite effect – a decrease of FGF21 levels. This discrepancy might be due to the different 
rates in metabolism between mice and humans (Matikainen et al., 2012). Moreover, it has 
been shown that exercise induces hepatic FGF21 expression through lipolysis of adipose 
tissue and consequently fatty acid signaling which promotes ER stress in liver (Cuevas-
Ramos et al., 2012).   
One of the conditions where FGF21 is induced is metabolic stress. It has been also 
shown that many different types of cellular stress can lead to its induction, which is why 
FGF21 is often referred to as a “stress hormone”. Under mitochondrial stress, FGF21 
production is increased in skeletal and cardiac muscle, and BAT (Dogan et al., 2014b; Keipert 
et al., 2015). Strikingly, the physiological relevance of this extrahepatic FGF21 is still 
unknown. Increased expression of FGF21 was observed in many mouse models with 
mitochondrial dysfunction (Dogan et al., 2014b; Trifunovic et al., 2004; Tyynismaa et al., 
2010). In Deletor mouse, the expression of Fgf21 was increased 3-fold and moreover, 
circulating levels of FGF21 were found to be upregulated. Serum FGF21 had systemic effects 
on metabolism of the mice, copying the starvation mode features, such as weight loss, high-
fat diet (HD) induced obesity resistance, smaller adipocytes and lower hepatic fat content 
(Tyynismaa et al., 2010). Mitochondrial diseases are associated with dysregulated lipid 
metabolism and FGF21 has been proposed to regulate lipid usability. However, further 
research is needed to connect mitochondrial dysfunction and potential effects of FGF21. 
It has been observed that FGF21 plays a physiological role in thermogenic activity of 
WAT. Adipose-derived FGF21 has been shown to have both autocrine and endocrine role and 
it is capable of increasing UCP1, as well as other thermogenic genes in adipose tissue during 
cold response. Pharmacological doses of FGF21 managed to induce thermogenic response in 
both BAT and WAT, by stabilizing the PGC1α protein (Fisher et al., 2012). Moreover, 
FGF21 increases insulin sensitivity in primary brown adipocytes by facilitating glucose 
uptake. This effect has been lost in mice lacking the β-Klotho co-receptor in adipose tissue 
(BonDurant et al., 2017). It is interesting to note that different studies showed contradictory 
		
	 21		
data on the FGF21 and lipolysis in adipose tissue. In vivo studies showed that there is a 
difference in acute and chronic FGF21 administration. A single dose of recombinant FGF21 
lowers FFA concentration in blood and decreases the rate of lipolysis in WAT (Fisher et al., 
2010), while the chronic states, where FGF21 is up-regulated, lead to higher levels of FFAs 
and increased lipolysis (Hotta et al., 2009). More than that, FGF21 was shown to mediate 
many more physiological roles, for instance – appetite control in brain (Markan & Potthoff, 
2016), regulation of macronutrient intake (Tanaka & Kido, 2008), effects on growth and 
lifespan etc. (Inagaki et al., 2008).  
Until recently, it has been thought that FGF21 is not expressed in heart. This is due to 
the fact that cardiac expression of FGF21 occurs only during stress, such as ischemic insults, 
fasting, obesity, mitochondrial stress etc. (Salminen, Kaarniranta, & Kauppinen, 2017). Both 
endogenous and exogenous FGF21, has an anti-apoptotic role and protects against 
isoproterenol induced cardiac insult by promoting FAO, inducing anti-oxidative signaling and 
reducing inflammation (Planavila, Fernandez-Sola, & Villarroya, 2017; Planavila et al., 
2013). Interestingly, it has been also shown that FGF21 secreted from liver and adipose tissue 
can act as an endocrine protection in the ischemic myocardium (S. Q. Liu et al., 2013). As 
previously mentioned, FGF21 binds the FGFR1 receptor, using β-Klotho, which further 
activates the dimerization of the tyrosine kinase receptor. This induces autophosphorylation of 
the receptor and recruits and phosphorylates first adaptor protein – FRS2α. After 
phosphorylation of FRS2α, 4 different known pathways can be activated in cardiomyocytes 
(Figure 1.3). The first one is activation of the ERK1/2-CREB-Sirt1-PGC1α signaling cascade, 
which leads to the improved FAO by increasing the expression of MCAD (Planavila et al., 
2013). The second pathway is associated with the inhibition of NFkβ, which prevents 
activation of pro-inflammatory cytokines such as TNFα, IL6 and MCP1. The third pathway 
results in a decrease in cardiac fibrotic formation, and the fourth results in the reduction of 
oxidative stress (Planavila et al., 2013). Very little is known about cardiac function of FGF21 
in conditions of mitochondrial stress. DARS2 depletion in heart and skeletal muscle induces a 
250-fold increase in Fgf21 mRNA levels, but the function of it is still unknown (Dogan et al., 
2014). In addition, a mouse model, where the mitochondrial protein p32 was depleted in 
heart, has shown a 40-fold increase in Fgf21 mRNA levels. P32 is suggested to be a protein 
and RNA chaperone required for functional mito-ribosome formation (Saito et al., 2017). 
Also, Fgf21 mRNA upregulation was detected in the hearts of mtDNA mutator mice, which 
are displayed with dilated cardiomyopathy and this increase was even more pronounced when 
the mice were additionally depleted of UCP2 (Kukat et al., 2014) 
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Figure 1.4 FGF21 signaling in cardiomyocyte 
Intracellular pathways of FGF21 production and action on the heart. In response to ischeamic injury, 
cardiomyocytes induce the expression of FGF21. The transcriptional pathway that has been implicated in 
governing this process is the Sirt1–PPARα pathway. The FGF21 produced in cardiomyocites can be secreted in 
the bloodstream and has an action on the heart, through FGFR1- β-Klotho complex, which results in the 
activation of the ERK1/2 pathway. Phosphorylated CREB and p38-MAPK act through different intracellular 
mechanisms to exert protection against cardiac damage (Planavila et al., 2013). 
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1.4.  Mouse models of mitochondrial diseases caused by defects in 
mitochondrial translation 
 
Defects in mitochondrial translation cause a plethora of mitochondrial diseases, which are 
tissue specific and have a variety of clinical representations. These diseases are mostly 
featured by respiratory chain deficiency and they affect the high-energy consuming organs 
such as brain, heart, skeletal muscle and liver. The other tissues could be affected too, and this 
also contributes to the differential clinical picture of this subgroup of diseases. The 
mitochondrial defects in protein synthesis are caused by mutations in the genes for tRNAs, 
ribosomal proteins, ribosome assembly proteins, mitochondrial aminoacyl-tRNA synthetases, 
tRNA modifying enzymes and initiation, elongation and termination factors of translation.  
 
1.4.1 Aminoacyl-tRNA synthethases in mitochondrial diseases 
 
Aminoacyl-tRNA synthethases (aaRSs) are crucial enzymes in the initial steps of 
protein synthesis. They are the catalysts of a two-step reaction that charges tRNAs with their 
cognate amino-acid. In the first step, they activate the amino-acid with ATP, and an 
intermediate aminoacyl-adenylcyclate is formed. Secondly, they transfer the aminoacyl group 
to the 3’ end of a tRNA and release adenosine monophosphate (AMP) (Diodato, Ghezzi, & 
Tiranti, 2014). There are cytoplasmic and mitochondrial aaRSs, and the latter are always 
marked with “2” after the name. Mitochondrial aaRSs are coded by nuclear DNA and 
imported into mitochondria due to the presence of a mitochondria targeting sequence (MTS), 
located at the N-terminus of the precursor. Mt-aaRSs are highly conserved enzymes and there 
are in total 19 of them acting in mitochondrial translation, of which two – glycine (Gly) and 
lysine (Lys)-RS- are coded by the same gene as nuclear homologs.  
Knowing the magnitude of the translation machinery, it is not surprising that 
mitochondrial disorders caused by its impairment are genetically heterogeneous. All the 
known diseases caused by mutations in different mt-aaRSs are described in the table 1.1.  
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Table 1.1.  Mutations in mitochondrial aminoacyl-tRNA synthethases and their clinical 
manifestations. 
gene protein clinical picture onset reference 
DARS2 Mt aspartyl-tRNA 
synthethase 
Leukoencephalopathy with brain 
stem and spinal cord 
involvement and lactate 
elevation 
Childhood/ 
adulthood 
(van Berge et al., 
2012) 
RARS2 Mt arginyl-tRNA 
synthethase 
Pontocerebellar hypoplasia type 
6  
Perinatal (Edvardson et al., 
2007) 
YARS2 Mt tyrosyl-tRNA 
synthethase 
Myopathy, lactic acidosis and 
sideroblastic anemia (MLASA) 
Childhood ( Riley et al.) 
SARS2 Mt seryl-tRNA 
synthethase 
Hyperuricemia, pulmonary 
hypertension, renal failure and 
alkylosis (HUPRA) 
Perinatal (Belostotsky et al., 
2011) 
AARS2 Mt alanyl-tRNA 
synthethase 
Cardiomyopathy, cerebellar 
ataxia 
Childhood (Gotz et al., 2011) 
MARS2 Mt methionyl-tRNA 
synthethase 
Autosomal recessive spastic 
ataxia 
Childhood/ 
adulthood 
(Sasarman, 
Nishimura, 
Thiffault, & 
Shoubridge, 2012) 
HARS2 Mt histidyl-tRNA 
synthethase 
Perrault syndrome Childhood/ 
adulthood 
(Pierce et al., 
2011) 
LARS2 Mt leucyl-tRNA 
synthethase 
Perrault syndrome Childhood/ 
adulthood 
(Rivera et al., 
2013) 
FARS2 Mt phenylalanine-
tRNA 
synthethase 
Epileptic encephalopathy, lactic 
acidosis 
Perinatal (Elo et al., 2012) 
EARS2 Mt glutamyl-tRNA 
synthethase 
Leukoencephalopathy with brain 
stem and thalamus involvement 
and high lactate 
Early 
childhood 
(Steenweg et al., 
2012) 
VARS2 Mt valyl-tRNA 
synthethase 
Psychomotor delay, seizures, 
lactic acidosis 
Childhood (Pierce et al., 
2013) 
TARS2 Mt threonyl-tRNA 
synthethase 
Psychomotor delay, hypotonia Perinatal/ 
early 
childhood 
(Diodato, 
Melchionda, et al., 
2014) 
GARS Glycyl-tRNA 
synthethase 
Charcot-Marie-Tooth (CMT) 
disease, distal motor neuropathy 
Childhood/ 
adulthood 
(Seburn, Nangle, 
Cox, Schimmel, & 
Burgess, 2006) 
KARS Lysyl-tRNA 
synthethase 
Autosomal recessive CMT Childhood/ 
adulthood 
(Santos-Cortez et 
al., 2013) 
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1.4.1.1 DARS2 in mitochondrial diseases 
 
The importance of undisrupted protein synthesis in mitochondria is shown through 
different disease phenotypes. The first mutation in mt-aaRSs was discovered in 2007 in 
mtAsp-RS or Dars2 gene (Scheper et al., 2007). Mutations in Dars2 were found in patients 
with affected white matter tracts, leading to motoric dysfunction and cognitive impairment. 
The disease is now known as leukoencephalopathy with brain stem and spinal cord 
involvement (LBSL) (van Berge et al., 2012). LBSL is an autosomal recessive disease with an 
early onset. The symptoms may vary, but the main features of the disease are learning 
problems, cognitive decline, spasticity and progressive cerebral ataxia. In magnetic resonance 
spectroscopy of the affected patients, increased lactate in the white matter can be observed. 
The patients are usually compound heterozygotes, with a splice mutation on one allele and a 
variable mutation on the other one. The splicing mutation is in intron 2, therefore affecting the 
splicing of the exon 3, which leads to a frameshift and premature stop codon, creating a 
truncated protein. The second allele usually contains a missense mutation, although deletions 
and nonsense mutations were found in few patients (van Berge et al., 2012). Interestingly, 
Dars2 mutations affect the nervous system at the highest extent, but it is still not clear if the 
defect stems from the neuronal or glial cell dysfunction. It has been shown that mutations in 
intron 2 have more pronounced effect on neuronal cells compared to glial cells (van Berge et 
al., 2012; van Berge et al., 2014). We have recently shown that DARS2 depletion primarily 
affects forebrain neurons and it is dispensable for myelin-producing cells in mice. DARS2 
deficiency in both mouse models caused appearance of COX deficient cells, but only 
forebrain neurons were susceptible to cell-death, followed by neuroinflammatory response 
(Aradjanski et al., 2017). This was in agreement with previous study where mitochondrial 
perturbation caused by the loss of the COX10 in Schwann cells did not induce glial cell-death 
(Funfschilling et al., 2012).  
Another mouse model with DARS2 depletion in the heart and skeletal muscle has 
shown that this enzyme is essential for protein synthesis in both tissues. However, 
mitochondrial stress responses such as increased mitochondrial unfolded protein response 
(UPRmt), increased biogenesis, decreased autophagy and upregulation of the mitokine FGF21 
is only present in DARS2 depleted cardiomyocytes. The activation of these stress responses is 
likely induced by the perturbed proteostasis in mitochondria (Dogan et al., 2014a). The 
phenotype of these mice is featured with a strong clinical presentation, due to the failing heart 
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and robust decrease in lifespan. Interestingly, loss of CLPP in these mice extends their 
lifespan and improves the gross-phenotype due to slowed-down mitochondrial translation 
which possibly allows an augmented generation of OXPHOS subunits (Seiferling et al., 2016) 
  
1.4.2 CLPP in mitochondrial diseases 
 
Mitochondrial proteases are essential for mitochondria’s health and moreover, the 
general cell homeostasis. CLPP, as mentioned before, is necessary for the degradation of 
misfolded and damaged protein. This is important for proper mitochondrial function since 
many potential substrates of human CLPP are involved in energy metabolism, mitochondrial 
translation, and amino acids and fatty acids metabolism (Bhandari et al., 2018). The 
phenotype of the CLPP null mice is infertility in both males and females with reduced size in 
male testes and female ovaries. Other prominent features of these mice are sensorineural 
deafness and reduction in physical growth and motor activity. Moreover, adult CLPP null 
mice have both a lower body weight gain and a shorter stature (Gispert et al., 2013). Clpp 
mutations in humans cause Perrault Syndrome that is featured with hearing loss, ovarian 
failure and growth retardation. The lifespan of the CLPP deficient mice is not affected and 
they have a mild mitochondrial dysfunction (Jenkinson et al., 2013). CLPP expression was 
found increased in some metastatic cells and research on its cellular roles has revealed that 
this protease is important for the pathology of several human cancers, including cell viability, 
proliferation, and metastasis, but it is also highly tissue-specific (Bhandari et al., 2018). In our 
lab, we demonstrated that in the absence of CLPP, ERAL1 degradation is attenuated and it 
stays attached to the small ribosomal subunit, which further leads to an impaired 
mitoribosomal assembly and subsequently impairs mitochondrial translation (Szczepanowska 
et al., 2016). CLPP deficient mice show mild respiratory chain deficiency, with complex I 
being the most affected and they are protected from diet-induced obesity and show a 
significant decrease in body weight (Becker et al., 2018).  
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1.5. Objectives 
 
Mitochondrial dysfunction caused by impaired protein synthesis in mitochondria is 
featured with defective MRC. However, different stress responses are being activated even 
before the appearance of a respiratory chain deficiency. Heart and skeletal muscle specific 
Dars2-deficient mice show increased mitochondrial proteostasis already early in life, 
suggesting that there might be other mechanism than respiratory chain deficiency leading to 
the activation of stress responses. One of the genes expressed at the highest extent in the 
neonatal hearts of these mice is Fgf21. Its expression at 1 week of age is around 8-fold and 
reaching closely 250-fold upregulation at 3 weeks, persisting until the death of the mice. This 
implies that FGF21 might have a pivotal role in mediating mitochondrial stress responses 
seen in DARS2 deficient mice.  
Besides, an upregulation of Fgf21 expression is also observed in the hearts of CLPP 
deficient mice. CLPP deficiency leads to a milder phenotype and the lifespan of these mice is 
not altered. Together with that, the Fgf21 expression in heart does not reach more than 5-fold 
of the increase. Furthermore, the increase in expression of this mitokine has been observed in 
other mouse models with mitochondrial dysfunction (Tezze et al., 2017; Tyynismaa et al., 
2010) 
In order to elucidate the role of FGF21, we created and analyzed different double-
deficient mouse models. Heart and skeletal muscle specific Dars2-deficient mice were used to 
investigate the role of autocrine FGF21 in heart. The second model was lacking FGF21 in the 
whole body, with tissue-specific depletion of DARS2 and it was used to scrutinize if the 
endocrine role of FGF21 is dispensable. Finally, a full body knockout of CLPP and FGF21 
was created in order to examine the role of FGF21 in mild mitochondrial dysfunction. 
The work outlined here is a significant step for understanding the biology and role of 
FGF21 in mitochondrial dysfunction. 
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2. Materials and Methods 
2.1 Mouse experiments and animal care 
 
All mice procedures were conducted in compliance with protocols and approved by local 
government authorities (Bezirksregierung Köln, Cologne, Germany) and were in accordance 
with NIH guidelines. The mice (Mus musculus, C57B1/6) were housed in groups of 3 - 5 mice 
per cage at an ambient temperature of 22 – 24 oC and kept at a 12-hour light / 12-hour dark 
cycle in the pathogen-free animal facility of the CECAD Institute. Mice were sacrificed by 
cervical dislocation  
2.1.1 Mouse handling and breeding 
 
All the handlings and breedings of mice were performed according to Silver’s “Mouse 
genetics” (Silver, 1995). 
 
2.1.2 Mice 
 
For conducting this research, different mouse lines were used for creation of double-
knockout models. Previously described (Dogan SA., 2014) mitochondrial aspartyl-tRNA 
synthetase (Dars2) gene targeting was carried out as part of the International Knockout 
Mouse Consortium (KOMP) (information available at http://www.knockoutmouse.org, 
Project ID: 41773). The mice lacking Dars2 in both heart and skeletal muscle were generated 
by mating Dars2loxP/loxP animals with transgenic mice expressing cre recombinase under the 
control of muscle creatine kinase promoter (Ckmm-cre) (Larsson et al., 1998). Conditional 
targeting of Fgf21 loxP mice was carried out in the lab of Prof. Dr. David Mangelsdorf 
(Potthoff et al., 2009). Fgf21 loxP mice were ordered from The Jackson Laboratory (strain: 
B6.129S6(SJL)-Fgf21tm1.2Djm/J). Double-knockout mice, in heart and skeletal muscle, were 
generated by mating homozygous Dars2loxP/loxP;Fgf21oxP/loxP mice with triple heterozygous 
ones -  Dars2loxP/wt;Fgf21 loxP/wt, Ckmm-Cretg/wt. To generate full-body Clpp knockout mice, 
Clppfl/fl were mated with transgenic mice ubiquitously expressing Cre recombinase under 
control of the β-actin promoter, resulting in Clpp+/-mice. Heterozygous Clpp+/- mice were 
further intercrossed to obtain homozygous. For the generation of double deficient Clpp and 
Fgf21 knockout animals, Clppfl/fl Fgf21fl/fl mice were mated with transgenic mice ubiquitously 
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expressing Cre recombinase (β-actin Cre). 
 
2.1.3 Submandibular bleeding for blood collection 
 
The submandibular bleeding of mice was performed without anesthesia, using a lancet and 
collecting a couple of drops of blood. The blood samples were stored on the room temperature 
for 15 minutes and subsequently centrifuged at 13.000 rpm for 20 minutes. Resulting serum 
was stored at -80 oC.  
 
2.1.4 Glucose levels 
 
Glucose concentrations in fed state were measured after submandibular bleeding using 
glucose strips, which were read for absorbance in a reflectance meter (ACCU-CHEK AVIVA, 
Roche, Mannheim, Germany). 
 
2.1.5 FGF21 serum levels 
 
The levels of FGF21 in serum were measured with a Mouse/Rat FGF-21 Quantikine ELISA 
Kit (R&D Systems, Minneapolis, USA), using the provided instructions. 
 
 
2.2  Molecular biology 
 
2.2.1 Isolation of genomic DNA from mice ear clips 
 
Mice ear clips were incubated overnight in the lysis buffer (100 mM Tris-HCl pH 8.5, 5 
mM EDTA, 0.2% (w/v) SDS, 0.2 M NaCl, 500 mg/ml Proteinase K) in an agitating 
thermoshaker (Eppendorf, Hamburg, Germany) at 55 oC. DNA was precipitated by adding an 
equivalent volume of isopropanol (100%) and centrifuging at maximum speed for 20 minutes. 
After removing the supernatant, the pellet was washed with 70% (v/v) ice-cold ethanol and 
centrifuged at maximum speed for 15 minutes. After complete removal of ethanol, the pellets 
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were left to get dry under the hood, for approximately 5 minutes. Finally, the DNA pellets 
were resuspended in 100 µl dH2O by shaking at 37 °C for 1 h.  
 
2.2.2 Isolation of total RNA from mice tissues 
 
Total RNA was isolated using the TRIzol reagent (Life Technologies GmbH, Darmstadt, 
Germany). Tissues were dissected and around 100 mg was placed into Precellys (Bertin 
Technologies, Versailles, France) 1.5 ml tubes with beads. The tubes were filled with 1 mL of 
TRIzol reagent. The tissues were further homogenized in a Precellys 24 (Bertin Technologies, 
Versailles, France) fast-prep machine at 5500-6000 rpm for 2x30 seconds. The homogenates 
were transferred to new tubes and the chloroform phase separation followed. The further 
RNA precipitation was done according to the manufacturer’s instructions. 
 
2.2.3 Quantification of nucleic acids 
 
Both DNA and RNA concentrations were quantified by measuring the sample absorption 
at 260 nm and 280 nm with a NanoDrop ND-1000 UV-Vis spectrophotometer (Peqlab, 
Erlangen, Germany). The purity was accessed by the ratio of absorbance at 260 and 280 nm. 
The ratio for the pure DNA is around 1.8 and for the pure RNA – around 2.   
 
2.2.4 Polymerase chain reaction (PCR) 
 
Polymerase chain reactions (PCR) (Mullis and Faloona, 1987) were rendered using 
customized primers (Sigma Aldrich) listed in the Table 2.1. All amplification reactions were 
carried out using the Veriti Thermocycler (Applied Biosystems, Life Technologies). PCR 
reactions were performed in a total volume of 20 µL with approximately 50 ng DNA 
template, 1x DreamTaq Buffer (Thermo Scientific), 62.5 µM dNTP mix (Promega), 0.4 µM 
of each primer and 1U DreamTaq Polymerase (Thermo Scientific). PCR products were 
separated by gel electrophoresis on 2% (w/v) agarose (Sigma Aldrich) gels prepared with gel 
red (1:10) or ethidium bromide (1:20). PCR reactions were used to determine the genotypes 
of the mice. 
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Table 2.1 Oligonucleotides used for genotyping of the mice 
Gene Company Sequence (5’ – 3’) 
FGF21 Sigma® 
WT: 
forward: GGGCTCTGATAAAGCATTCC 
reverse: CAGCACTAAGGGAGGCAGAG 
KO: 
forward: CCTCCAGATTTAGGAGTGCAGA 
reverse: AGGGAGGCAGAGGCAAGTGATT 
CLPP Sigma® 
WT: 
forward: GTGGATGATGGTCAGTAGAATCC 
reverse: CCCAGACATGATTCCTAGCAC 
KO: 
forward: TGTGCATTCTTACCATAGTCTGC 
DARS2 Sigma® 
forward: ATGAATTCTAGGCCAGCCAC 
reverse: TGGCAATCTCTTAGGACTAAG 
CRE Sigma® 
Transgene forward: TAAGTCTGAACCCGGTCTGC 
Transgene forward 3’ Label: 
GTGAAACAGCATTGCTGTCACTT 
Internal pos. control forward: CAAATGTTGCTTGTCTGGTG 
Internal pos. control reverse: GTCAGTCGAGTGCACAGTTT 
  
 
PCR programs for Ckmm-cre, Dars2 and Clpp PCR started with 5 minutes of denaturation 
at 95 oC, followed by 35 cycles consisting of denaturation at 95 oC for 30 seconds, annealing 
(at 53 oC for Ckmm Cre, 61 oC for Clpp, 56 oC for Fgf21 KO and 60 oC for Dars2 ) for 30 sec 
and elongation at 72 oC for 30 sec, and a final elongation step at 72 oC for 5 min. For Fgf21 
WT the annealing temperature was decreased by 0.5 oC for each cycle. 
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2.2.5 Reverse transcriptase PCR and quantitative real-time PCR 
 
The total RNA that was previously isolated was treated with DNAse. 10 µg RNA in 1x 
DNase buffer and 2U DNaseI (NEB) at 37 oC for 10 min. This was further followed with the 
addition of 10 mM EDTA and heat inactivation of the DNase at 75 oC for 10 min. Digested 
RNA (100 ng µL-1 per sample) was reverse transcribed using the High capacity reverse 
transcription kit (Applied Biosystems, Life Technologies). So generated cDNA was amplified 
with Brilliant III Ultra-Fast SYBR QPCR Master Mix (Agilent Technologies, see Table 2.2). 
Real-time PCR was performed on QuantStudio K FlexSystem (Applied Biosystems, Life 
Technologies). Samples were adjusted for total RNA content by Hypoxanthine-guanine 
phosphoribosyltransferase (HPRT). Relative expression of mRNAs was determined using a 
comparative method (2−δδCT) according to the ABI Relative Quantification Method.  
 
 
Table 2.2 Oligonucleotides used for SYBR real-time PCR. 
gene forward primer reverse primer 
Hprt GCCCCAAAATGGTTAAGGTT TTGCGCTCATCTTAGGCTTT 
Ndufa9 GGCCAGCTTACCTTTCTGGAA GCCCAATAAGATTGATGACCACG 
Ndufb6 TGGAAGAACATGGTCTTTAAGGC TTCGAGCTAACAATGGTGTATGG 
Ndufs2 TCGTGCTGGAACTGAGTGGA GGCCTGTTCATTACACATCATGG 
Ndufv2 GGCTACCTATCTCCGCTATGA TCCCAACTGGCTTTCGATTATAC 
Sdha GAACACTCCAAAAACAGACCTGC TCCACCACTGGGTATTGAGTAG 
Uqcrc1 AGACCCAGGTCAGCATCTTG GCCGATTCTTTGTTCCCTTGA 
Ucp1 AGCCATCTGCATGGGATCAAA GGGTCGTCCCTTTCCAAAGTG 
Cidea TGACATTCATGGGATTGCAGAC GGCCAGTTGTGATGACTAAGAC 
Dio2 CAGCTTCCTCCTAGATGCCTA CTGATTCAGGATTGGAGACGTG 
Cdsn TTGCTGATGGCCGGTCTTATT GCCAGTCTTTCCAATGAGACAAG 
Scd3 GTTGCCACTTTACTGAGATACGC GAAGCCCTCGCCCATACTT 
Pparα AACATCGAGTGTCGAATATGTGG CCGAATAGTTCGCCGAAAGAA 
Pparγ CCTGAAGCTCCAAGAATACCA GCCTGATGCTTTATCCCCACA 
Pgc1α TATGGAGTGACATAGAGTGTGCT CCACTTCAATCCACCCAGAAAG 
Fgf21 GTGTCAAAGCCTCTAGGTTTCTT GGTACACATTGTAACCGTCCTC 
Atf4 GCAAGGAGGATGCCTTTTC GTTTCCAGGTCATCCATTCG 
Chop CTGGAAGCCTGGTATGAGGAT CAGGGTCAAGAGTAGTGAAGGT 
mtHsp70 TGGTGAGCGACTTGTTGGAAT ATTGGAGGCACGGACAATTTT 
Lonp1 ATGACCGTCCCGGATGTGT CCTCCACGATCTTGATAAAGCG 
Afg3l2 GTTGATGGGCAATACGTCTGG GACCCGGTTCTCCCCTTCT 
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Psat1 AGTGGAGCGCCAGAATAGAA CTTCGGTTGTGACAGCGTTA 
Phghd GACCCCATCATCTCTCCTGA GCACACCTTTCTTGCACTGA 
Fgf21 GTGTCAAAGCCTCTAGGTTTCTT GGTACACATTGTAACCGTCCTC 
Fgfr1 TATGTCCAGATCCTGAAGAC GAGAGTCCGATAGAGTTACC 
Fgf19 CCAGAGAACAGCTCCAGGAC TCCATGCTGTCACTCTCCAG 
Fgf23 TGGGCACTGCTAGAGCCTAT CTTCGAGTCATGGCTCCTGT 
Klb CTAAACCAGGTTCTTCAAGC GATCTGCTTGTAGTAATGAGC 
Sirt1 GCAGGTTGCAGGAATCCAA GGCAAGATGCTGTTGCAAA 
Nppa ATGGGCTCCTTCTCCATCA CCTGCTTCCTCAGTCTGCTC 
Nppb GGATCTCCTGAAGGTGCTGT TTCTTTTGTGAGGCCTTGGT 
Tfam AACCTTTGACACTCAGTTCATTTTTCT CAAGGCTCAAAAGGTCAACAGA 
Tnfα GGAACTGGCAGAAGAGGCACTC GCAGGAATGAGAAGAGGCTGAGAC 
Il6 CTCTGGGAAATCGTGGAAA CCAGTTTGGTAGCATCCATC 
Ilb GCACTACAGGCTCCGAGATGAAC TTGTCGTTGCTTGGTTCTCCTTGT 
Glut4 GAGCCTGAATGCTAATGGAG GAGAGAGAGCGTCCAATGTC 
Cd36 AGATGACGTGGCAAAGAACAG CCTTGGCTAGATAACGAACTCTG 
Igf1 AAATCAGCAGCCTTCCAACTC GCACTTCCTCTACTTGTGTTCTT 
Pdk4 AGGGAGGTCGAGCTGTTCTC GGAGTGTTCACTAAGCGGTCA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		
	 34	
2.3 Biochemistry 
 
2.3.1 Protein extraction from tissues 
Approximately 3 mm3 of tissues were used as the starting point. The dissected piece was 
placed into Precellys (Bertin Technologies, Versailles, France) 1.5 ml tubes with beads 
containing 500 µl of organ lysis buffer (50 mM HEPES, pH 7.4, 50 mM NaCl, 1% (v/v) 
Triton X-100, 0.1 M NaF, 10 mM EDTA, 0.1% (w/v) SDS, 10 mM Na-orthovanadat, 2 mM 
PMSF, 1x protease inhibitor cocktail (Sigma Aldrich) and if necessary 1x PhosSTOP 
phosphatase inhibitor (Roche)). The tissues were homogenized in a Precellys 24 (Bertin 
Technologies, Versailles, France) fast-prep machine at 5500 rpm for 2x30 seconds. After 
incubation on ice for 10 minutes, the samples were centrifuged at 13000 rpm for 45 minutes 
at 4 °C. The supernatant was transferred into a new tube and the protein concentrations were 
measured by Bradford reagent (Sigma Aldrich, Seelze, Germany), according to the 
manufacturer's instructions. The adipose tissue required one extra centrifugation step in order 
to remove the fat layer which was forming on the top of the samples. Proteins were stored at -
80 °C until used. 
 
2.3.2 Mitochondria isolation from heart  
 
The freshly dissected tissues for mitochondria isolation were transferred into a 50 ml 
falcon tube which includes 20 ml of mitochondria isolation buffer (MIB: 100 mM sucrose, 50 
mM KCl, 1 mM EDTA, 20 mM TES, 0,2% BSA free from fatty acids, pH 7.2). After the 
blood removal, the tissues were grinded using a razor blade. Furthermore, the pieces were 
transferred into a glass homogenizer tube and further processed with a Potter S homogenizer 
(Sartorius) at 1200 rpm with 10-15 strokes (1 mg/ml of Subtilisin A was added). The 
homogenate was transferred into 50 ml Falcon tube and centrifuged at 8500 g for 5 minutes at 
4 °C. The supernatant, with floating fat, was discarded and the pellet was resuspended by 
shaking in 30 ml MIB. Another centrifugation step (at 800 g for 5 minutes at 4 °C) was 
performed and this time the supernatant, comprising of mitochondria, was transferred into a 
new 50 ml tube. The supernatant was then centrifuged at 8500 g for 5 minutes at 4 °C to 
pellet mitochondria. The supernatant was decanted and the remaining pellet in resuspended in 
50 µl MIB without BSA. The concentrations were measured by Bradford reagent (Sigma 
Aldrich, Seelze, Germany) according to the manufacturer's instructions.  
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2.3.3 Blue Native polyacrylamide gel electrophoresis (BN-PAGE)  
 
BN-PAGE was conducted using the Novex Bis-Tris system (Life Technologies GmbH, 
Darmstadt, Germany) following the manufacturer’s instructions. For the mitochondrial 
complexes analysis, approximately 20-40 µg were lysed using 1% DDM. The lysed 
mitochondria were run on 4-16% Bis-Tris gradient gels. The transfer onto PDVF membranes 
was followed by immunodetection using antibodies for mitochondrial complexes. 
 
2.3.4 Western blot analysis 
 
Protein extracts were boiled for 5 min at 95 °C in Laemmli loading buffer (50 mM Tris-
HCl, pH 6.8, 2% SDS, 10% Glycerol, 1% β-mercaptoethanol, 12.5 mM EDTA, 0.02% 
Bromophenol Blue). Proteins were resolved on SDS polyacrylamide gels, which were in the 
range between 8% and 15%, depending on the size of protein. Protein marker (PageRuler™ 
Prestained Protein Ladder) was loaded in the first well of the gel. Wet transfer (Bio-Rad) for 3 
hours at 400mA was used for the proteins to pass to the nitrocellulose membrane. The 
membrane was later on stained with Ponceau solution in order to access the efficiency of the 
transfer. For the blocking, 5% non-fat dried milk in PBST or 5% BSA in TBST according to 
the antibodies was used. Membranes were further incubated in the primary antibodies at 4 °C 
overnight (Table 2.3). After washing the membranes three times in PBST or TBST for 5 min 
each, membranes were incubated for 1 h at RT with the respective secondary antibody 
(diluted 1:2000, Sigma Aldrich). Again membranes were washed three times in PBS-T or 
TBS-T and signals were visualized using ECL solution (GE Healthcare) and exposition to X-
ray films (Fujifilms). Films were developed in an automatic developer (Kodak). Western blots 
were quantified using the ImageJ software 
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Table 2.3 Primary antibodies used for immunodetection. 
 
Antigen Company  Dilution 
GLUT-4 Millipore 1:1000 
HSP60 BD Biosciences 1:1000 
ClpP Sigma Aldrich 1:1000 
HSC 70 Santa Cruz 1:10000 
Grp75 Abcam 1:1000 
LONP1 Abcam 1:1000 
ATF5 Abcam 1:1000 
ATF4 Santa Cruz 1:1000 
TRAP-1 BD Biosciences 1:1000 
ERAL-1 Abcam 1:1000 
NDUFA9 Molecular Probes 1:1000 
NDUFB6 Invitrogen 1:5000 
NDUFS2 Abcam 1:2000 
NDUFS3 Mitosceinces 1:1000 
NDUFV2 Proteintech 1:2000 
SDHA Invitrogen 1:10000 
UQCRC1 Invitrogen 1:5000 
UQCRFS1 Mitosceinces 1:1000 
COX1 Invitrogen 1:2000 
COX4I1 Invitrogen 1:2000 
ATP5A1 Mitosceinces 1:1000 
MnSOD2 Millipore 1:1000 
PGC-1alpha Santa Cruz 1:1000 
Akt Cell Signaling  1:1000 
Phospho-Akt Cell Signaling  1:1000 
LC-3 Cell Signaling  1:1000 
TOM20 Santa Cruz 1:1000 
UCP2 (C-20) Santa Cruz 1:1000 
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Antigen Company  Dilution 
OAT Abcam 1:1000 
EIF2S1 Abcam 1:1000 
EIF2S1-Phospho S51 Abcam 1:1000 
ACADS  Santa Cruz 1:1000 
ACADVL  Santa Cruz 1:1000 
MCAD Santa Cruz 1:1000 
GDF-15 Santa Cruz 1:1000 
MTHFD-2 Abcam 1:1000 
OXPHOS cocktail Abcam 1:1000 
Klotho ß R&D Systems 1:500 
TFAM  Courtesy of N.Larsson’s Lab 1:1000 
AFG3L2 Courtesy of E. Rugarli’s Lab 1:1000 
VDAC Cell Signaling  1:1000 
AMPK Cell Signaling  1:1000 
Phospho-AMPK Cell Signaling  1:1000 
Beclin Cell Signaling 1:1000 
Sirt-1 Cell Signaling 1:1000 
UCP1 Courtesy of N.Larsson’s Lab 1:1000 
Calnexin Calbiochem 1:2000 
Ubiquitin BD Biosciences 1:1000 
PRAS-40 Cell Signaling  1:1000 
Phospho-PRAS-40 Cell Signaling  1:10000 
4EB-P1 Cell Signaling  1:1000 
Phospho- 4EB-P1 Cell Signaling  1:1000 
CPT-1 Santa Cruz 1:1000 
MRPS35  Proteintech 1:1000 
Phospho-ERK1/2 Cell Signaling  1:1000 
Tubulin Sigma Aldrich 1:5000 
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2.4  Histological Analyses 
 
2.4.1 Cryostat sections 
 
For fresh-frozen sections, tissues were directly isolated after sacrificing the animals, 
directly embedded in Tissue-Tek (Sakura, Alphen aan den Rijn, The Netherlands) and placed 
onto dry ice until they froze. Frozen tissues were cut on a Leica CM1850 cryostat with a 
thickness of 7 µm. Sections were directly mounted onto microscope slides and stored at -20 
°C. 
 
2.4.2 COX-SDH staining 
 
COX-SDH staining was performed on fresh-frozen sections, which were air-dried for half 
an hour after removal from the -80 °C. Firstly, COX staining solution (0.8 ml 3,3 
diaminobenzidine tetrahydrochloride, 0.2 ml 500 µM cytochrome c, a few grains of catalase) 
was applied in amount to cover the sectioned tissue and incubated in a humid chamber at 37 
°C for 40 minutes. After the washings step with PBS, sections were further incubated in SDH 
staining solution (0.8 ml 1.875 mM Nitroblue tetrazolium, 0.1 ml 1.3 M sodium succinate, 0.1 
ml 2 mM Phenazine methosulphate, 0.01 ml 100 mM Sodium azide) for half an hour at 37 °C 
and consequentially washed in PBS, dehydrated with increasing ethanol concentration (75% 
for 2 minutes, 95% for 2 minutes, 100% for 10 minutes), air dried, and mounted in D.P.X. 
(VWR, Darmstadt, Germany).  
 
2.4.3 Hemotoxylin and Eosin staining (H&E Staining) 
 
H&E staining, used for a morphology overview, was applied on paraffin sections of 
adipose tissue. The adipose tissues were fixed in 4 % PFA in PBS overnight at 4 °C. The 
following day, the tissues were transferred into fresh PBS and dehydrated (Leica ASP200S) 
using increasing concentrations of ethanol (30 %, 2 h; 50 %, 2 h; 96 %, 1 h; 100 %, 4 h). 
After 4-hour-incubation in Xylol, the samples were incubated in paraffin for 4 h at 62 °C, 
followed by embedding (Leica EG1150H).  Furthermore, embedded tissues were cut with the 
thickness of 5 micrometers using microtome (Leica RM2255) and transferred onto Polysine 
microscope glass slides (VWR). After an overnight incubation at 37 °C, the samples were 
		
	 39		
deparaffinized (20 min Xylol, 2 min 100 % EtOH, 2 min 96 % EtOH, 2 min 75 % EtOH, 1 
min tap water) and stained 
in hematoxylin for 4 minutes, followed by a short wash in tap water. Additionally, the 
sections were incubated in tap water for 15 minutes, short washed in deionized water and 
stained in Eosin for 1 minute. Next, the tissues were transferred into deionized water and 
drained in an increasing ethanol row (75 % EtOH, 1 min; 96 % EtOH, 1 min; 100 % EtOH, 1 
min; Xylol, 1 min). Eventually, the samples were mounted with Entellan and glass coverslips. 
Finally, the stained sections were visualized in 20 x magnification (Leica SCN400 slide 
scanner & Client software). 
 
2.4.4 Oil red O staining 
 
Oil red O (ORO) staining is used for the visualization of fat content and it was performed on 
adipose tissue cryosections. The sections were air dried for 10 min and surrounded with a 
PAP pen (Sigma-Aldrich). The staining involved sections being covered with ORO solution 
for 5 min and counterstained with Mayer’s Hematoxylin for 30 sec. The slides were then 
rinsed under running tap water before they were mounted with FluorSave Reagent 
(Calbiochem). 
 
 
2.5  Proteomics analyses 
 
2.5.1 In-solution digest 
 
Heart and liver tissues were both used for label-free quantification of the proteome. First of 
all, the tissues were disrupted using liquid nitrogen and dissolved in 8M Urea buffer, with the 
addition of 1x proteinase inhibitor. After acetone-precipitation, 50 µg of proteins was used for 
the digestion. The heart samples that were used for phospho-proteomics analyses were 
additionally containing phosphatase inhibitor and 500 µg was used for the digestion. Proteins 
were reduced by one-hour incubation with 5mM dithiothreitol at 37 °C and thiols were 
carboxymethylated with 10 mM iodoacetamide for 30 minutes. The digestion with Lys-C at 
37 °C for 4 hours followed and, in the end, samples were left overnight with trypsin at 37 °C. 
The digestion was stopped with 1% formic acid the next day. StageTip purification of the 
samples was performed according to the CECAD proteomics facility instructions.  
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2.5.2 Serum proteomics 
 
7 µL of serum that was collected as previously described in 2.1.3, was handed  
to the CECAD proteomics facility and further used for analyses. 
 
2.5.3 Mass-spectrometry 
 
  The label-free proteomic profiling of heart and liver tissues was performed in the CECAD 
proteomics facility according to the provided protocols. The mass spectrometry (LC-MS/MS) 
device was made up of an EASY n-LC1000 (Thermo Scientific) linked via a nano-
electrospray ionization source (Thermo Scientific) to an ion-trap based bench top Q-
Executive Plus (Thermo Scientific). The experiment and data analysis were performed by the 
CECAD proteomics facility.  
 
2.6  Computer analyses 
 
2.6.1 Statistical analyses 
 
Statistical significance of data sets with two independent groups were analyzed for using 
two-tailed unpaired Student’s t-test. Data sets with more than two groups were analyzed using 
one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test. All p-values 
below 0.05 were considered statistically significant; *p <0.05, ** p< 0.01, ***p< 0.001, 
****p< 0.0001. All data are presented as mean ± SD. 
 
2.6.2 Software 
 
  Statistical analysis and data visualization were managed using Microsoft Excel and 
Graphpad Prism 6 (Graphpad Software). Figures and Illustrations were prepared with Adobe 
Illustrator CS4 (Adobe Systems). For the enrichment of proteomics data, Bioconductor, 
Enrichr and Reactome software were used.  
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2.7  Chemicals and biological material 
 
Table 2.5 Chemicals 
 
Chemical Supplier 
β-mercaptoethanol Sigma Aldrich 
Acetic acid AppliChem 
Catalase, bovine liver Sigma Aldrich 
Acryamide-Bisacrylamide 40 Carl Roth 
Agarose LE Ambion 
Albumin from bovine serum fatty acid free 
(BSA) 
Sigma Aldrich 
Ammonium bicarbonate Sigma Aldrich 
Ammonium persulfate (APS) Sigma Aldrich 
Bromophenol blue Merck 
Coomassie Brilliant Blue R-250 Merck 
Cytochrome C, bovine heart Sigma Aldrich 
Diaminobenzidine tetrahydrochloride (DAB) Sigma Aldrich 
Dithiothreitol (DTT) Sigma Aldrich 
Ethanol AppliChem 
Ethylenediaminetetraacetic acid (EDTA) Sigma Aldrich 
Glucose Merck 
Glycerol Sigma Aldrich 
Glycine AppliChem 
HEPES AppliChem 
Hydrochloric acid (HCl) VWR 
Isopropanol AppliChem 
Magnesium sulfate (MgSO4) Merck 
Methanol AppliChem 
Milk powder AppliChem 
Monopotassium phosphate (KH2PO4) Sigma Aldrich 
Nitrotetrazolium blue (NTB) Sigma Aldrich 
Paraformaldehyde Sigma Aldrich 
Phenazine methosulphate (PMS) Sigma Aldrich 
Polyethylenglycol Sigma Aldrich 
PonceauS Sigma Aldrich 
Potassium chloride (KCl) Sigma Aldrich 
Potassoium hydroxide (KOH) Sigma Aldrich 
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Sodium azide Sigma Aldrich 
Sodium chloride (NaCl) Sigma Aldrich 
Sodium dodecyl sulfate (SDS) AppliChem 
Sodium fluoride (NaF) AppliChem 
Sodium hydroxide (NaOH) AppliChem 
Sodium orthovanadat AppliChem 
Sucrose Sigma Aldrich 
Tetramethylethylenediamine (TEMED) Sigma Aldrich 
Tris Sigma Aldrich 
Triton X-100 Sigma Aldrich 
Trizma Base Sigma Aldrich 
Tween-20 VWR 
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3. Results 
 
3.1. Tissue-specific depletion of FGF21 under Ckmm-Cre promoter does not 
influence the overall phenotype of the DARS2-deficient mice. 
 
To decipher the in vivo role of FGF21 in DARS2-deficient hearts, where the immense 
mRNA upregulation of this cytokine was shown (Dogan et al., 2014), FGF21 was selectively 
deleted in a tissue-specific manner. Using Ckmm-promoter driven Cre recombinase, both 
Dars2 and Fgf21 were deleted in heart and skeletal muscle. Dars2 conditional gene targeting 
was conducted in the context of the International Knockout Mouse Consortium (KOMP) as 
previously reported (Dogan et al., 2014). The fibroblast growth factor 21 (Fgf21) gene 
targeting was carried out in the lab of Prof. David Mangelsdorf that was described earlier 
(Potthoff et al., 2009). 
 
 
Figure 3.1 Breeding scheme for generation of double-knockout mice. 
Heterozygous mice Dars2 loxP/wt; Fgf21 loxP/wt; Ckmm-Cre tg/wt were mated with the homozygous mice 
Dars2 loxP/loxP; Fgf21 loxP/loxP. 
 
Double-knockout mice (DKO_fl), in heart and skeletal muscle, were generated by 
mating homozygous Dars2loxP/loxP;Fgf21oxP/loxP mice with triple heterozygous ones -  
Dars2loxP/wt;Fgf21 loxP/wt, Ckmm-Cretg/wt (Figure 3.1). Finally, 4 different genotypes were 
obtained and used for the next experiments. As a Wt, we used all the mice without Ckmm-Cre 
transgene; Dars2loxP/wt;Fgf21 loxP/loxP, Ckmm-Cretg/wt is further reffered as fgf21_fl; 
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Dars2loxP/loxP;Fgf21 loxP/wt, Ckmm-Cretg/wt is further reffered as dars2_fl and 
Dars2loxP/loxP;Fgf21 loxP/loxt, Ckmm-Cretg/wt is referred in the text as dko_fl. 
        
 
Figure 3.2 Heart to body weight ratio stays unchanged with the depletion of FGF21 in cardiac 
and skeletal muscle of DARS2 deficient mice. 
(A) Relative expression levels of Fgf21 in hearts of the 6-week-old mice (n=5) (B) Heart to body weight ratio in 
mice at 3-4 weeks of age (n=6). (C) Heart to body weight ratio in mice at 6 weeks of age (n=20). (D) Photos 
representing the size of hearts at 6 weeks of age in designated genotypes. Data are presented as mean ± SD 
(***P<0.001; **** P<0,0001; one-way ANOVA, Tukey’s post hoc test). 
 
We showed earlier that Dars2 deletion in heart leads to a severe cardiomyopathy, 
which causes death at 7-8 weeks of age (Dogan et al., 2014). As a primary stress response, an 
immense Fgf21 mRNA upregulation was observed, starting at 1 week of age. The increase 
was further intensified at 3 and 6 weeks of age. This suggested that FGF21 might have a 
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pivotal role in mediating stress responses in DARS2-deficient hearts. In the double knockout 
model, both Fgf21 and Dars2 deletion in heart and skeletal muscle was mediated by the 
Ckmm promoter that triggers activation of Cre after embryonic day 15.5 (E15.5) (Lyons et al., 
1991). Interestingly, these double knockout mice were not different from the Dars2 KO 
animals concerning the lifespan and gross phenotype. Fgf21 expression levels were strongly 
upregulated in DARS2-deficient hearts, and its expression was absent in DKO_fl (Figure 
3.2A). Heart to body weight ratio both at 3 and 6 weeks of age was not significantly different 
between DARS2-deficient mice and the DKO_fl mice (Figure 3.2B-C). The heart size was 
not affected by the depletion of FGF21 (Figure 3.2D).  
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3.2. The severity of cardiomyopathy is not affected by additional depletion of 
FGF21 in DARS2-deficient hearts. 
 
 
 
Figure 3.3 Cardiomyopathy levels are not affected by the depletion of FGF21. 
(A) Relative expression levels of cardiomyopathy markers (Nppa, Nppb) in 6-week-old mice (n=5). (B) Western 
Blot analysis of GDF15 levels in total protein extracts from heart (n=3).  
Data are presented as mean ± SD (*P<0.05,  ***P<0.001; one-way ANOVA, Tukey’s post hoc test). 
 
In order to access the molecular phenotype of the cardiomyopathy, the expression 
levels of hypertrophy markers were measured in the hearts of mice. Natriuretic peptides A 
(Nppa) and B (Nppb) were measured using real-time PCR and while Nppa levels were 
increased in both DARS2- and FGF21-deficient hearts, Nppb levels have not showed the 
same trend. However, there was no difference in Nppa levels between Dars2 KO and DKO_fl 
mice (Figure 3.3A). This further suggested that there might be some compensation from 
different cardiomyokines, therefore the protein levels of GDF15 were measured by Western 
Blot. GDF15 has been given the role of cardiomyokine, which could also improve the 
metabolic state of an organism and affect the stress response pathways Interestingly, protein 
levels were not affected in any of the knockout mice (Figure 3.3B). Even though the overall 
HSC70 	
GDF15 	
HSC70 	
GDF15 
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phenotype of the DARS2-deficient mice was not affected by FGF21 depletion, further 
analyses of DKO_fl mice were performed due to the possibility that this cytokine could affect 
metabolic and stress response pathways. 
 
3.3. Strong respiratory chain deficiency in DARS2-deficient hearts is not 
further aggravated, nor improved by additional FGF21 depletion.  
 
It has been shown earlier that CI and CIV of mitochondrial respiratory chain were 
severely affected in DARS2-deficient hearts (Dogan et al., 2014). To investigate if the 
OXPHOS was affected with the additional  topical depletion of FGF21, complexes were 
separated by Blue-native polyacrilamide-gel electrophoresis (BN-PAGE). Interestingly, the 
levels of CI and CIV were decreased to the same level in DARS2-deficient and DKO_fl mice 
(Figure 3.4A). Furthermore, the steady-state levels of different OXPHOS subunits were 
measured by Western Blot analyses and led to the same result, confirming once more that 
FGF21 depletion does not affect the functionality of mitochondrial respiratory chain (Figure 
3.4B) . As an additional outlook, an enzymatic COX/SDH staining was performed on the 
heart cryosections. This staining has shown a decrease in cytochrome c oxidase (COX) 
activity in both DARS2-deficient and DKO_fl hearts, which is represented by the blue colour 
coming from succinate dehydroganese activity (SDH) which can penetrate when COX 
activity is decreased (Figure 3.4C).  
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Figure 3.4 Characterization of mitochondrial respiratory chain deficiency by different methods 
shows no effect of FGF21 depletion. 
 (A) Blue-native PAGE (BN-PAGE) analysis of respiratory chain complexes in the heart mitochondria from 6-
week-old mice. (B) Western Blot analysis MRC steady state levels from total heart extracts (n=3). (C) COX-
SDH enzymatic histochemical double staining of fresh-frozen hearts (size: 7 µm). 
 
It is interesting to note that in previous work on DARS2-deficient hearts it was shown 
that respiratory chain subunits were not overall decreased at 3 weeks of age. Moreover, 
DARS2-deficient mice show no drastic changes in phenotype compared to WT mice at 3 
weeks of age (Dogan et al., 2014). In this study, additional subunits of CI were checked, and 
they showed the decrease in their levels already at 3 weeks of age (Figure 3.5). However, 
every change observed is due to the DARS2 depletion exclusively. NDUFA9, a subunit of CI, 
show no changes at the 3 weeks of age, in contrast to NDUFS4, which is already severely 
decreased at this point (Figure 3.5A). On the other hand, steady-state levels of other 
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complexes show DARS2-dependent changes. CIII subunit RIESKE show much more drastic 
decrease in DARS2 and DKO hearts than Core1 CIII subunit (UQCRC1). Both COXI and 
COXIV, which are subunits of CIV, show decrease when DARS2 is absent in the heart at the 
3 weeks of age (Figure 3.5B). Moreover, TFAM levels, which could suggest the equivalent of 
mitochondrial biogenesis, stay unchanged at 3 weeks of age (Figure 3.5C). Taken together, 
these data clearly show that FGF21 depletion does not influence the MRC levels regardless of 
the age and overall state of the animals. On the other hand, DARS2 depletion in the heart 
affects the steady-state levels of some OXPHOS subunits already at 3 weeks of age. 
 
 
 
Figure 3.5 Steady-state levels of MRC subunits in hearts of 3-week-old mice show no changes 
upon FGF21 depletion. 
(A) Western Blot analysis of indicated complex I subunits from total heart extracts (n=3). (B) Western Blot 
analysis of MRC steady state levels from total heart extracts (n=3). (C) Western Blot analysis TFAM levels from 
total heart extracts (n=3). 
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3.4. Mitochondrial and cellular stress responses seen in DARS2-deficient hearts 
do not depend on the presence of FGF21. 
 
Increased mitochondrial biogenesis is often a compensatory mechanism for the 
respiratory chain deficiency, when cell will try to produce more mitochondria in order to 
increase its energetic capacity. To investigate if the mitochondrial biogenesis is occurring, 
multiple methods are necessary for an end confirmation. In the previous study of DARS2 
deficient hearts, citrate-synthase activity assay, mtDNA levels, PGC1α and TFAM expression 
were measured to confirm the increased biogenesis (Dogan et al., 2014). In this study, the 
PGC1α and TFAM protein and expression levels were analyzed (Figure 3.6A-B). 
Interestingly, both PGC1α and TFAM are mildly increased at the protein level in both DARS2 
deficient and DKO_fl hearts (Figure 3.6A), but decreased at mRNA level (Figure 3.6B).  
Pgc1α expression is significantly decreased in DKO_fl hearts, when compared to the WT. 
 
 
Figure 3.6 Protein and expression levels of PGC1α and TFAM, which are involved in 
mitochondrial biogenesis.  
(A) Western Blot analysis of PGC1α and TFAM from total heart extracts of 6-week-old mice (n=3). (B) Relative 
expression levels of Pgc1α and Tfam in heart extracts (n=5). Data are presented as mean ± SD (*P<0.05, 
**P<0.01, ***P<0.001; one-way ANOVA, Tukey’s post hoc test). 
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Taken together, further analyses would be necessary to conclude if mitochondrial biogenesis 
is affected by the FGF21 depletion. 
 
Furthermore, the translational defect in DARS2-deficient hearts was shown to affect 
mitochondrial proteostasis. This leads to the activation of UPRmt. As shown before, DARS2 
depletion in heart leads to the upregulation of proteases LONP1 and AFG3L2 and increased 
levels of mitochondrial chaperones HSP60 and GRP75. Seeing that proteostasis response is 
activated already at 3 weeks of age has led to the clue that there is something other than MRC 
deficiency mediating all the stress responses (Dogan et al., 2014). As FGF21 was one of the 
primarily upregulated parameters, it was necessary to check if this protein might have 
influence on the proteostatic response. Expression levels of Lonp1 and Afg3l2 were increased 
in a DARS2-dependent manner (Figure 3.7A), since FGF21 depletion has not induced any 
changes. Moreover, Hsp60 levels were not even affected by the DARS2 depletion (Figure 
3.7A). On the protein level, proteases LONP1 and AFG3L2 (not shown) were upregulated in 
both DARS2 deficient and DKO_fl hearts, followed by increase in GRP75 protein levels. 
HSP60 levels were not increased significantly, which is also in agreement with its mRNA 
levels (figure 3.7B). In conclusion, FGF21 has no influence on proteostasis, which is 
unbalanced in DARS2 deficient hearts.  
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Figure 3.7 Protein and expression levels of mitochondrial proteases. 
(A) Relative expression levels of Lonp1 and Afg3l2 in heart extracts (n=5). (B) Western Blot analysis of LONP1 
from total heart extracts of 6-week-old mice (n=3). Data are presented as mean ± SD (*P<0.05; one-way 
ANOVA, Tukey’s post hoc test). 
 
From the previous data shown here, it could be hypothesized that mitochondrial 
stresses are over-activated in DARS2-deficient hearts and the effects of FGF21 are not visible 
due to the possible stress overload. This could point out that some higher levels of regulation 
still could be affected and therefore cellular stresses needed an examination. Integrated stress 
response (ISR) is regulated through the phosphorylation of translational initiation factor alpha 
(eIF2a). When phosphorylated, the global translation is attenuated and internal ribosome 
entry sites (IRES) - containing mRNA are preferentially translated, which means that only 
proteins needed for cell survival are produced. A master regulator of ISR is the transcription 
factor ATF4, which activates transcription of cell-survival genes, among, which is also 
CHOP10. We showed that phosphorylation of eIF2a was increased in mice lacking DARS2 
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in heart, and FGF21 depletion has not additionally affected its levels. It is puzzling that non-
phosphorylated form of eIF2a showed decrease in the hearts lacking DARS2 (Figure 3.8A). 
This creates even more increased ratio of phosphorylated and non-phosphorylated form and 
emphasize the severity of the stress caused by DARS2 depletion. 
 
 
Figure 3.8 Protein and expression levels of integrated stress response keyplayers. 
(A) Western Blot analysis of phosphorylated and non-phosphorylated eIF2α protein from total heart extracts of 
6-week-old mice (n=3).  (B) Relative expression levels of Atf4 and Chop10 in heart extracts (n=5). Data are 
presented as mean ± SD (*P<0.05, **P<0.01; one-way ANOVA, Tukey’s post hoc test). 
 
ATF4 protein levels were not changed at all (Figure 3.8A), but the expression levels were 
significantly upregulated in Dars2 knockout mice (Figure 3.8B). Remarkably, the depletion of 
FGF21 in DARS2-deficient heart did have an effect and it decreased the expression levels of 
the Atf4. Still, the Atf4 expression in DKO_fl was significantly increased when compared to 
the WT. Notwithstanding, Chop10 expression was increased in both DARS2-deficient and 
DKO_fl hearts. Considering that ISR is also activated by endoplasmatic reticulum (ER) stress, 
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the mRNA levels of ER chaperone Grp78 were measured, but no difference was observed 
(Figure 3.8B). 
 
Another cells’ survival mechanism activated in the times of elevated stress is 
autophagy. In DARS2-deficient hearts, the suppression of LC3B-I to LC3B-II conversion and 
accumulation of p62 and BECLIN-1 was detected, suggesting a reduction in autophagy. 
Polyubiquitinated proteins were not observed, but this could be due to the high background of 
the immuno-detection (Figure 3.9). Collectively these data suggest that FGF21 depletion in 
heart does not affect the level of autophagy. 
 
 
 
 
 
 
Figure 3.9 Protein levels of autophagy markers in 6-week-old hearts.  
Western Blot analysis of p62, Beclin, LCIII and Ubiquitin in total heart extracts of 6-week-old mice (n=3).  
 
 
The evident lack of changes caused by FGF21 depletion in heart, prompted us to look 
further for possible roles of this mitokine. One study suggested that FGF21 might have 
protective effects, by helping stressed heart to withstand oxidative stress (Planavila et al., 
2015). Therefore, we measured UCP3 and MnSOD2 proteins levels, but no changes were 
observed (Figure 3.10). This might be due to the fact that different triggers of stress in heart 
activate different coping mechanisms.  
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Figure 3.10 The levels of proteins involved in oxidative stress in 6-week-old hearts. 
Western Blot analysis of UCP3 and MnSOD2 in total heart extracts of 6-week-old mice (n=3).  
 
Cellular metabolism can be affected by mitochondrial dysfunction. Recently, it has 
been shown that in mitochondrial diseases de novo serine biosynthesis drives gluthatione 
production and moreover the cellular folate driven one-carbon cycle is disturbed. The one-
carbon cycle produces formyl-methionine for mitochondrial translation, nicotinamide adenine 
dinucleotide phosphate (NADPH) for membrane synthesis, and format - the leading 1C donor 
for cytoplasmic purine synthesis (Nikkanen et al., 2016). Here we have showed that the rate-
limiting enzyme of the folate cycle – methyltetrahydrofolate dehydroganese 2 (MTHFD2) 
was markedly upregulated both at 3 and 6 weeks of age, again, in DARS2-deficient hearts and 
independently of FGF21 depletion (Figure 3.11A). Both Mthfd2 and Fgf21 gene expression is 
induced by the ATF4 binding their promoters.  
 
 
 
		
	 56	
 
 
Figure 3.11 The protein and expression levels of 1-carbon-metabolism enzymes in the total heart 
extracts. 
(A) Western Blot analysis of MTHFD2 protein from total heart extracts of 3 and 6-week-old mice (n=3).  (B) 
Relative expression levels of Phghd and Psat1 in heart extracts of 6-week-old mice (n=5).  
Data are presented as mean ± SD (*P<0.05, **P<0.01, one-way ANOVA, Tukey’s post hoc test). 
 
The rate-limiting enzymes in de novo serine biosynthesis (Phghd, Psat1) were 
upregulated at mRNA level and this increase was not attenuated by the FGF21 depletion 
(Figure 3.11B). These results show that disrupted one-carbon metabolism is one of the early 
changes in DARS2-deficient hearts and FGF21 depletion does not affect it. 
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Mechanistic (mammalian) target of rapamycin (mTOR) complex I (mTORC1) is a 
major regulator of metabolic signaling (Khan et al., 2017). The function of mTORC1 in 
mitochondrial dysfunction is poorly understood in vivo. The next question was if mTORC1 
had a role in the induction of the various stress responses seen in DARS2-deficient hearts and 
if this is affected by FGF21 loss.  Different proteins serve as a read-out for mTORC1 
activation. Here, phosphorylated forms of 4EBP1 and PRAS40 were increased in DARS2-
deficient hearts and not affected by further depletion of FGF21 (Figure 3.12).   
 
 
 
                                             
    
 
Figure 3.12 mTORC1 activation is increased in DARS2-deficient hearts and it is not affected by 
the loss of FGF21. 
Western Blot analysis of phosphorylated and non-phosphorylated mTORC1 proteins from total heart extracts of 
6-week-old mice (n=3).   
 
In conclusion, FGF21 depletion in heart does not influence cellular metabolism and 
ISR. The ATF4, which has been shown to bind directly the promoter of Fgf21 (Tyynismaa et 
al., 2010), is decreased in its absence, but this does not affect the overall stress caused by 
DARS2 depletion.  
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3.5 . The loss of DARS2 in heart affects glucose and fatty-acid metabolism, 
independently of FGF21. 
 
The heart metabolism relies mostly on the usage of fatty-acids and partly on energy 
yielded by glycolysis (Grynberg & Demaison, 1996). In order to investigate the overall 
metabolism in hearts of DARS2-deficient and DKO mice, glucose levels were measured. 
These mice, due to their poor health, could not get through the starvation process, therefore 
the glucose levels were measured in fed state. However, there was still a significant drop in 
the levels in both Dars2 KO and DKO_fl (Figure 3.13A). Moreover, the GLUT4, an insulin-
dependent glucose transporter found in heart, skeletal muscle and adipose tissue, was 
decreased at the protein level in DARS2-deficient hearts, additionally indicating the decrease 
in glucose metabolism. Insulin-induced translocation of GLUT4 to the plasma membrane 
requires phosphorylation of Akt kinase at Ser473 (Zhu et al., 2013). The results of this study 
showed the increase in phosphorylation of Akt regardless of decreased GLUT4 protein levels, 
which could be due to the insulin resistance (Figure 3.13B). Glut4 expression was decreased, 
following the trend of the protein levels (Figure 3.13C). Moreover, insulin-growth-factor 1 
(IGF-1), which is an activator of Akt-pathway and it has insulin-like effects (Rotwein, 2017), 
showed upregulated expression in both DARS2-deficient and DKO_fl hearts. The 
upregulation is more pronounced in DKO_fl hearts and this might be due to the fact that 
FGF21 is a known inhibitor of IGF-1 (Figure 3.13C).  
Mitochondrial pyruvate dehydrogenase kinases (PDKs) catalyze the oxidative 
decarboxylation of pyruvate, and link glycolysis to the tricarboxylic acid cycle and ATP 
production. There are 4 different PDKs, where PDK4 is expressed in most of the tissues. 
Expression levels of Pdk4 were significantly upregulated in DARS2-deficient hearts when 
compared to the DKO_fl. It is known that upregulation of Pdk4 occurs in insulin-resistant 
state, but how the FGF21 loss influence it in cardiac tissue, is still not clear. Lastly, Pparg, 
which is implicated in cardiac health, showed no changes in its expression levels (Figure 
3.13C). These results show that glucose metabolism is impaired in DARS2-deficient hearts, 
independently of FGF21. The impaired glucose metabolism in failing heart could be due to 
the increased availability of non-esterified free-fatty acids (NEFA) in blood. The increased 
serum NEFA in Dars2 KO mice was previously reported in our lab (Dogan et al., 2014). 
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Figure 3.13 Glucose metabolism is affected upon loss of DARS2 in heart, but not affected with 
the further depletion of FGF21 in the same tissue. 
(A) Glucose levels (mg/mL) measured in non-fasted mice at 6 weeks of age (n=5). (B) Western Blot analyses of 
GLUT4 protein in 6-week-old hearts (n=3). (C) Relative expression levels of Igf1, Pparg, Glut4 and Pdk4 in 
heart extracts of 6-week-old mice (n=5).  
Data are presented as mean ± SD (*P<0.05, **P<0.01; one-way ANOVA, Tukey’s post hoc test). 
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Mitochondria are crucial for fatty-acid oxidation (FAO). In order to gain more insight 
in cardiac FAO of DARS2-deficient mice and how FGF21 influences it, acyl-CoA 
dehydroganese enzymes were analyzed. These enzymes differ in their specificity for short 
(ACADS), medium (MCAD), long (ACADL) and very long (ACADVL) chain acyl-CoAs. 
The Western Blot analyses showed no changes in ACADS and MCAD levels (Figure 3.14A), 
in contrary to ACADVL, which was increased in DARS2-dependent manner (Figure 3.14B). 
This result might imply that the increased NEFA detected in blood serum of DARS2-deficient 
mice are comprised of very long chain fatty-acids.  
 
 
 
 
 
 
Figure 3.14 Protein levels of fatty-acid oxidation (FAO) enzymes. 
(A) Western Blot analyses of FAO enzymes – MCAD and ACADS protein levels in 6-week-old hearts (n=3). 
(B) Western Blot analysis and protein quantification of ACADVL protein in 6-week-old hearts (n=3). 
Data are presented as mean ± SD (*P<0.05, **P<0.01, ***P<0.001; one-way ANOVA, Tukey’s post hoc test).    
 
Cytokines have been reported to have a role on the cardiovascular health. Different 
cytokines are divided into several classes, according to their function. TNF-a belongs to the 
family of tumor necrosis factors and it is mostly expressed in macrophages, but it has been 
shown that cardiomyocytes produce it too (Y. Chen et al., 2010). The expression level 
measurements gave a surprising result – a decrease in both DARS2 and DKO_fl compared to 
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WT. Additionally, the expression in DKO_fl hearts was significantly reduced compared to 
DARS2-deficient heart. Il1-b mRNA levels stayed unaffected and Il-6 expression was 
increased in a DARS2-dependent manner (Figure 3.15). This inconsistency in results could be 
due to a few reasons. One cause could be of technical nature, since the immune cells are 
mainly present in blood and this could interfere with the expression levels seen only in 
cardiomyocytes. Another cause could be the fact that these three cytokines belong to different 
groups, and it has been shown before, that IL-1 interleukins are more involved in the 
pathogenesis of ischemia/reperfusion cardiac injury, where IL-6 is more involved in different 
cardiomyopathies (Bartekova, Radosinska, Jelemensky, & Dhalla, 2018). According to these 
results, increase in Il-6 might indicate that there is a DARS2-dependent increase in 
inflammation, however this is independent of FGF21.  
 
 
Figure 3.15 Inflammation response in 6-week-old hearts of WT, DARS2 and double knockout 
hearts. 
Relative expression levels of different cytokines (TNFα, IL-1β and IL-6) involved in inflammatory response. 
Data are presented as mean ± SD (*P<0.05, **P<0.01, ***P<0.001; one-way ANOVA, Tukey’s post hoc test).    
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3.6. Liver phenotype is not affected by mitochondrial dysfunction in heart.  
 
The previous data in cardiac tissue were consistent in showing that FGF21 has no 
evident autocrine effects on the heart. This was the reason to have a further look on possible 
cell-non-autonomous effects of both DARS2 and FGF21 deficiency in heart. Liver is the main 
metabolic tissue and FGF21 has a relevant role in many metabolic processes, therefore this 
was the next organ of choice for further experiments. Overall liver phenotype was not 
affected by depletion of neither DARS2 nor FGF21, as H&E staining revealed (Figure 3.16).  
 
 
 
Figure 3.16 The overal liver phenotype is not affected by mitochondrial dysfunction in 
(H&E staining on cryosections (7µm) from liver of the 6-week-old mice (scale bar: 100 µm).  
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Furthermore, OXPHOS deficiency was not observed in liver. Both protein (Figure 
3.17A) and mRNA levels (Figure 3.17B) of different MRC subunits stayed unchanged in all 
genotypes. 
 
            
 
Figure 3.17 Liver OXPHOS is not affected by the depletion of DARS2 or FGF21 in heart and 
skeletal muscle. 
Western Blot from total liver extracts (A) and relative expression levels (B) of indicated MRC subunits. Data are 
presented as mean ± SD (one-way ANOVA, Tukey’s post hoc test). 
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Figure 3.18 Mitochondrial proteases expression levels stay unchanged in liver the livers of DARS2 
deficient mice. 
Relative expression levels of indicated mitochondrial proteases in liver (n=4-5). 
Data are presented as mean ± SD (*P<0.05, **P<0.01, ***P<0.001; one-way ANOVA, Tukey’s post hoc test). 
 
Liver mitochondrial proteostasis was not affected by the proteostatic stress observed 
in heart of DARS2-deficient mice. Here, mRNA levels of Spg7, Afg3l2, Lonp1 and Clpp were 
not changed with the DARS2 and FGF21 depletion in the heart (Figure 3.18). Interestingly, 
markers of mitochondrial biogenesis – TFAM, TOMM20 and PGC1a were not changed when 
analyzed at the protein level (Figure 3.19A), however Pgc1a mRNA was substantially 
upregulated (~5-fold) (Figure 3.19B) in the liver of heart-specific Dars2 KO mice. 
Additionally, the master regulator of integrated stress response – ATF4, was not affected at 
the protein level, but its mRNA levels were 2-fold upregulated in Dars2 heart-specific 
knockout mice. This could suggest that liver is also accommodating to some cellular stress 
caused by the overall pathological state of the DARS2-deficiency in heart (Figure 3.19A-B). 
MTHFD2 and GDF15, which are known to be involved in cellular metabolism, were not 
affected in the liver of Dars2 KO mice (Figure 3.19A). Furthermore, Fgf21 expression was 
comparable between genotypes, but Klb was upregulated in Dars2 KO and DKO_fl mice 
(Figure 3.19C). 
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Figure 3.19 Non-cell-autonomous mitochondrial stress response is not activated in the liver of 
DARS2 deficient mice. 
(A) Western Blot analyses of TOM20, TFAM, ATF4 and PGC1α in total protein extracts from the livers of 6-
week-old mice (n=3). (B) Relative expression levels of Pgc1α and Atf4 in liver (n=4-5). (C) Relative expression 
levels of Fgf21 and Beta klotho (Klb) in liver (n=4-5). Data are presented as mean ± SD (*P<0.05; one-way 
ANOVA, Tukey’s post hoc test). 
 
In summary, these data obtained from the liver, show that there are some significant 
changes, but it is still not clear if these mild changes could be assigned to cell non-
autonomous effects of the failing heart. The increased expression of Pgc1a and Atf4 could 
suggest that there is an activation of cellular stress response, which might be due to the 
metabolic changes caused by cardiac failure.  
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3.7. Loss of DARS2 in heart and skeletal muscle leads to whitening of BAT and 
increased lipolysis in WAT. 
 
Brown adipose tissue (BAT) influences the whole body energy expenditure. Together 
with the beige adipose tissue, BAT has capacity to burn glucose and fat to produce heat. This 
thermogenic capacity is mediated in large part by uncoupling protein 1 (UCP1), which is 
located in the inner mitochondrial membrane and can dissipate the proton gradient (Ricquier, 
2017). One of the aims in this study was to see how mitochondrial dysfunction in heart can 
influence distant metabolic tissues, and therefore, BAT and white adipose tissue (WAT) were 
analysed. In BAT, complex I subunits remained unchanged (Figure 3.20A), as well as the 
subunits of CIII, CIV and CV (published in the master thesis of Christoph Brandsheid). The 
morphology analyses of BAT showed the features of whitening when DARS2 was absent in 
heart. Moreover, DKO_fl mice showed even more pronounced phenotype of whitening 
(Figure 3.20 B).  
 
 
Figure 3.20 BAT is going through the process of whitening in DARS2-dependent manner. 
(A) Western Blot analyses of indicated mitochondrial complex I subunits in total protein extracts from BAT of 
6-week-old mice (n=3). (B) H&E staining on cryosections from BAT of 6-week-old mice (n=3). (C) Western 
Blot analyses of UCP1 protein in total extract from BAT of 6-week-old mice (n=3). 
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It was surprising to see that UCP1 protein was almost absent in BATs of DARS2-deficient 
mice and this was not affected in any way by the loss of FGF21 (Figure 3.20C). These results 
show that failing heart due to the DARS2 depletion leads to the whitening of BAT, 
independently of FGF21. 
WAT is another important metabolic tissue, which can function as energy storage. 
What makes it so metabolically important is its capability of “browning”, which can increase 
overall energy expenditure (Carobbio, Guenantin, Samuelson, Bahri, & Vidal-Puig, 2018). 
Browning of WAT is displayed as appearance of multilocular lipid droplets and large number 
of mitochondria. That type of adipocytes is referred as “beige” or “brite”. They also show 
increased expression in thermogenic genes such as Dio2, Cidea and Ucp1. There are different 
types of WAT – subcutaneous inguinal WAT (iWAT) and epididymal WAT (eWAT). Here, 
the morphology of both iWAT and eWAT was changed in mice with DARS2-deficient hearts. 
In both Dars2 KO and DKO_fl mice, WAT showed the brown-like phenotype. On the other 
hand, the observed smaller adipocytes could be the result of the increased lipolysis in WAT 
(Figure 3.21).  
 
Figure 3.21 iWAT and eWAT show brown-like phenotype in DARS2 and DKO mice. 
H&E staining on cryosections from iWAT and eWAT of 6-week-old mice (n=3).  
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  To access the browning status, the expression levels of brown adipocytes markers 
were measured in both types of WAT. The results are contradicting, since they show major 
decrease in Ucp1, Cidea and Dio2 levels in iWAT of DARS2-deficient and DKO_fl mice. 
(Figure 3.22A). This result is not in line with the morphological phenotype of the browning 
WAT showed previously (Figure 3.22). In eWAT, expression levels of Ucp1, Cidea and Dio2 
show inconclusive result, suggesting that those might be not the only markers of the browning 
status (Figure 3.22B).  
 
 
Figure 3.22 Browning markers in iWAT and eWAT. 
Relative expression levels of browning markers Ucp1, Cidea and Dio2 in iWAT (A) and eWAT (B) from 
extracts of 6-week-old mice (n=5). Data are presented as mean ± SD (*P<0.05; one-way ANOVA, Tukey’s post 
hoc test). 
 
In summary, the BAT and WAT analyses show that there are changes in overall 
metabolism associated with the failing heart caused by mitochondrial dysfunction. Further 
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analyses are necessary to confirm the metabolic signaling pathways leading to the whitening 
of BAT, considering that UCP1 might be not the only factor that is involved in browning.  
3.8. Label-free quantitative profiling of hearts show no significant differences 
between Dars2 KO and DKO_fl mice. 
 
In order to verify previous evidence on the missing autocrine role of FGF21 in heart, 
the label-free quantitative profiling by mass-spectrometry was performed on heart lysates of 
the 6-week-old mice. Whole proteome was analyzed and this included a detection of 5890 
proteins of which 736 were annotated in mitocarta. Four different replicates for each of four 
different genotypes were used and significance in differential expression was calculeted using 
p-values <0,05, which was adjusted to a false discovery rate (FDR) of 5%. In the end, this 
provided a q-value which was accounted for a final significance factor, when lower than 0,05. 
This reduces the number of false positive findings among the significant p-values.  The fold 
change was represented in log2 scale, which means that a unit change of 1 corresponds to a 2-
fold difference.  The whole proteome data of 6-week-old hearts show no significant changes 
between DARS2-deficient and DKO_fl mice. Gluthathione- S transferase (GST) enzyme, was 
detected in 2 samples out of 4 in both DARS2 and DKO_fl, and absent in controls. However, 
this enzyme was increased in DKO _fl hearts in comparison to Dars2 KO. The best known 
role of GST is its engagement in xenobiotics detoxification. But more interestingly, recently it 
has been shown that different isoforms of GST can modulate signaling pathways controling 
cell proliferation and apoptosis. Moreover, mitogen-activated protein kinases (MAPKs) were 
showed to induce the expression of xenobiotic enzymes. MAPK1 and MAPK3 were 
specifically showed to be important in FGF21 signaling pathway (Tanajak, Chattipakorn, & 
Chattipakorn, 2015). The volcano plots of WT vs. Dars2 KO and WT vs. DKO_fl show 
slightly different patterns, even though DKO_fl vs. Dars2 KO show no significant changes 
(Figure 3.23). 
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Figure 3.23 Quantitative assessment of heart proteomics in 6-week-old mice. 
Proteins were quantified by label-free mass-spectrometry analysis. Volcano plots of differential abundance of 
heart proteins between WT and DARS2 KO (A) WT and DKO (B) and DARS2 KO and DKO_fl mice (C). 
Proteins are plotted according to statistical significance (−log10 p-value) and relative abundance (log2 fold 
change) (FDR<0.1). 
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In order to access those differences shown in the volcano plots, some filtering of data 
was performed. The proteins that were detected only in DARS2-deficient heart and were not 
present in DKO_fl hearts (marked in black), and vice versa (marked in red), are shown below 
(Table 3.8).  
 
Table 3.1 Proteomics data of differentially expressed proteins in DARS2 deficient and DKO 
hearts. 
The proteins expressed in DARS2-deficient hearts and absent in DKO_fl are marked in black, while 
proteins marked in red represent the ones detected in DKO_fl, but absent in DARS2-deficient hearts.  
 
    The proteins absent in DKO_fl hearts were analyzed using KEGG pathways library. 
The enriched pathways include histidine metabolism, coagulation cascade, lysosome and 
ubiquitin-mediated proteolysis pathway. The proteins that are present only in DKO_fl hearts, 
when enriched and analyzed using KEGG pathways, were shown to be part of arginine 
biosynthesis pathway, arginine and proline metabolism and mTOR signaling (Table 3.8).  
 
  
Histamine N-methyltransferase Hnmt 
Synaptopodin-2 Synpo2 
Extracellular matrix protein 1 Ecm1 
Niemann-Pick C1 protein Npc1 
Phospholipid-transporting ATPase;Probable phospholipid-
transporting ATPase IIA 
Atp9a 
Ras-related protein Rab-33B Rab33b 
Complement component C9 C9 
Serum amyloid A-4 protein Saa4 
Ubiquitin-conjugating enzyme E2 H Ube2h 
Desmoglein-4 Dsg4 
Arginase-1 Arg1 
Protein archease Zbtb8os 
Ubiquitin thioesterase OTUB2 Otub2 
Conserved oligomeric Golgi complex subunit 3 Cog3 
N-acetylgalactosamine-6-sulfatase Galns 
Phosducin-like protein Pdcl 
Target of rapamycin complex subunit LST8 Mlst8 
Methionine-R-sulfoxide reductase B1 Msrb1 
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The overall difference in whole proteome between DARS2-deficient and DKO_fl 
hearts are subtle and there is so no significant difference in any of the detected proteins. 
Conversely, DARS2-deficient heart shows many significant changes when compared to the 
WT hearts. Those are the first whole proteome data achieved from this mouse model. The 
protein that is strikingly upregulated in DARS2-deficient hearts is ALDH18A1. This enzyme 
catalyzes a critical step in biosynthesis of proline, ornithine and arginine. The log2 difference 
is 8,77, which is nearly 400-fold change. The MTHFD1L, the enzyme involved in 
tetrahydrofolate synthesis in mitochondria, is ~30-fold increased In DARS2-deficient hearts. 
In the scale of ~20-fold increase are: PHDGH – an enzyme involved in serine biosynthesis, 
ERO1L – oxidoreductase in ER, PCK2 – phosphoenolpyruvate carboxykinase 2, PYCR2 – 
mitochondrial enzyme involved in the last step of proline synthesis and PSAT1 – involved in 
serine biosynthesis (Figure 3.24A). Enrichment of the proteins increased in DARS2-deficient 
hearts showed that one-carbon metabolism and amino-acid biosynthesis pathways are the 
most upregulated ones (Figure 3.24B). Moreover, mitochondrial ribosomal proteins of both 
small and large subunits are significantly upregulated, as well as some of the amino-acid 
transporters. Interestingly, none of the fibroblast growth factors was detected in the analyzed 
hearts.  
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Figure 3.24 Quantitative assessment of the most up-regulated proteins in Dars2 knockout 
compared to wild type mice.  
(A) Significantly increased proteins in DARS2-deficient hearts compared to WT; Log2 difference DARS2 vs 
WT >2, q<0,05. (B) Enrichment analysis of the upregulated pathways in DARS2-deficient hearts (Wiki 
Pathways). 
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Analysis of the proteins decreased in DARS2-deficient hearts compared to WT 
showed that CPS1 – a protein involved in urea cycle, is most prominently downregulated. 
Right after it comes BHMT – an enzyme involved in homocysteine metabolism. CI and CIV 
subunits also show a strong downregulation in DARS2-deficient hearts, as well as some of the 
CIII subunits, but to a lower extent (Figure 3.25A). In summary, the proteins that are 
significantly downregulated in DARS2-deficient hearts belong to the OXPHOS system and 
amino-acid metabolism pathways (Figure 3.25B).  
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Figure 3.25 Quantitative assessment of the most down-regulated proteins in Dars2 knockout 
compared to wild type mice.  
(A) Significantly decreased proteins in DARS2-deficient hearts compared to WT; Log2 difference DARS2 vs 
WT >2, q<0,05. (B) Enrichment analysis of the down-regulated pathways in DARS2-deficient hearts (Wiki 
Pathways). Log2 difference DARS2 vs WT <2, q<0,05. 
 
Coupled with the previous data, the whole proteome analysis at early stage (between 3 
and 4 weeks) was performed in the same manner in order to observe the first changes in 
DARS2-deficient mice, when animals were still in good health. Moreover, the analysis of the 
early changes in proteome could exclude the possibility of strong Dars2 KO phenotype 
masking the effects of FGF21 loss. 5735 proteins were detected in total heart lysates. There 
were no significant differences between DARS2-deficient and DKO_fl hearts and the volcano 
plots of Dars2 KO proteome compared to WT showed less changes than at 6 weeks of age, 
which is in line with the age-related phenotype of the mice (Figure 3.26A). Complex I and IV 
subunits were already significantly downregulated at 3 weeks of age (Figure 3.26B).  
Strikingly, ALDH18A1, PHGHD, PCK2 and SLC3A2 are strongly increased already at the 
early stage, which might suggest that the primary stress responses are related to the 
unbalanced amino-acid metabolism (Figure 3.26C). Additionally, the whole proteome data 
showed that already at 2 weeks of age, PHGHD, PSAT1 and ALDH18A1 are the most 
upregulated proteins in DARS2-deficient hearts (Kaspar S., unpublished data). These data 
demonstrate that autocrine FGF21 is dispensable for the pathology of DARS2 deficiency in 
heart and there are possibly some other key players causing the primary stress responses. The 
amino-acid biosynthetic pathways disbalance could be one of the earliest pathological 
changes in DARS2 - deficient hearts. 
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Figure 3.26 Quantitative assessment of heart proteomics in 3-week-old mice. 
(A) Proteins were quantified by label-free proteomic analysis. Volcano plots of differential abundance of heart 
proteins between Dars2 KO and WT. (B) Down-regulated proteins in Dars2 KO vs WT from mitocarta. (C) Up-
regulated proteins from mitocarta in Dars2 KO vs WT. Proteins are plotted according to statistical significance 
(−log10 p-value) and relative abundance (log2 fold change) (FDR<0.1). 
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3.9. Downstream ERK1/2 signaling in the heart is still activated in the absence 
of FGF21.  
 
Next, downstream signaling pathways of FGF21 were analysed in 6-week-old hearts. 
It is  known that FGF21 next to FGFR1 receptor requieres b-KLOTHO (KLB) co-receptor in 
order to activate downstream signaling pathways. ERK1/2, also known as MAPK3/MAPK1, 
is one of the kinases known to be activated by FGF21. Here, protein levels of both KLB and 
ERK1/2 were analysed and surprisingly we detected the upregulation in both DARS2-
deficient and DKO_fl mice (Figure 3.27A). This result once more confirmed that the absence 
of autocrine FGF21 does not influence the stress signaling in DARS2-deficient hearts. 
Moreover, expression levels of Klb were significantly increased in DKO_fl when compared to 
the WT hearts (Figure 3.27B). This might imply that there is some compensatory effect due to 
the lack of FGF21. Two more endocrine fibroblast growth factors, FGF19 and FGF23, have 
the preference for the same receptor, but they have not shown increase in their expression 
levels (Figure 3.27B). PPARa and SIRT1 were shown to induce Fgf21 expression in 
cardiomyocytes, by binding to its promoter (Planavila et al., 2013). Ppara expression levels 
were significantly decreased in both DARS2-deficient and DKO_fl hearts. On the other hand, 
Sirt1 was mildly upregulated in DKO_fl when compared to the WT hearts (Figure 3.27B).  
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Figure 3.27 FGF21 signaling cascade is activated even with its absence in the heart. 
(A) Western Blot analysis of β-Klotho (KLB) and phosphorylated ERK1/2 protein from total heart extracts of 6-
week-old mice (n=3).  (B) Relative expression levels of Klb, Fgfr1, Fgf19 and Fgf23 in heart extracts of 6-week-
old mice (n=5). Data are presented as mean ± SD (*P<0.05, ***P<0.001, ****P<0.0001; one-way ANOVA, 
Tukey’s post hoc test). 
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This unexpected upregulation of ERK1/2 and KLB despite the absence of FGF21 
suggested that endocrine FGF21 from bloodstream could still activate the signaling cascade in 
the heart. Endocrine FGF21 indeed requires KLB for its action. Therefore, serum levels of 
FGF21 were measured by an immunoassay. The increased FGF21 serum levels were detected 
in DARS2-deficient mice, which is in line with previous findings (Dogan et al., 2014). 
Moreover, the levels of this cytokine were significantly downregulated in DKO mice, but still 
present at low level (Figure 3.28). It is not clear if those low levels could still activate the 
signaling pathways in an endocrine way. In order to answer this question, a new mouse model 
was created. 
 
 
 
Figure 3.28 FGF21 serum levels are decreased, but still present with the loss of FGF21 in heart. 
FGF21 levels in serum of 6-week-old mice measured by using ELISA FGF21kit (n=6-10). Data are presented as 
mean ± SD (*P<0.05; one-way ANOVA, Tukey’s post hoc test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		
	 80	
3.10. Full body depletion of FGF21 in mice lacking DARS2 in heart and skeletal 
muscle does not affect the overall phenotype of the knockout. 
 
 
To investigate if the endocrine FGF21 secreted from other tissues is compensating for 
its absence in heart, a new mouse model was created. This time, heart and skeletal muscle 
specific Dars2 KO mice were lacking FGF21 in whole body. Surprisingly, these new double-
deficient (DKO) mice were also indistinguishable from Dars2 KO mice. They did not differ 
in lifespan nor body weight. The heart to body weight ratio was not significantly changed 
(Figure 3.29A). Moreover, cardiac label-free quantitative profiling of 6-week-old mice 
showed no significant changes in the whole proteome (Figure 3.29B). Additionally, the 
proteins shown to have a role in amino-acid biosynthesis and one-carbon metabolism were 
checked by Western Blot. In previous model, whole proteome data showed strong 
upregulation of those proteins (Figure 3.24). Here, MTHFD2, PYCR2 and SHMT2 showed 
strong increase in Dars2 KO hearts, but again, full-body depletion of FGF21 did not have any 
further effects (Figure 3.29C). In previously described model, LONP1 was also shown to be 
one of the most prominent changes among the mitochondrial proteases. Here, the protein 
levels of LONP1 measured by Western Blot were upregulated in DARS2-dependent manner 
(Figure 3.29C) and this was also confirmed by proteomics data. The decrease in steady state 
levels of different OXPHOS subunits in Dars2 KO was not changed in DKO (Figure 3.29D). 
Curiously, even when FGF21 is missing in BAT, the morphology of the tissues remains the 
same like in Dars2 KO mice (Figure 3.29E). This is peculiarly interesting because it has been 
shown that FGF21 induces UCP1 expression. Taken together, these results show that even 
full-body depletion of FGF21 does not influence the phenotype of the Dars2 KO mice.   
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Figure 3.29 Full-body depletion of FGF21 in DARS2 tissue-specific KO does not affect heart 
phenotype.  
 (A) Heart to body weight ratio in indicated genotypes. (B) Western Blot analyses of the proteins involved in 1-
carbon metabolism and LONP1 protease from total heart lysates of 6-week-old mice (n=3). (C) Volcano plots of 
differential abundance of heart proteins between DKO and DARS2 KO. (D) Western Blot analyses of the 
mitochondrial complex I subunits and GLUT4 from total heart lysates of 6-week-old mice (n=3). 
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Since full-body depletion of FGF21 showed no difference in Dars2 KO phenotype, 
next thing to access were the signaling pathways that are known to be involved in FGF21 
signaling. mTOR pathway was shown to be activated in Dars2 KO heart, but neither the 
heart-specific (Figure 3.12) nor full-body FGF21 depletion (Figure 3.30A) leads to any 
change in its activation. The major regulator of the ISR, phosphorylated eIF2a, was shown to 
be upregulated in DARS2-deficient hearts. It is also known that FGF21 is a downstream 
target of ATF4, whose expression is induced by phosphorylated eIF2a. However, full-body 
(Figure 3.30B) as well as the heart-specific FGF21 depletion (Figure 3.8) does not change the 
level of phosphorylation of this factor.  
                    
 
 
Figure 3.30 Full-body depletion of FGF21 in Dars2 tissue-specific KO does not influence the 
phosphorylation status of different proteins.  
Western Blot analyses of phosphorylated 4EBP1 (A) eIF2 alpha (B) and ERK1/2 (C) from total heart lysates of 
6-week-old mice (n=3). 
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The ultimate question is if the known cascade through ERK1/2 can be activated also in 
the absence of FGF21. Here, phosphorylated ERK1/2 levels were analysed in both full-body 
(DKO) and heart-specific (DKO_fl) double-deficient mice. Interestingly, ERK1/2 was 
activated at the same level in Dars2 KO, DKO_fl and DKO mice, independently of autocrine 
or endocrine FGF21 (Figure 3.30C). This suggests that there might be some compensatory 
pathways in the absence of this cytokine. Since FGF21 binds a receptor which is a tyrosin 
kinase, phosphorylation status in heart was accessed. In order to find  alternative pathways 
which could be activated with the loss of FGF21, phospho-proteomics analyses were 
performed on heart tissue lysates from all five genotypes. The enrichment analyses using 
KEGG pathways showed that there are differences between tissue-specific DKO_fl and DKO 
hearts. The common pathways that were upregulated in both double-deficient mouse models 
when compared to DARS2-deficient mice were involving ribosome, splicosome and PPAR 
signaling (Figure 3.31A). The downregulated patways in both double-deficient mouse models 
are shown in Figure 3.31B. The proteins which were downregulated to the highest extent in 
DKO compared to DARS2-deficient hearts are listed in Table 3.9. Interestingly, we did not 
observe changes in ERK1/2 kinases  (MAPK3/MAPK1), which is in line with the Western 
Blot data shown in Figure 3.30.  
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Figure 3.31 Phospho-proteomics analyses; KEGG pathways enrichment. 
 KEGG pathways enrichment of phospho-proteome in DKO compared to DARS2 KO and DKO_fl 
compared to DARS2 KO (DKO_fl: tissue-specific double-deficient mice; DKO: double-deficient mice 
lacking FGF21 in whole body, and DARS2 in heart and skeletal muscle). Pathways which are 
upregulated (A) and downregulated (B) in DKO and DKO_fl compared to DARS2 KO. 
 
 
Moreover, we compared pathways which were differentially regulated in DKO_fl and DKO 
(Figure 3.32).  
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Figure 3.32 Phospho-proteomics analyses; KEGG pathways enrichment. 
Enrichment of the upregulated and downregulated in DKO_fl compared to DKO using KEGG pathways 
 
 
Table 3.2 Phosphorylated proteins which are decreased in DKO vs DARS2-deficient hearts. 
Proteins are selected according to significance q<0,05 and log2 fold change <-1. 
 
protein function Log2 change 
Bnip3 
 
Apoptosis -3,3 
Arpp19;Ensa Insulin secretion stimulation -3,1 
Fam126a Not known -2,4 
Ppp1r12a Phosphatase -2,1 
Araf Mitogenic signaling -1,8 
Map1a Cytoskeletal organization -1,7 
Pak2 Cytoskeleton; stimulation of cell proliferation -1,7 
Tomm70a Mitochondrial import -1,5 
Slc8a1 Calcium transmembrane transport -1,5 
Slc25a4 Mitochondrial ADP/ATP transport -1,5 
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 Furthermore, we analyzed serum proteome in order to check if there are possible 
candidates that might be compensatory to the lack of FGF21. Unfortunately, we did not detect 
any other protein belonging to the fibroblast gorwth factor family. The only changes we 
observed are decreased epidermal growth factor receptor – EGFR and elongation factor 1 
alpha-1 – EEF1A1 in DKO when compared to DARS2-deficient mice. Increased 
apolipoprotein D, as well as the fructose bisphosphatasealdolase, were observed in Dars2 KO 
when compared to control. Apolipoprotein D was shown to have cardioprotective effects and 
its plasma levels are increased during myocardial infarction (Tsukamoto et al., 2013).  
 
 
3.11. FGF21 is not responsible for the induction of stress responses in CLPP KO 
mice. 
 
The severity of stress caused by DARS2 deficiency is possibly masking the effects of 
FGF21 depletion. In order to exclude this option, a new double-deficient mouse model was 
created, lacking FGF21 and CLPP in whole body (DKO_wb). CLPP deficiency induces mild 
phenotype and lifespan stays unaffected. The main features of Clpp KO mice is moderate 
complex I deficiency, accompanied by decreased body weight and hearing loss (Jenkinson et 
al., 2013). Despite the loss of FGF21, phenotype of DKO_wb mice at 16-18 weeks of age was 
almost identical to Clpp KO mice. Fgf21 expression is approximately 5-fold increased in Clpp 
KO hearts (Figure 3.33A). The body fat was decreased at the same extent  in both Clpp KO 
and DKO_wb mice (Figure 3.33B). Concerning the glucose metabolism, both glucose and 
insulin tolerance test od DKO_wb followed the trend of Clpp KO mice (Figure 3.33C). 
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Figure 3.33 Body weight and insulin/glucose tolerance in Clpp KO mice is not affected with the 
loss of FGF21. 
(A) Relative expression levels of Fgf21 in total RNA from heart in 16-week-old mice (n=5) (B) Body fat in 
grams measured by NMR (n=6-8). (C) Glucose and insulin tolerance test in fasted mice.  
Data are presented as mean ± SD (*P<0.05, **P<0.01, ***P<0.001; one-way ANOVA, Tukey’s post hoc test). 
 
Along with the previous analyses in Dars2 KO hearts, versatile stress response 
markers were analyzed also in Clpp KO mice, where the depletion of FGF21 did not induce 
any change. LONP1 protease levels stayed unchanged, while mitochondrial chaperone 
GRP75 and CLPP substrate -TRAP1, were induced at the same level in both Clpp KO and 
DKO_wb. Moreover, ATF4 was not differentially upregulated when FGF21 was absent in 
Clpp KO. The PGC1a levels were increased in both Clpp KO and DKO_wb hearts and 
MnSOD2 was not changed in any of the genotypes (Figure 3.34A).   
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In our lab, we have recently identified some of the CLPP substrates - ornithine 
aminotransferase (OAT) and elongation factor G1 (EFG1) (Szczepanowska et al., 2016). Both 
substrates were accumulated in Clpp KO and DKO_wb hearts (Figure 3.34B). Cardiomyokine 
GDF15 protein levels were accessed, hence its similar functions with FGF21. The levels of 
GDF15 were not changed in any genotype (Figure 3.34C). Given the previous findings in 
DARS2 and FGF21 double-deficient mice, it was surprising to observe that ERK1/2 
activation in Clpp KO mice is absent with the loss of FGF21 in full body (Figure 3.34C). This 
result may be an indication that different cardiac stress load activates divergent signaling 
pathways.  
 
 
 
 
 
Figure 3.34 Stress responses in the heart of Clpp KO mice are not affected by the additional 
depletion of FGF21. 
Heart lysates Western Blot analyses of mitochondrial stress response markers (A), CLPP known substrates (B), 
phosphorylated ERK1/2 and cardiomyokine GDF15 (C) in 16-week-old mice. 
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3.12. Label-free quantitative profiling of heart reveals upregulation in 
cytoplasmic ribosomal proteins, histones and cytoskeleton proteins in mice 
lacking both CLPP and FGF21.  
 
Previous data showed that most of the changes observed stem from CLPP depletion, 
however, ERK1/2 activation was ablated with the loss of FGF21. To analyze it in more 
unbiased way and check for other possible changes, the label-free quantitative profiling of 
whole cardiac proteome was performed, in pursuence for new possible effectors. For the 
analysis we used whole heart lysates from the mice between 16 and 18 weeks of age, 
including 4 biological replicates per genotype. The data showed 38 significantly upregulated 
(Figure 3.35A) and 13 downregulated proteins in DKO_wb compared to Clpp KO hearts 
(Figure 3.35A). KEGG and GO enrichment analyses of DKO_wb differences compared to 
Clpp KO were perfomed and revealed that most of the upregulated proteins in DKO_wb 
belong to the splicesome machinery, cytoplasmic ribosome and cytoskeletal proteins involved 
in cardiac-contraction (Figure 3.35B). When the list of these proteins was analyzed by Enrichr 
platform, the results associated the increase in cytoskeletal proteins to hypertrophic and 
dilated cardiomyopathy, impliying that loss of FGF21 can possibly  influence the cardiac 
muscle contraction. Moreover, RAB8B is a GTPase that has been shown to react with 
cytoskeletal proteins and it was also upregulated in DKO_wb hearts. When analysing these 
proteins in Clpp KO compared to WT, it is interesting to observe that 19 out of 51 proteins 
are significantly changed in Clpp KO compared to WT. Those are the proteins belonging to 
cytoplasmic ribosome and splicesome and interestingly, they are downregulated in Clpp KO. 
The cytoskeletal proteins related to cardiomyopathy were specifically seen upregulated in 
DKO_wb hearts.  
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Figure 3.35 Quantitative assessment and enrichment of upregulated proteins in the hearts of 
DKO_wb compared to Clpp KO. 
(A) Label-free quantification of heart proteomes showing proteins, which are up-regulated in the DKO_wb when 
compared to the Clpp KO mice. (B) The panel representing KEGG enrichment analysis using Wilcoxon 
statistical test.  
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On the other hand, 13 proteins were shown to be downregulated in DKO_wb 
compared to Clpp KO hearts (Figure 3.36A). Those are mostly involved in different 
metabolic pathways (Figure 3.36B), but it is difficult to claim the significance of certain 
pathways obtained from Enrichr analysis, since the number of differentially regulated proteins 
was very low. Further analysis using Reactome Pathway Database showed the involvement of 
those downregulated proteins in fructose metabolism, fatty acyl- CoA biosynthesis, negative 
regulation of MAPK pathway and tRNA modification in nucleus and cytosol, among many 
others. 
                
 
Figure 3.36 Quantitative assessment of proteins downregulated in hearts of DKO_wb compared 
to Clpp KO. 
(A) Label-free quantification of heart proteomes showing proteins, which are down-regulated in the DKO_wb 
when compared to the Clpp KO mice. (B) Most upregulated pathways in Wiki Pathways Database.  
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In the end, the changes seen in a single full-body Fgf21 KO were compared to control mice 
(Figure 3.37A-B).  
 
 
 
Figure 3.37 Quantitative assessment of KEGG enrichment pathways changed in Fgf21 KO 
hearts.  
Most upregulated (A) and downregulated (B) pathways in FGF21 KO hearts using KEGG Pathways Database.  
 
 
Most of the significantly changed proteins in Fgf21 KO are downregulated. 5 
mitochondrial proteins are strongly downregulated in the absence of FGF21. NNT or 
mitochondrial  NAD(P) transhydroganese is the most severely affected enzyme and it is 
involved in transhydrogenation of NAD and NADP. Also, it functions as a proton pump and it 
may play a role in ROS detoxification (Murphy, 2015). Another 2 severely downregulated 
proteins are aminotrasferases, ABAT and GPT2. The former is 4-aminobutyrate and the latter 
is alanine aminotransferase. Also, mitochondrial 5(3)-deoxyribonucleotidase was shown to be 
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downregulated, followed by mitochondrial 39S ribosomal protein (Figure 3.37). These data 
show that FGF21 loss in Clpp KO mice does have an effect and possibly worsens the cardiac 
health, even though the changes are still not visible. On the other hand, the lack of FGF21 
alone induces changes in mitochondria. Further analyses of the older mice would be necessary 
to see if the heart of these mice is getting impaired.  
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3.13. FGF21 loss in Clpp KO mice leads to the whitening phenotype. 
 
Morphological analysis of BAT showed that the loss of FGF21 leads to the whitening 
phenotype, increasing the size and number of white unilocular adipocytes. This is even more 
evident in DKO_wb when compared to single Fgf21 KO mice. Clpp KO mice were more 
abundant in paucilocular adipocytes (Figure 3.38A).  
     
 
Figure 3.38 The loss of FGF21 in Clpp KO BAT leads to the loss of UCP1 protein and whitening 
phenotype. 
(A) H&E staining on cryosections from BAT of 16-week-old mice (n=3). (B) Oil-red O staining on BAT 
cryosections (n=3); (Scale bar=100 µm). (C) Western blot analyses of indicated mitochondrial complex I 
subunits and (D) UCP1 protein. 
 
Oil-Red staining was used to detect lipid content in BAT and Fgf21 KO showed apparent 
lipid increase, but surprisingly DKO_wb lipid content seemed lower (Figure 3.38B) when 
compared to the morphology of adipocytes (Figure 3.38A). To further access the role of 
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FGF21, OXPHOS analysis in BAT was performed. Steady-state levels of NDUFS2, 
NDUFV2 and NDUFB6 showed visible decrease in their levels in the CLPP-dependent 
manner, while on the other hand, CIII and CIV subunits remain unchanged (Figure 3.38C). 
Apart from the mitochondrial respiration, BAT is engaged in producing heat with the help of 
UCP1, which uncouples respiratory chain and ATP production. Therefore, UCP1 levels were 
measured and interestingly, no significant changes were observed (Figure 3.38D). It has been 
shown in our group that UCP1 levels are mildly downregulated in Clpp KO female mice, and 
not affected in males. When exposed to cold, both male and female mice were affected and 
showed deranged thermogenesis capacity. Moreover, it was claimed that FGF21 induces 
thermogenic capacity of BAT (Wall et al., 2015). Together, these data show that loss of 
FGF21 worsens browning phenotype by increasing the lipid content, but it does not affect 
mitochondrial dysfunction seen in Clpp KO mice.  
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Upon histological analyses of different fat depots, it has been observed that both 
iWAT (subcutaneous) and eWAT (visceral) are not going through the browning process when 
FGF21 is absent (Figure 3.39A-B). The browning is taking place only in Clpp KO white 
depots, and more extensively in iWAT (Figure 3.39B). This result was not foreseen, since the 
previous data showed more intensive browning phenotype in eWAT (Becker et al., 2018). 
 
 
 
Figure 3.39 The loss of FGF21 induces whitening of both eWAT and iWAT. 
H&E staining on cryosections from eWAT (A) and iWAT (B) of 16-week-old mice (n=3) ; (Scale bar=100 µm). 
 
In summary, browning observed in Clpp KO mice is inhibited when FGF21 is absent 
and this is not relient on UCP1 levels.  
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4. Discussion 
The multifaceted mitochondria have always been of a great interest for different research 
areas. The knowledge of mitochondrial physiology has dramatically increased in the last 
decade and many new aspects of this organelle are being investigated. Mitochondria are prone 
to damage, that could come from mtDNA defects, oxidative stress or different functional or 
morphological alternations. Mitochondria dysfunction leads to many different types of 
diseases, such as neurodegenerative disorders, metabolic diseases, cancer etc. An interesting 
question left unanswered is how mitochondria dealwith different sources of stress and which 
mechanisms are activated in different tissues.  
In recent years, FGF21 got a lot of attention in metabolism research and not so much 
later, its relation to mitochondrial diseases and ageing has been observed. FGF21 can function 
in an endocrine manner and it has been shown to elicit diverse aspects of the adaptive 
starvation response. The main functions asigned to this cytokine are improvement of insulin 
sensitivity, increases in hepatic fatty acid oxidation, blocking of somatic growth, increasing 
glucose uptake in adipocytes etc. (Fisher & Maratos-Flier, 2016) However, its upregulated 
expression was observed recently in different mouse models with mitochondrial dysfunction 
(Dogan et al., 2014b; Tyynismaa et al., 2010). Correspondingly, in DARS2  heart and skeletal 
muscle deficient mice, which are featured with the activated mitochondrial stress responses 
due to impaired OXPHOS, we observed an immense 250- fold Fgf21 upregulation in heart 
(Dogan et al., 2014a). Besides, in CLPP deficient mice, which are mirroring the mild 
mitochondrial dysfunction phenotype, we observed around 20-fold increase in cardiac Fgf21 
expression (Becker et al., 2018)  
We created different double-deficent mouse models in order to investigate the role of 
FGF21 in mild and severe mitochondrial dysfunction, as well as its cell-autonomous and non-
cell-autonomous effects on different tissues. The mouse model lacking DARS2 and FGF21 
only in heart and skeletal muscle aimed to investigate the autocrine effects of FGF21 in 
cardiomyocytes, whereas another model, which in oppposite lacks FGF21 in the whole body, 
was created to answer the question if endocrine FGF21 serves the role in failing heart. The  
Dars2 KO model is displayed with severe mitochondrial dysfunction and the lifespan of these 
mice is strikingly shortened. Finally, we wanted to investigate the role of FGF21 in mild 
mitochondrial dysfunction and therefore we created the full-body deficient CLPP mice, 
lacking FGF21 in the same manner.  
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4.1 Autocrine role of FGF21 in DARS2-deficient cardiomyocytes is 
expendable. 
 
    The cardiac Fgf21 expression upregulation was observed already at 1 week of age in 
DARS2 KO mice and raised up to 250 fold, prior to death at 7-8 weeks of age. Moreover, its 
upregulation was present even before the other stress responses were activated in this mouse 
model. Increased proteostatic response and UPRmt  were observed at 3 weeks of age, which 
was prior to OXPHOS deficiency (Dogan et al., 2014a). Together, those results led to the 
conclusion that something  different than OXPHOS impairment that causes the activation of 
all those stress responses in DARS2-deficient cardiomyocytes and FGF21 appeared as a 
plausible candidate to investigate. Additionally, Fgf21 expression levels were not increased in 
other tissues. However, we detected an increase in serum and speculated that this increase 
reflects the upregulation of Fgf21 in heart (Dogan et al., 2014a).  
    In this study, first we generated a mouse model which lacks both DARS2 and FGF21 
in heart and skeletal muscle. Surprisingly, there were no differences in gross phenotype nor 
lifespan of the DKO mice, compared to Dars2 KO. Heart to body weight ratio stayed 
unchanged with the loss of FGF21, as well as cardiomyopathy markers (Section 3.1). Those 
first results suggested that there might be some compensatory mechanism taking over in the 
absence of FGF21. Therefore the levels of another well known cardiomyokine –GDF15, were 
accesed. GDF15 was shown to be induced during heart failure and it may influence different 
processes in cardiac remodeling (Wollert & Kempf, 2012). Moreover, the blood levels of 
GDF15 might reflect mitochondrial dysfunction, and thus it could be used as a biomarker for 
mitochondrial diseases (Fujita, Taniguchi, Shinkai, Tanaka, & Ito, 2016). Interestingly, its 
expression upregulation is very often following the increase in Fgf21 expression (Khan et al., 
2017; Tezze et al., 2017). Furthermore, GDF15 was detected as a cell-non-autonomous 
myomitokine which regulates systemic energy homeostasis in a mouse model lacking a 
protein of the large mitoribosomal subunit in skeletal muscle (Chung et al., 2017). This is in 
line with the results from the Deletor mouse, where FGF21 was assigned a role of a 
myomitokine that is capable of improving the overall metabolic state (Tyynismaa et al., 
2010). However, the heart protein levels of GDF15 were not changed in any of the genotypes 
in our tissue-specific knockouts. On the other hand, its expression level was immensly 
upregulated at a very early stage (2 weeks), but not the protein levels (unpublished data from 
S. Kaspar).  
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   In DARS2-deficient hearts we observed the activation of mitochondrial stress 
responses, such as increased mito-biogenesis, activation of UPRmt , increased mitochondrial 
proteases and decrease in autophagy (Dogan et al., 2014b). Remarkably, primary changes 
reflected in the levels of proteases  and the other stress responses followed at the later stage. 
When FGF21 is absent, none of these stress responses is additionally affected. Even though 
its expression is already increased at 1 week of age, autocrine FGF21 seems not to be a 
mediator of previously mentioned stress responses seen in DARS2 –deficient hearts (Section 
3.4).  In conjunction with the increased Fgf21 expression, transcription factors Atf4 and Atf5 
were also increased in DARS2-deficient hearts. Those transcriptions factor were shown to be 
involved in an evolutionary conserved stress response pathway known as integrated stress 
response (ISR). There is a compelling evidence that Fgf21 expression can be stimulated by 
ISR through the eIF2α/ATF4 axis. Several studies detected AARE – amino acid response 
elements – in the promoter of the FGF21 gene (De Sousa-Coelho et al., 2012). This ISR 
induction of Fgf21 helps in combating different cellular stresses, such as mitochondrial stress, 
ER stress, amino-acid deprivation stress etc. (Salminen et al., 2017). In our study, we 
observed increased eIF2α phosphorylation in both DARS2-deficient and DKO hearts. 
Interestingly, the non-phosphorylated form of eIF2α was decreased in DARS2-dependent 
manner, which was not reported before. Additionally, ATF4 protein levels were not affected 
by DARS2 nor FGF21 depletion, in spite of the increase in its mRNA levels in DARS2-
deficient heart. This increase was significantly alleviated in DKO, confirming that ATF4 can 
induce FGF21, but obviously this did not influence the phenotype of already severely affected 
Dars2 KO mice. Furthermore, it has been shown that ISR induces several survivial 
mechanisms, such as autophagy (B'Chir et al., 2013). In our study, we observed a decrease in 
autophagy in DARS2-deficient hearts, by following markers such as BECLIN-1, conversion 
of LC3-I to LC3-II and p62. The loss of FGF21 did not affect the status of autophagy. 
Curiously, it has been demonstrated that loss of Atg7 in skeletal muscle, which is an important 
constituent of autophagy machinery, induced mitochondrial dysfunction and concomitant 
Fgf21 expression through the eIF2α/ATF4 axis (Keipert et al., 2014). As mentioned before, 
eIF2α reduces the cytoplasmic translation and preferentially induces mRNA which contains 
short upstream open reading frames (uORF). In Dars2 KO mice, CHOP-10 is one of the first 
transcription factors which is upregulated at a very early stage (Dogan et al., 2014). It has 
been shown that in the case when ATF4 is not able to restore proteostatic control, CHOP10 is 
induced, which switches the cell to a terminal outcome  (Teske et al., 2013). This is in line 
with our findings in DARS2 KO hearts, where Chop-10 expression levels are exceeding Atf4 
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with time and this immense upregulation is in agreement with the severity of the phenotype 
observed in DARS2-deficient mice. However, FGF21 depletion did not affect the levels of 
CHOP10 in Dars2 KO hearts.  
    The AARE response also induces the expression of methylene tetrahydrofolate 
dehydrogenase 2 (MTHFD2), which is important for the mitochondrial folate cycle, as a rate-
limiting enzyme. It has been reported in Deletor mice that induction of MTHFD2 is 
associated with abberant nucleotide synthesis, imbalanced dNTP pools and the induction of 
serine and gluthathione synthesis.   The one-carbon (1C) metabolism is a metabolic pathway, 
which is essential to most cell types and organisms. It provides 1C-units to major anabolic 
cellular pathways: nucleotide synthesis, methylation reactions and mitochondrial translation 
initiation. (Nikkanen et al., 2016). The mitochondrial folate metabolism is of great importance 
for mitochondrial translation. It uses THF and 1C-donors serine, glycine or sarcosine as 
inputs and produces fMet for mitochondrial translation initiation, NADPH and formate (Fan 
et al., 2014). In recent studies it was reported that mitochondrial DNA depletion triggers, via 
the transcription factor ATF4, expression of serine synthesis genes – PHGHD, PSAT1, 
and PSPH - thereby increasing 1C-metabolism (Bao et al., 2016). In our study, we observed a 
robust upregulation in  protein levels of MTHFD2 in DARS2-deficient and DKO hearts, 
already at 3 weeks of age and persisting till 6 weeks of age, when the animals were dying. 
Moreover, expression levels of Psat1 and Phghd were around 20-fold increased in DARS2-
dependent manner, while the FGF21 depletion did not have any influence on folate and serine 
metabolism, even though Atf4 expression was alleviated in DKO hearts. In a recent follow-up 
of the Deletor mouse study, it has been observed that the main manifestations of 
mitochondrial myopathy, such as induction of GDF15 and FGF21, UPRmt and imbalances in 
1-C metabolism, are all part of skeletal muscle ISR which is controlled by mTORC1 (Khan et 
al., 2017). It is interesting to note that in this case mTORC1 is an upstream regulator of 
FGF21, however, there are many studies showing tissue-specific effects of FGF21 being 
upstream of mTORC1. It has been reported that FGF21 activates mTORC1 in adipocytes 
through MAPK signaling and it led to surprisingly beneficial metabolic effects, such as 
increased glucose uptake and improved insulin sensitivity, increased adiponectin secretion 
and induction of UCP1 (Minard et al., 2016). Nevertheless, administration of FGF21 in mice 
inhibits mTORC1 in the liver, and improves insulin sensitivity of hepatocytes (Gong et al., 
2016). In an earlier study, it has been shown that mice overexpressing FGF21 have extended 
lifespan up to 40%. Remarkably, this was due to the blunting of GH/IGF-1 signaling, which 
FGF21 is exerting through the control of STAT5, independently of mTORC1 (Y. Zhang et al., 
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2012). In our study, we observed a strong upregulation of Igf-1 expression in DARS2-
deficient hearts, which was intensified in DKO. Binding of insulin-growth-factor 1 to its 
receptor leads to phosphorylation of Akt1, which further phosphorylates PRAS40 that relieves 
inhibition of mTORC1 (H. Wang et al., 2012). mTORC1 boosts protein synthesis by 
phosphorylating the eukaryotic initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) and 
the p70 ribosomal S6 kinase 1 (S6K1). Those proteins are also used as read-outs for mTORC1 
activation. Our results showed that both phosphorylation of PRAS40 and 4E-BP1 are 
increased in DARS2-deficient hearts and not affected by the loss of autocrine FGF21. These 
data suggest that FGF21 in cardiomyocytes is not implicated in the control of mTORC1.  
   Taken together, the presented data indicate that all mitochondrial and cellular stress 
responses seen activated in DARS2-deficient hearts are not affected by the endogenous loss 
of FGF21. On one hand, increased mitochondrial biogenesis, proteostasis, UPRmt , decreased 
autophagy and on the other hand, imbalanced one-carbon metabolism, serine synthesis, FAO 
and glucose metabolism, are all disrupted to the same extent in DARS2-deficient and DKO 
hearts (Sections 3.4 and 3.5). The loss of FGF21 alone does not differ from the WT 
phenotype. Overall, these data show that autocrine FGF21 is dispensable in Dars2 KO heart 
pathology. However, we wanted to further look into non-cell-autonomous effects of cardiac 
FGF21 loss in DARS2 deficient animals. 
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4.2 Cell non-autonomous effects of DARS2 depletion in cardiomyocytes are 
not dependent on FGF21. 
 
   The endocrine action of FGF21 is not a typical hormonal response, since its induction 
was confirmed in many different tissues. Moreover, it can be secreted from one organ, and 
have effects on distant others. One demonstration of this communication between distal 
tissues was done in C. elegans, where UPRmt that was induced in the nervous system 
generated the same stress response in intestine (Durieux et al., 2012). Another example comes 
from Drosphila study where the AMPK-induced autophagy in brain promoted intestinal 
autophagy in a cell non-autonomous manner (Ulgherait, Rana, Rera, Graniel, & Walker, 
2014). FGF21 has some of the properties needed for a cell non-autonomous mediator. It is 
secreted during stress and can improve metabolic homeostasis of the whole organism by 
communicating with the other tissues. It has been shown that during heart ischemia FGF21 is 
secreted from liver and adipose tissue with the aim to alleviate myocardial injury and help the 
recovery of the heart (S. Q. Liu et al., 2013). There is currently a lot of evidence on how 
skeletal muscle FGF21 secretion improves whole body metabolism by influencing adipose 
tissue (Kim et al., 2013; Miyake et al., 2016). In the case of the Deletor mouse, FGF21 
secreted from skeletal muscles leads to widespread changes in lipid metabolism, such as low 
fat content in the liver, with resistance to high-fat diet and smaller adipocyte size (Tyynismaa 
et al., 2010). However, Deletor mice lack TWINKLE in the whole-body and therefore it is not 
clear if these changes in metabolism come from an underlying mitochondrial dysfunction in 
all tissues. In our study, we analyzed the cell non-autonomous effects on the liver and adipose 
tissue. The overall liver phenotype was not changed – OXPHOS was not affected by the loss 
of DARS2 in heart, nor by the additional depletion of FGF21. Proteases AFG3L2, SPG7, 
CLPP, LONP1 stayed unchanged as well as ATF4 and MTHFD2 protein levels. Generally, 
liver morphology looked unchanged when all of the mouse models were compared to WT. 
Label-free proteome profiling showed no significant differences when different genotypes 
were compared to WT livers. Interestingly, liver Pgc1α expression levels were approximately 
5-fold increased in both DARS2 and DKO mice. This could be assigned to a metabolic stress 
response, since liver is the main metabolic tissue and it is probably trying to compensate for 
the general energy deprivation observed in DARS2 KO mice. Moreover, Atf4 expression was 
slightly increased in DARS2 KO, but both PGC1α and ATF4 protein levels were unchanged 
(Section 3.6).  It is important to highlight that liver is the major tissue for FGF21 expression 
and in order to prevent a feedback effect of the autocrine FGF21, it does not express FGFR1. 
However, KLB – the co-receptor is still expressed, because other endocrine FGFs can use it 
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for its effects. Interestingly, we observed increased expression of Klb in the liver, while Fgf21 
was not significantly changed. Furthermore, expression of fatty-acid translocators - Pparγ and 
Cd36, were increased in DARS2 KO and DKO mice. This suggests that the demand for 
transferring FFAs from the blood into the liver is increased, which is consistent with the 
previously observed increase in serum FFA in DARS2 KO mice.  
    Autophagy deficiency in skeletal muscle induces mitochondrial dysfunction, which 
results in expression of Fgf21 through ATF4. FGF21 is secreted from the skeletal muscle and 
has beneficial effects such as increasing insulin sensitivity and protecting from diet-induced 
obesity, with increased FAO and browning of WAT (Kim et al., 2013). The mouse model 
lacking tuberous sclerosis complex 1 (TSC1) in skeletal muscle, which causes constitutive 
activation of mTORC1 and enhances protein synthesis, also induces FGF21 secretion from 
skeletal muscle and improves overall systemic metabolism. This again shows that FGF21 is a 
stress-induced mitokine, in this case induced by endoplasmatic reticulum (ER) stress, through 
the PERK/eIF2a/ATF4 axis (Guridi et al., 2015). On the other hand, TFAM deletion has 
tissue-specific consequences. Its deletion in pancreas leads to impaired mitochondria and 
glucose intolerance (Silva et al., 2000), while a skeletal-muscle-specific TFAM depletion 
leads to improved glucose tolerance (Wredenberg et al., 2006). Moreover, TFAM deletion in 
adipose tissue leads to increased mitochondrial oxidation in fat and positive metabolic effects, 
despite an increased oxidative stress. These mice are protected from age- and diet- induced 
obesity, they have improved glucose and insulin function and higher energy expenditure 
(Vernochet et al., 2012).  
    In our heart and skeletal muscle specific DARS2 KO model we observed changes in 
both white and brown adipose tissue. BAT contains many mitochondria involved in FAO and 
it can express UCP1, which allows mitochondrial proton leak that leads to thermogenesis 
through energy expenditure (Ricquier, 2005). In previously mentioned models, where 
mitochondrial dysfunction was caused in skeletal muscle, BAT was featured with increased 
thermogenic capacity and upregulated Ucp1 expression. However, we observed something 
different. First of all, the morphology of BAT showed increased lipid content in DARS2 KO 
mice and this was even more pronounced in DKO mice. Apart from that, UCP1 protein levels 
were barely detectable in both DARS2 KO and DKO mouse. These results confirmed the 
“whitening” of BAT, which is contrary to what has been shown before in relation to 
cardiomyopathy. Nevertheless, BAT “whitening” related to mitochondrial dysfunction has 
been reported. A Costeff syndrome model has a mutation in the mitochondrial membrane 
protein Opa3 gene, which leads to mitochondrial fragmentation. These mice show a failure to 
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thrive and have a reduced body weight, due to disturbances in lipid metabolism. They 
observed enlargement of BAT, increased lipid content and decreased UCP1 levels (90%). 
This phenotype presentation resembles the one we saw in DARS2 KO mice. Intrinsically, in 
these mice lipid uptake is unimpeded, but there is impaired lipid utilization. Moreover, the 
browning of eWAT and decrease in its weight was observed, which was explained through 
subsided availability of FFA, that are now taken by BAT. Interestingly, UCP1 changes were 
not detected, despite the appearance of multilocular beige adipocytes (Wells et al., 2012). 
When we analyzed WAT, we observed the decrease in adipocyte size in Dars2 KO and DKO 
mice, in both eWAT and iWAT. Moreover, Ucp1 expression levels were downregulated in 
iWAT and stayed unchanged in eWAT (Section 3.7). It is important to emphasize that loss of 
FGF21 in heart and skeletal muscle does not influence the adipose tissue phenotype observed 
in DARS2 KO mice. Moreover, we checked the steady-state levels of OXPHOS subunits in 
BAT and they were not affected in any of the KOs. Besides, we investigated the levels of 
FAO enzymes, glucose transporters 1 and 4, mitochondrial stress markers in BAT and none of 
them was affected. These results are perplexing since we did not observe obvious signs of 
mitochondrial dysfunction in BAT, besides downregulation of UCP1. Interesting question 
here is what is causing this impairment in lipid usage and decrease in UCP1? Is it the 
immense increase of FFA observed in serum of the DARS2 KO mice? Is BAT trying to 
hamper the heat production and prevents energy waste in the mice that are already suffering 
energy deficiency? Those questions still have to be addressed. 
 
 
4.3 What is happening downstream of FGF21 signaling and is there a 
compensation from exogenous factors? 
 
   In previously presented data, we have showed that endogenous FGF21 does not affect 
stress responses observed in DARS2 KO. Moreover, FGF21 in heart does not have cell non-
autonomous effects on liver and adipose tissue. This led us to inspect what is happening 
downstream of FGF21 in heart. Until recently, it has been believed that FGF21 was not 
induced in heart. This was mainly because FGF21 is not detectable in heart under 
physiological conditions, but only under conditions of increased stress. This was 
demonstrated in a study where isproterenol was applied to induce cardiac injury in mice, and 
they observed how mice lacking FGF21 are withstanding the stress compared to WT animals. 
This study demonstrated that FGF21-/- mice have decreased FAO, increased inflammatory 
response and worsened cardiac hypertrophy, followed by apoptosis (Planavila et al., 2013). It 
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has been demonstrated that FGF21 can both be induced and target cardiac cells. The induction 
was shown to occur through PPARα/SIRT1 binding directly to the Fgf21 promoter. The 
targeting of cardiac cells was taking effect through the FGFR1/KLB complex and 
concomitant ERK1/2 phosphorylation (Planavila et al., 2013). Interestingly, in our study 
induction of Fgf21 under PPARα/SIRT1 control was not shown. On the contrary, we 
observed a downregulation of Pparα expression in both DARS2-deficient and DKO hearts, 
while Sirt1 levels were mildly increased in DKO. Curiously, we saw an upregulation of KLB 
co-receptor protein levels in both Dars2 KO and DKO hearts. This result suggests that there 
might be some compensation through exogenous factors (Section 3.9). KLB is expressed at 
low levels in heart, when compared to the other tissues. Nevertheless, skeletal muscle does 
not express KLB and therefore it is an organ that only contributes to the systemic FGF21 pool 
but cannot be targeted by it (Kilkenny & Rocheleau, 2016). What we showed earlier in Dars2 
KO mice is that immense upregulation of Fgf21 expression is detected only in 
cardiomyocytes. Liver, skeletal muscle, pancreas, brown and white adipose tissue did not 
show any increase in this mitokine, therefore we concluded that the FGF21 serum level 
increase originates from a cardiac secretion (Dogan et al., 2014). This is a bit puzzling bearing 
in mind that in our DKO mice, we observed the KLB upregulation at the same extent as in the 
Dars2 KO mice. How do we explain the FGF21 serum levels? When we measured serum 
levels of FGF21 in DKO mice, we saw a decrease in comparison to the Dars2 KO mice, 
however it was not completely absent. Does even a small amount of FGF21 in blood can 
compensate for the absence of the endogenous one? Is it exogenous FGF21 or something else 
that is compensating for the absence of the autocrine one? In order to answer this question in 
a well-grounded manner, we created a new mouse model, DARS2-heart-and-skeletal muscle - 
specific KO, which is this time lacking FGF21 in whole body. The DKO mice showed no 
difference in phenotype compared to the DKO_fl. We checked activation of ERK1/2 through 
phosphorylation, which is a well-established signaling pathway of the FGF21/FGFR1/KLB 
axis and to our surprise, we saw that ERK1/2 activation occurred to the same extent in Dars2 
KO, DKO and DKO_fl hearts (section 3.10).  
   There are multiple possible hypotheses rising from the presented data. First of all, 
different kind of stresses might probably use different signaling pathways for their activation. 
Ischemia/reperfusion injury and severe mitochondrial dysfunction in heart might not both 
necessarily use only the ERK1/2 pathway for FGF21 induction. Secondly, the severe 
phenotype of DARS2-deficient mice might be overpowering any possible effect of FGF21 
depletion, or more precisely, the saturation with stress responses is diminishing the role of 
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FGF21 in severe mitochondrial dysfunction. Thirdly, other endocrine fibroblast growth 
factors might be compensating for the lack of FGF21 and activating the same signaling 
pathways. Lastly, there might be some unknown factors, which are substituting FGF21. 
However, serum proteomics data did not yield enough comprehension on this possibility, 
since none of the growth factors nor other cardiomyokines were detected in the samples.  
   
 
4.4 Loss of FGF21 in CLPP deficient mice leads to increased 
cardiomyopathy markers and cytoplasmic ribosomal proteins. 
 
  Next, we created a new mouse model to study the role of FGF21, with the idea that 
DARS2 depletion might be too severe for detecting changes caused by loss of FGF21. We 
used CLPP-deficient mice, which are featured with mild mitochondrial dysfunction, without 
any impact on longevity (Becker et al., 2018). CLPP deficient mice reproduce the Perrault 
syndrome clinical picture, seen in humans with mutations in this gene, which is displayed 
with reduced body weight and growth retardation, deafness and sterility (Jenkinson et al., 
2013). Moreover, we detected around 20-fold upregulation of Fgf21 expression in heart of 
Clpp KO mice. Therefore, we depleted FGF21 in the whole body in Clpp KO mice to study 
its role in mild mitochondrial dysfunction. 
    Recently, it has been shown that different kind of mitochondrial perturbations can 
induce FGF21 secretion from different tissues to serum (Dogan et al., 2014b; Tyynismaa et 
al., 2010; Vandanmagsar et al., 2016). In Clpp KO mice, serum levels of FGF21 are increased 
as well, and elevated Fgf21 expression was observed in different tissues, correlating with the 
degree of mitochondrial dysfunction (Doctoral dissertation of C. Becker). In our study, we 
analyzed heart, liver, BAT and WAT of the CLPP/FGF21-double-deficient mice (DKO_wb), 
due to the previously observed Fgf21 expression upregulation in those tissues in CLPP-
deficient mice. No systemic metabolic adaptation of Clpp KO mice, such as reduced body 
weight and increased insulin sensitivity, were due to FGF21 (Section 3.13). In our DKO_wb 
mice, glucose and insulin tolerance test results followed the trend of CLPP-deficient mice.  
    Liver, as the main site of FGF21 production, showed no difference in mitochondrial 
complex and supercomplex levels between CLPP-deficient and DKO mice (Doctoral 
dissertation of C. Becker).  
     Next, we wanted to investigate the role of FGF21 in heart with mild mitochondrial 
dysfunction and compare it to the previously described models. From all the tissues tested in 
CLPP-deficient mice, the most immense upregulation of the Fgf21 expression was detected in 
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heart, which correlates with the level of mitochondrial dysfunction (Doctoral dissertation of 
C. Becker). This could already suggest a tissue-specific importance of this mitokine. 
However, mitochondrial stress response markers were upregulated in CLPP-deficient mice 
and FGF21 depletion had no impact on it. Additionally, GDF15 levels were not changed in 
any of the genotypes, excluding a possible compensation of this cardiomyokine. Surprisingly, 
activation of ERK1/2 by phosphorylation was observed only in CLPP-deficient mice. FGF21 
depletion completely ablated this activation, which is in contrary to the previously described 
results in DKO and DKO_fl mice. This result might point out that the FGF21-ERK1/2 
signaling axis is the pathway of choice in mild mitochondrial dysfunction. There is not much 
data on the role of FGF21 in heart in association with mitochondrial disease. However, it has 
been shown previously that FGF21 protects heart from apoptosis in diabetic mouse models 
via the ERK1/2 signaling pathway (C. Zhang et al., 2015). ERK1/2 belongs to the family of 
mitogen-activated protein kinases (MAPKs) and it is able to phosphorylate a great number of 
different kinases and transcription factors to regulate cellular development, cell survival and 
death. Activation of ERK1/2 controls the regulation of meiosis, mitosis, and post-mitotic 
function, which are closely related to cell growth, cell proliferation, differentiation, migration, 
and survival and therefore this pathway is crucial in understanding cancer biology. The 
canonical MAPK pathway is activated by a process in which the growth factors, such as 
fibroblast growth factors (FGFs) and epidermal growth factors (EGFs), bind to the cell-
surface receptors, mainly tyrosine kinase receptors (RTK), resulting in the dimerization and 
trans-phosphorylation of RTK (F. Liu, Yang, Geng, & Huang, 2018). Well-known 
intracellular targets of ERK1/2 include Elk-1, c-Fos, MSK-1, c-Myc, GATA4, Ets1/2, Mcl-1, 
Bcl-XL, IEX-1 etc. (Xu et al., 2016).  
   Our result suggests that severe mitochondrial dysfunction as seen in DARS2-deficient 
mice, might use alternative signaling pathways and skip the FGF21-ERK1/2 axis. On the 
other hand, in moderate mitochondrial deficiency, ERK1/2 might be the pathway of choice 
for FGF21. But the question still remains – what are the effects of this FGF21-ERK1/2 
activation? 
    Label-free quantification of the whole proteome in heart showed significant 
upregulation of sarcomeric proteins in DKO. Cardiac muscle as well as skeletal muscle 
consists of sarcomeres, which are built of thick and thin filaments, comprised of myosin and 
actin respectively. Those proteins and the ones spanning between filaments, such as vimentin, 
myomiosin and nebulin, are very important for cardiac contractility (Martonosi, 2000). This 
increase in contractile proteins in cardiac pathology is in the line with previous research on 
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skeletal musle myopathies, where the accumulation of those proteins was also observed on 
proteomics data (Maerkens et al., 2016). Interestingly, we also detected a large number of 
histone proteins being upregulated in DKO, which might suggest changes in chromatin 
structure. Changes in chromatin structure are known to alter transcriptional programs of cells 
and this was already shown to be the case in adult-onset cardiomyopathies, where the 
transcriptional reprogramming led to hyper-contractility followed by heart failure (Mahmoud 
& Poizat, 2013). However, we could not observe other signs of failing heart in our DKO 
mice, which were analyzed at 16 weeks. Therefore, analysis of older animals might reveal if 
the cardiomyopathy is in development. Another puzzling result obtained from the whole 
proteome data is a confident upregulation of the cytoplasmic 60S ribosomal proteins in DKO 
mice. The ribosome has historically been considered to have no cell-specific functions, but 
rather serving a "housekeeping" role. Yet, there are novel data in literature pointing out on 
non-canonical roles of ribosomal proteins. In one study, it has been shown that the 60S 
ribosomal protein L13a is a molecular switch for translational silencing of a gene that might 
be involved in oxidative damage and is a risk for cardiovascular diseases. Moreover, they 
have demonstrated that L13a protein can bind 3’UTR element and act as a regulatory protein 
of translation (Mazumder et al., 2003). For instance, RPL26, that we detected in our 
proteomics data, was shown to trigger cell-death by binding the 5’UTR of p53 gene (Takagi, 
Absalon, McLure, & Kastan, 2005). Furthermore, RPL3L, also seen in our data, was shown to 
be a negative regulator of striated muscle growth (Chaillou, Zhang, & McCarthy, 2016). The 
roles of individual RPs are difficult to predict, and the question is if the increase in 60S 
ribosomal proteins specifically represent a new stress response. Not so much is known about 
this, but there are some data showing a consistent dysregulation of individual RPs in different 
diseases (Guimaraes & Zavolan, 2016). Moreover, our phospho-proteomics data show 
upregulation of ribosomal proteins in DKO compared to DARS2-deficient mice. Further 
studies are needed to investigate if there is a functional connection between FGF21 and 
changes observed in the proteomics data. 
 One of the first identified actions of FGF21 was its ability to increase thermogenesis 
via UCP1 induction and expression of other thermogenesis genes in BAT. Moreover, it has 
been shown that cold exposure induced BAT Fgf21 expression through beta-adrenergic 
signaling that further induced activating transcription factor 2 (ATF2) (Hondares et al., 2011). 
This regulation of non-shivering thermogenesis by FGF21 was not limited only to BAT, but it 
also involved iWAT and eWAT, where appearance of Ucp1-expressing multilocular brown-
like adipocytes was detected (Fisher et al., 2012). Interestingly, in CLPP-deficient mice we 
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observed increased fat depots in BAT, which was exacerbated with the loss of FGF21. 
However, we have not observed changes in UCP1 levels, despite the dissociation of lipid 
storage from lipid use, contrary to the DARS2/FGF21 model. Previously reported data from 
our lab showed decreased UCP1 levels in female Clpp KO mice upon cold exposure (Becker 
et al., 2018). Furthermore, we observed a browning phenotype in iWAT and eWAT of CLPP-
deficient mice. eWAT was presented with a decrease in adipocyte size in CLPP-deficient 
mice, which was abrogated by the FGF21 loss. On the other hand, iWAT was featured with 
the appearance of brown-like adipocytes, but this effect was also diminished with the loss of 
FGF21. This cytokine is also required for physiological adaptations during cold exposure, 
where it has been shown to stabilize protein levels of PGC-1α in order to exert its effects 
(Fisher et al., 2012). However, a very recent work has demonstrated that cold-induced 
browning of iWAT was not dependent on FGF21. RNA sequencing revealed major changes 
in UCP1 - deficient BAT and iWAT, but the loss of FGF21 had no effects at all (Keipert et 
al., 2017). In conclusion, FGF21 release from BAT of UCP1 - deficient mice is probably a 
compensatory mechanism. Additionally, transcriptional profiling in Ucp1 KO iWAT showed 
a selective increase in the Pm20d1 gene, which codes for an enzyme that has been suggested 
to be involved in n-acyl amino acids generation, which were earlier proposed to be 
endogenous uncouplers (Keipert et al., 2017; Long et al., 2016). However, these alternative 
thermogenic mechanisms require more in-depth investigations using mouse models.  
In our mouse models, the loss of FGF21 exacerbates the whitening phenotype, but this 
is not in relation with UCP1 levels. Further analyses of the transcriptome and proteome are 
needed in order to look for potential alternative mechanisms of the whitening. 
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4.5 Integrated whole proteome data show FGF21-dependent changes. 
 
 All three mouse models showed that FGF21 has no effect on the gross phenotype of 
the mice. However, some changes on the molecular level were detected. Starting with the 
DKO_wb mice, whole proteome data revealed significant influence of FGF21 on 
cardiomyopathy markers, ribosomal stress and structural components of chromatin. This does 
imply that FGF21 might have a role in cardiac stress, but the mechanisms are still up to be 
elucidated. Interestingly, the most prominent change in the whole proteome data from heart 
related to FGF21 loss is a severe decrease of the mitochondrial NAD(P)-transhydrogenase, 
(NNT) in both FGF21 and DKO_wb. In comparison, data from DKO mice showed the NNT 
downregulation in single Fgf21 KO, but to lesser extent. This might be due to the age 
difference, since the mice lacking DARS2 were analyzed at 6 weeks and Clpp KO mice at 16 
weeks. Curiously, we have not observed this change in tissue-specific Fgf21 KO. NNT is an 
inner mitochondrial membrane integral protein and it uses the proton motive force generated 
by the ETC to catalyze the transfer of hydride (H−) between NAD(H) and NADP(+) . Under 
physiological conditions, NNT uses energy from the mitochondrial proton gradient to produce 
NADPH, which is used for the TCA intermediates replenishment and in free radical 
detoxification (Ciccarese & Ciminale, 2017). Silencing of this enzyme in cells showed 
increased sensitivity to oxidative stress (Yin, Sancheti, & Cadenas, 2012). Reduced NNT 
activity is responsible for diminished insulin secretion and impairment in glucose metabolism 
in C57BL/6J mice that have a naturally occurring in-frame five-exon deletion in Nnt that 
removes exons 7-11 (Freeman, Hugill, Dear, Ashcroft, & Cox, 2006). However, we used 
C57BL/6N strain in our study, which has a wild-type version of Nnt. Curiously, it has been 
reported that in situations of pathological cardiac workload, NNT can reverse its function and 
oxidize NADPH to regenerate NADH for ATP, at the cost of an antioxidative capacity. This 
reverse mode of NNT increases ROS emission and leads to maladaptive heart remodeling 
(Nickel et al., 2015). 
 Gpt2 codes for a mitochondrial alanine aminotransferase, that catalyzes the 
transamination reaction in the glucose-alanine cycle, which exports amino acid catabolites 
from muscle to the urea cycle. We detected downregulation of this enzyme in our 16-week-
old Fgf21 KO, but not the 6-week-old mice. Interestingly, elevated plasma alanine was 
reported to be a biomarker of pediatric mitochondrial diseases (Shatla et al., 2014). On the 
other hand, GPT2 was more than 4-fold-increased in CLPP-deficient hearts, which was 
balanced out in DKO_wb. Another mitochondrial enzyme decreased in Fgf21 KO is pyruvate 
dehydrogenase kinase isoform 4 (PDK4), which is phosphorylating and inhibiting pyruvate 
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dehydrogenase and thereby reduces the capacity for glucose oxidation (Chambers et al., 
2011). It is known from literature that both Fgf21 and Pdk4 are targets of hepatic PPARα 
(Vernia et al., 2014) and that administration of FGF21 in hepatocytes induces PDK4 levels, 
which is in line with previous findings that FGF21 improves FAO (Samms et al., 2015). A 
mitochondrial protein affected by FGF21 depletion in CLPP-deficient mice is NADH-
cytochrome b5 reductase 1 (CYB5R1). This enzyme is involved in desaturation and 
elongation of fatty acids, cholesterol biosynthesis, and, in erythrocytes, methemoglobin 
reduction (Plitzko et al., 2016). Moreover, Cyb5r1 was shown to be a target of ATF4 and 
MYC in mouse hearts with mitochondrial dysfunction (Kuhl et al., 2017). In this interesting 
study, they compared several mouse models with mitochondrial dysfunction in heart, 
differing in severity and onset of the phenotype. Strikingly, ALDH18A1 - the first enzyme in 
glutamate to proline conversion pathway, was among the most upregulated proteins in almost 
all the knockouts (Kuhl et al., 2017). Our study has shown that this enzyme was immensely 
upregulated in DARS2-deficient hearts, but the loss of FGF21 did not have any effect on it. 
Moreover, ALDH18A1 was increased in CLPP-deficient hearts to a much lesser extent, and 
also not influenced by the FGF21 depletion. Moreover, enzymes of one-carbon metabolism 
were shown to be among the most upregulated proteins in all of our models, but FGF21 also 
has no influence on their levels. However, phospho-proteomics data from DARS2 and 
DKO_fl mice showed that purine metabolism pathways, which are tightly regulated by one-
carbon metabolism, were enriched in the latter. Furthermore, the enrichment of the phospho-
proteome also showed upregulation of PPARa signaling in both whole-body and tissue-
specific DKO. In DARS2-deficient mice lacking FGF21 in whole body, alanine, aspartate and 
glutamate metabolism pathways were upregulated. Notably, the importance of glutamate got a 
lot of attention lately and it was demonstrated that glutamine-glutamate influx into 
mitochondria delivers α-ketoglutarate to the TCA cycle for the generation of high-energy 
molecules such as NADH and FADH2. The oxidation of α-ketoglutarate is an OXPHOS-
independent energy-generating pathway offering a potentially significant source of ATP in 
mtDNA mutant cells (Q. Chen et al., 2018).  
 It is very challenging to draw a conclusion about the role of FGF21 from the 
integrated proteomics data obtained from different mouse models representing mild and 
severe mitochondrial dysfunction. It might be that FGF21 is associated with modulation of 
how energy is being used in the time of stress, but it is not a crucial mediator of these stress 
responses seen in mitochondrial dysfunction. Potentially, FGF21 might be important for ROS 
regulation and its function in signaling through NNT. Further functional analyses of NNT, 
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PDK4 and different aminotransferases are needed to answer if those changes were specifically 
FGF21-dependent. Metabolomics data would yield additional clues on whole-body 
metabolism, especially the amino-acid content and preferentially used energy sources in the 
time of mitochondrial stress of different severity.  
 
 
4.6  Summary 
 
 Our results demonstrate that FGF21 depletion in mouse models with either mild or 
severe mitochondrial dysfunction does not change the gross phenotype of the mice. However, 
our proteomics data showed changes in cardiomyopathy markers with FGF21 depletion in 
CLPP-deficient mice, which are featured with mild complex I deficiency and a leaner 
phenotype. Moreover, the enzymes involved in glucose/fatty-acid/amino-acids metabolism, 
such as NNT, PDK4 and GPT2 showed immense decrease in 16-week-old whole-body Fgf21 
KO mice. Furthermore, the ERK1/2 signaling axis is abrogated with the loss of FGF21 in 
Clpp KO mice, while in the model of severe cardiomyopathy induced by DARS2 depletion, 
ERK1/2 cascade is active even in the absence of FGF21, suggesting alternative compensatory 
pathways. This result proposes a more relevant role of this cytokine in late-onset 
mitochondrial diseases and its expression might be dose-dependent, mirroring the level of 
stress.  
 This research is contributing to the general knowledge of FGF21 in mitochondrial 
disease and cardiomyopathy, and to our knowledge, it is the first study where FGF21 was 
depleted in different mouse models of mitochondrial dysfunction to access its cardiac role. 
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Abstract
Althoughmitochondria are ubiquitous, each mitochondrial disease has surprisingly distinctly different pattern of tissue and
organ involvement. Congruently, mutations in genes encoding for different mitochondrial tRNA synthetases result in the
development of a very flamboyant group of diseases. Mutations in some of these genes, including aspartyl-tRNA synthetase
(DARS2), lead to the onset of a white matter disease—leukoencephalopathy with brainstem and spinal cord involvement, and
lactate elevation (LBSL) characterized by progressive spastic ataxia and characteristic leukoencephalopathy signature with
multiple long-tract involvements. Puzzled by the white matter disease phenotypes caused by DARS2 deficiency when numer-
ous other mutations in the genes encoding proteins involved in mitochondrial translation have a detrimental effect predomi-
nantly on neurons, we generated transgenic mice in which DARS2 was specifically depleted in forebrain-hippocampal neu-
rons or myelin-producing cells. Our results now provide the first evidence that loss of DARS2 in adult neurons leads to strong
mitochondrial dysfunction and progressive loss of cells. In contrast, myelin-producing cells seem to be resistant to cell death
induced by DARS2 depletion despite robust respiratory chain deficiency arguing that LBSL might originate from the primary
neuronal and axonal defect. Remarkably, our results also suggest a role for early neuroinflammation in the disease progres-
sion, highlighting the possibility for therapeutic interventions of this process.
Introduction
Although mitochondrial diseases are often multisystemic, brain
and muscle are the most commonly affected tissues. Central ner-
vous system (CNS) involvement in mitochondrial disorders is clini-
cally heterogeneous, manifesting as epilepsy, stroke-like episodes,
migraine, ataxia, spasticity, extrapyramidal or hypophysial abnor-
malities, bulbar dysfunction, psychiatric abnormalities or neuropsy-
chological deficits. Leucoencephalopathy has also been added to
this long list of symptoms (1). Leucoencephalopathy with brain
stem and spinal cord involvement and high brain lactate (LBSL) is a
childhood or juvenile-onset disorder clinically characterized by
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slowly progressive cerebellar ataxia and spasticity with dorsal col-
umn dysfunction (2). LBSL is defined by a characteristic magnetic
resonance imaging showing signal abnormalities in the cerebral
white matter, specific brain stem and spinal cord tracts.
Additionally, there are spectroscopic findings of increased lactate in
the abnormal white matter in almost all affected individuals (1–3).
LBSL is caused by recessive mutations in the DARS2 gene,
which encodes the mitochondrial aspartyl-tRNA synthetase (1).
DARS2 belongs to the group of mitochondrial tRNA synthases
(mtARSs), which differ from their cytoplasmic counterparts (4).
These enzymes are responsible for the first step in mitochondrial
protein synthesis that involves covalently attaching an amino
acid to its cognate tRNA in a process referred to as tRNA charging
or loading (4). Howmutations in this ubiquitously expressed gene
cause a disorder in which tracts of the central and peripheral ner-
vous systems (PNS) are selectively affected is unexplained. An in-
creased number of patients with DARS2 mutations indicates that
the phenotypic spectrum in LBSL is much wider than originally
assumed. Adult-onset oligosymptomatic cases were described as
well as patients with infantile onset, rapid neurological deteriora-
tion and early demise (5). Almost all patients are compound het-
erozygous for different DARS2 mutations of which one is almost
invariably a splice site mutation in intron 2, upstream of exon 3
(1). As a consequence, exon 3 is not included in the messenger
RNA, leading to a frameshift, premature stop and absence of a
functional protein (6). Other mutations in DARS2 include dele-
tions, non-sense, missense and splice site mutations, for which
very little, if any, molecular data are available. More recently, an-
other white matter disease characterized by hypomyelination
(HBSL—hypomyelination with brain stem and spinal cord in-
volvement) has been associated with the mutations in DARS2
gene (7). Intriguingly, a majority of other mitochondrial diseases
caused by mutations that disrupt mitochondrial protein synthe-
sis usually lead to syndromes with devastating consequences in
neurons, while DARS2mutations leading to LBSL or HBSL suggest
a primary defect in white matter (1,7). To shed more light on this
important question, we generated transgenic mice in which
DARS2 was specifically depleted in forebrain-hippocampal neu-
rons ormyelin-producing cells.
Our analysis revealed that loss of DARS2 in adult neurons
leads to strong mitochondrial dysfunction accompanied by an
early inflammation response and progressive loss of cells.
Remarkably, DARS2 deficiency in adult myelin-producing cells,
despite clear signs of high level of mitochondrial dysfunction,
had no effect on survival, inflammatory response ormyelination.
Results and Discussion
We recently demonstrated that DARS2 is an essential protein
needed for early mammalian development, as depletion of
DARS2 in the whole body leads to lethality around the time of
organogenesis (8). To analyse the role of DARS2 in diverse neu-
ral cell types, we generated two different models where condi-
tional Dars2 mice (Dars2fl/fl) were bred with mice that
postnatally express the Cre recombinase specifically in neurons
or in myelin producing cells. Neuron-specific DARS2-deficient
mice were obtained by mating Dars2fl/fl to mice expressing Cre
recombinase under the calcium/calmodulin-dependent kinase
II alpha promoter (CaMKIIa-Cre) resulting in Dars2fl/fl; CaMKIIa-
Cre mice (referred to as Dars2NEKO mice). In this model, Cre
recombinase is active in forebrain, hippocampus and striatum
neurons from postnatal Day 14, with maximal recombination at
postnatal Day 29 (9). To deplete DARS2 in myelin-producing
cells, we used mice that express Cre recombinase under the
control of the tamoxifen-inducible proteolipid 1 promoter (Plp1-
CreERT), which allows temporal control of the recombination
(10). The resulting Dars2fl/fl; Plp-CreERT animals (referred to as
Dars2MYKO mice) were injected intraperitoneally with tamoxifen
for five consecutive days at 4weeks of age. Recently, we demon-
strated high sensitivity and specificity of the Cre expression in
oligodendrocytes using this protocol, after crossing Plp1-CreERT
mice with a reporter transgenic line expressing a floxed, mito-
chondrially targeted YFP (ROSA26þ/SmY) (11). Using this specific
timing for the activation of Cre-mediated recombination in PLP
positive cells, we ensured that DARS2 depletion occurs at about
the same time in both models.
Progressive degeneration of cortex and hippocampus
owing to massive cell loss observed in DARS2NEKOmice
Initially, we followed the development of phenotypes by moni-
toring the growth curves in both transgenic lines. We did not
observe any change in the growth curves of Dars2MYKO mice,
while Dars2NEKO animals had a lower weight gain already at the
time of weaning, and this became more prominent around
15weeks of age (Supplementary Material, Fig. S1A). The gross
morphology and weight of Dars2NEKO brains did not change until
around 24-26weeks of age when obvious loss of brain mass oc-
curred, with a strong atrophy of the forebrain (Fig. 1A). Early on,
most mice showed no obvious behavioral abnormalities, but
around 27-28weeks of age some mice started scratching their
necks and faces, resulting in self-inflicted wounds, at which
point mice had to be sacrificed (Supplementary Material, Fig.
S1B). In the rest of Dars2NEKO cohort, progressive nature of the
phenotype led to a shorter lifespan of up to 32-34weeks of age.
In contrast, neither changes in gross appearance, body weight
nor behavior in Dars2MYKO mice were observed (up until
80weeks of age when the mice were terminated).
In agreement with previous results, no clear change in struc-
ture, morphology and size of Dars2NEKO cortex and hippocampus
was observed at 20weeks of age. However, a significant decrease
of the cortical thickness was detected at 28weeks of age, accom-
panied by an apparent decrease in mean hippocampal area (Fig.
1B and C). Curiously, the number of cells within cortical and hip-
pocampal area seemed increased (Fig. 1B), suggesting that a pro-
gressive atrophy is accompanied by cellular infiltration, most
likely caused by an immune response. Conversely, a number of
neurons within the stratum granulosum of the dentate gyrus
(DG) or parts of the stratum pyramidale of the cornu ammonis
(primarily CA1 and CA2) was prominently reduced in 28-week-
old Dars2NEKO mice (Supplementary Material, Fig. S1C and D). An
increasing level of pyknotic cells with clear signs of chromatin
condensation suggested an irreversible state of heading into cell
death (Supplementary Material, Fig. S1C and E). Vacuolar lesions
in the same brain regions of the 28-week-old Dars2NEKO mice fur-
ther implied cell loss (Supplementary Material, Fig. S1C–E).
Transmission electron microscopy of the hippocampus area in
the 28-week-old Dars2NEKO brain revealed less dense mitochon-
dria that presented an apparent loss of lamellar-shaped cristae as
a clear sign of mitochondrial dysfunction in these cells (Fig. 1D).
Next, we used the TUNEL assay to detect nuclear DNA frag-
mentation, a hallmark of cells undergoing apoptosis. A massive
increase in apoptosis occurred at 20weeks of age (Fig. 2A and B;
Supplementary Material, Fig. S2), although at this time no ap-
parent morphological changes were detected in the same brain
regions (Fig. 1B). Remarkably, apoptotic cells in distinct brain re-
gions seem to appear at different dynamics; neurons in the
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second and third cortical layer of retrosplenial area (RS) undergo
considerable apoptosis only around 20weeks of age, while in
the rest of the cortex massive apoptotic cell death is observed
until 26weeks of age (Fig. 2A and B; Supplementary Material,
Fig. S2). At 28weeks of age, almost no TUNEL-positive nuclei
could be observed, suggesting that the majority of them had al-
ready been lost (Fig. 2A and B; Supplementary Material, Fig. S2).
In general, cortical neurons seem to be more vulnerable to
the loss of DARS2 and mitochondrial translation than hippo-
campal neurons (Fig. 2A and 2C). The hippocampal CA1 region
displayed a high occurrence of progressive apoptotic cells with
increased age, while in the DG region, despite having a large
number of COX deficient cells, only a few neurons seemed to
undergo apoptosis. The variances in the cell death dynamics
might be a result of differences in neuronal types and physiol-
ogy, and therefore their reliance on mitochondrial respiratory
function. Indeed, selective neuronal vulnerability to oxidative
stress (12), Parkinson’s disease (13) or Alzheimer’s disease (14)
was previously described suggesting distinctive metabolic pro-
files in different brain regions.
Strong mitochondrial deficiency and neuroinflammation
precede loss of DARS2-deficient neurons
Severe respiratory chain deficiency was observed already at
15weeks of age, and reached its peak in 20weeks old Dars2NEKO
brains (Fig. 3A). The number of COX deficient cells markedly de-
creased from 24weeks on, likely owing to the massive apoptosis
of DARS2-deficient cells (Fig. 2A). As a result, 28-week-old brains
had almost no COX()SDH(þ) (Complex IV deficient/Complex II
positive cells), but a severely reduced cortex. It also became ap-
parent that, instead of cell bodies, Dars2NEKO mice had holes
throughout the hippocampus and cortex area (Fig. 3A). Analysis
of mitochondrial respiratory chain (MRC) enzyme activities in
neocortical samples demonstrated decreased activities of com-
plexes containing critical mitochondrial DNA (mtDNA)-encoded
subunits, in 28-week-old Dars2NEKO mice (Fig. 3B). The observed
alterations in the MRC levels and enzyme activities matched
the reduction in the amount of fully assembled complex I (C I)
and IV (C IV—COX) in Dars2NEKO mice (Fig. 3C). The F1 subcom-
plex of complex V (C V) was also detected in Dars2NEKO mito-
chondria, implying a defect in mitochondrial protein synthesis,
as previously reported (8,15,16). Remarkably, at 28weeks of age,
mitochondrial de novo protein synthesis in Dars2NEKO cortex ap-
peared better than at 22weeks of age (Fig. 3D). This is likely ow-
ing to vast loss of DARS2-deficient cells at 28weeks, hence the
majority of mitochondria in these samples stems from other
cell types, unaffected by Cre-mediated deletion of Dars2.
The essential role of the OXPHOS function in neurons has
been previously demonstrated in other mouse models. Tissue-
specific depletion of Tfam in forebrain and hippocampus neurons
(TfamL/L; CamKIIa-Cre) guided the reduction of mtDNA levels and
Figure 1. Analyses of cortex and hippocampus degeneration in control (Ctrl) and Dars2NEKO (NEKO) mice. (A) Brain weights of Ctrl and NEKO mice at the indicated age;
representative photographs of isolated brains from both knockout and control mice at the indicated age. Bars present mean levels6SD. Statistical difference was calcu-
lated by Student’s t-test; **P<0.005, ***P<0.001 (n¼35). (B) Representative Nissl staining (Scale bars: 500 lm) of hippocampal regions of Ctrl and NEKOmice at indicated
age. Close-ups are for the indicated areas. (C) Quantification of brain cortical thickness [mm] at the indicated age in Ctrl and NEKO mice; bars represent mean levels
6SD. Statistical difference was calculated by Student’s t-test; **P<0.005, ***P<0.001 (n¼3–5). (D) Representative transmission electron micrographs (Scale bar: 0.5 lm) of
Ctrl and NEKO 29-week-old mice.
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strong respiratory chain deficiency from four months of age, re-
sulting in a severe, progressive neurodegeneration and massive
apoptosis (17). A complete loss of the complex I (C I) NDUFS4 sub-
unit (Ndufs4/) resulted primarily in a CNS defect and rapid de-
velopment of a Leigh-like phenotype characterized by ataxia,
blindness, retarded growth rate, lethargy and increased serum
lactate, leading to premature death at about 7weeks of age (18).
Similarly, depletion of Cox10 in neurons (Cox10L/L; CaMKIIa-Cre)
rendered them respiratory-deficient already at 2months of age in
both the cortex and hippocampus areas, while the neurodegener-
ative phenotype progressed slowly until the ages of 8 and
12months when the mice die (19,20). Typically, there is a time lag
between the occurrence of OXPHOS deficiency and onset of neu-
rodegeneration (17,20), during which neurons seems to compen-
sate for the disruption of oxidative phosphorylation. Increased
glycolysis and support from other cell types have been proposed
to account for this (21). However, here we show that DARS2 de-
pletion in neurons leads to a respiratory chain deficiency around
15weeks of age that quickly culminates in the occurrence of mas-
sive cell death at 20weeks, resulting in a severe brain atrophy
(30% loss) within the next four weeks. Therefore, if existing, com-
pensatory ATP supplementation by other cell types seems to be
insufficient to maintain neuronal function for prolonged time pe-
riods in Dars2NEKOmice.
In agreement with a strong OXPHOS defect and disturbed
mitochondrial protein synthesis, increased levels of mitochon-
drial HSP70 chaperone and LONP1 protease were detected, sug-
gesting higher activation of mitochondrial stress responses,
possibly mitochondrial unfolded protein response (UPRmt), in
20-week-old Dars2NEKO animals (Supplementary Material, Fig.
S3A). Increased mitochondrial biogenesis might also contribute
to the observed change, as suggested by higher SDH levels
(Fig. 3C). Remarkably, the increase was statistically significant
only in the hippocampus, possibly owing to a higher number of
cells other than neurons in the isolated cortex samples
(Supplementary Material, Fig. S3B and C).
Neuronal degeneration frequently leads to a local change in
physiological conditions that in turn promotes an inflammatory
response and activation of microglia, which are the resident im-
mune cells of the nervous system. Indeed, we detected high lev-
els of activated microglia in the cortical and hippocampal regions
of Dars2NEKO mice, starting from 15weeks of age (Fig. 4A). The
number of infiltrated microglia in the hippocampal CA1 and DG
regions dramatically increased with age, with an almost com-
plete loss of recognizable structure at 32weeks (Fig. 4A and
Supplementary Material, Fig. S4A). On the contrary, the level of
activated microglia in the cortex (SC and RS) peaked at 20weeks
(Fig. 4A and Supplementary Material, Fig. S4A), coinciding with
the highest levels of OXPHOS deficiency observed in these
Dars2NEKO brains. The decline of reactive microgliosis over time
coincides with a more robust, apoptotic neuronal loss in the cor-
tex layers than observed in the hippocampus (Fig. 4A and 2A).
Reactive astrocytes were increasingly detected from 15weeks of
age in both, cortex and hippocampal region of Dars2NEKO mice,
further emphasizing the presence of a neuroinflammatory re-
sponse (Fig. 4B and Supplementary Material, Fig. S4B). The high-
est level of GFAP positive cells was observed around 20weeks,
and was persistently present until the end of the lifespan at
around 32weeks (Fig. 4B and Supplementary Material, Fig. S4B).
Certainly, neuroinflammation is increasingly recognized as a
contribution to processes underlying neurodegeneration.
Primarily activated in response to diseases, toxins or mechani-
cal injury, neuroinflammation is strongly associated with de-
myelinating diseases (22). It is now clear that the microgliosis
and astrogliosis primarily intended to clear up debris and sup-
port neurons in distress, when chronically activated, can con-
vert from a beneficial program into a cytotoxic insult promoting
neuronal death (22). This might be one of the mechanisms to
explain the abrupt worsening of the Dars2NEKO phenotype after
20weeks of age when we could observe massive micro- and
astrogliosis.
Remarkably, activated microglia were detected in both the
cortex and hippocampus already at 15weeks of age before any
cell death could be observed, suggesting that respiratory-
deficient cells emit specific signals leading to activation of neu-
roinflammatory processes. We previously showed that DARS2
depletion in heart and skeletal muscle leads to accumulation of
unfolded/misfolded proteins that serve as the first signal caus-
ing activation of stress signals and systemic changes in metabo-
lism (8). It is tempting to speculate that the buildup of unfolded
and/or unassembled respiratory chain subunits owing to the
DARS2 depletion, and therefore imbalanced mitochondrial de
novo protein synthesis acts as an early signal for the cell autono-
mous activation of stress responses, which might also trigger
neuroinflammatory response. This would be in agreement with
previous studies where the activation of microglia coincided
with the accumulation of misfolded proteins in Alzheimer’s dis-
ease, amyloid lateral sclerosis or Huntington’s disease (23).
DARS2 depletion in myelin-producing cells does not
affect the number of oligodendrocytes nor myelin pro-
duction, despite strong OXPHOS deficiency
In agreement with our initial observation, DARS2 depletion in
adult myelin producing cells (Dars2MYKO mice) did not affect cell
Figure 2. Apoptotic cell death in cortical and hippocampal regions in control
(Ctrl) and Dars2NEKO (NEKO) mice. (A) Representative TUNEL staining of brain
hemispheres (cortex and hippocampus regions) in Ctrl and NEKO mice at the in-
dicated age. (B, C) Quantification of TUNEL positive cells per hemisphere in the
region of cortex (B) and hippocampus (C) at the indicated age in Ctrl and NEKO
mice. Bars present mean levels 6SD. Statistical difference was calculated by
Student’s t-test; *P<0.05, ***P<0.001 (n¼3).
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survival and therefore cell numbers at either 18 or 28weeks
(Supplementary Material, Fig. S5A). Moreover, the level of mye-
lin basic protein, which is one of the most abundant proteins in
myelin sheaths, was unchanged in Dars2MYKO mice
(Supplementary Material, Fig. S5B). We also analyzed myelina-
tion in the PNS and found no difference in the thickness of mye-
lin sheaths or appearance of Schwann cells (myelin producing
cells in PNS) on both sciatic nerve and spinal cord
(Supplementary Material, Fig. S5C).
Puzzled by the initial results, we wondered if DARS2 deple-
tion causes respiratory chain deficiency in myelin producing
cells as observed in neurons. Therefore, we analyzed OXPHOS
function, again turning to COX-SDH staining. A large number of
COX-deficient cells were detected in the striatum of Dars2MYKO
mice, indicating the presence of strong OXPHOS deficiency (Fig.
5A). In the corpus callosum, the largest white matter structure
in the brain, we detected COX-deficient oligodendrocytes in
Dars2MYKO mice, and in agreement with results on PNS, no
changes in the myelination (Fig. 5C). Furthermore, a very promi-
nent stream of OXPHOS deficient axons could be detected in 15-
week-old Dars2NEKO mice (Fig. 5B), which, remarkably, also did
not affect the myelination of the corpus callosum (Fig. 5C
and D).
DARS2 deficiency in forebrain and hippocampal neurons in-
duced strong OXPHOS deficiency and neuroinflammatory re-
sponse (Fig. 4 and Supplementary Material, Fig. S4). Despite
clear evidence of strong OXPHOS deficiency in oligodendrocytes,
no signs of neuroinflammatory response were detected in
Dars2MYKO mice (Supplementary Material, Fig. S6).
Finally, using simple composite phenotype scoring system
we tested to what extent DARS2 depletion affects motor skills in
our two models (24). In accordance with previous results,
Dars2MYKO mice did not show any signs of motor dysfunction
(Fig. 5E). In contrast, DARS2 deficiency in neurons led to progres-
sive loss of motor skills characterized by tremor, ataxia and
age-dependent kyphosis (Fig. 5E).
Our results demonstrate that DARS2 deficiency in forebrain
and hippocampal neurons leads to devastating cell death and
severe neurodegeneration preceded by an early neuroinflam-
matory response (Supplementary Material, Fig. S7). The loss of
DARS2 in oligodendrocytes, despite leading to strong respiratory
deficiency, does not trigger any of these responses on either a
Figure 3. Characterization of mitochondrial function in control (Ctrl) and Dars2NEKO (NEKO) mice. (A) COX-SDH staining of brain hemispheres (cortex and hippocampus
region) in Ctrl and NEKO mice at the indicated age. (B) Relative MRC complex activities in isolated cortex mitochondria of Ctrl and NEKO mice at 28weeks of age. Bars
present mean levels 6SD. Statistical difference was calculated by Student’s t-test; *P<0.05 (n¼3). (C) Western blots for OXPHOS complexes (with indicated position of
specific complexes) and representative Coomassie Brilliant Blue (CBB) stained BN-PAGE gel in cortex mitochondria from 28-week-old Ctrl and NEKO mice.
(D) Representative gel of in organello translation of 22- and 28-week-old Ctrl and NEKOmice cortex mitochondria. CBB stained gel used as loading control.
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cellular or physiological level (Supplementary Material, Fig. S7).
Remarkably, a recent study showed that the most common
DARS2 patient mutation, located in a splice-site of intron 2, has
the strongest effect causing exon 3 exclusion in neuronal cell
lines (6). Therefore, it is tempting to conclude that LBSL in
DARS2 patients is a consequence of a primary neuronal defi-
ciency, as neurons seems to be more affected with the splice-
site mutation and here we show that they are also much more
sensitive to a Dars2 depletion than myelin producing cells.
However, one has to keep in mind that our models induce the
post-natal ablation of DARS2, whereas LBSL is typically owing to
a hypomorphic allele which partially impairs the function of
DARS2 throughout the embryonic and brain development.
Therefore, a detrimental role of the mutation during
oligodendrocyte-mediated myelinization of the developing
brain cannot be excluded in the pathogenesis of the disease.
This is in agreement with a study showing that the most
common DARS2 patient mutation located in a splice-site of in-
tron 2, has the strongest effect causing exon 3 exclusion in neu-
ronal cell lines (6).
Why would these two cell types react so differently to the
loss of respiratory chain function? A different metabolic profile
of adult oligodendrocytes and Schwann cells, enabling them to
survive primarily using glycolysis for energy production when
mitochondrial respiration is impaired, might be the main
reason. In support of this hypothesis, Schwann-cell-specific de-
pletion of Tfam (TfamL/L, P0-Cre), the mitochondrial transcription
factor A gene, which is essential for mtDNA transcription and
maintenance, did not affect cell proliferation or survival, despite
severe mtDNA depletion and respiratory chain abnormalities
(25). Oligodendrocyte-specific deletion of Cox10 (Cox10L/L; Cnp1-
Cre), an essential assembly factor for complex IV, also did not
lead to axonal degeneration, demyelination or cell death (26). In
fact, recent data suggest that oligodendrocytes’ mitochondria
may be essential for specialized functions relevant for myelin
maintenance, such as lipid synthesis or fatty acid oxidation,
rather than for ATP production (27). In agreement with this
idea, a complete ablation of the m-AAA protease using the
same promoter and Cre-induction paradigm as in this study
(Afg3l1/; Afg3l2L/L; Plp1-Cre) resulted in progressive motor dys-
function and demyelination, owing to rapid oligodendrocyte
cell death (11). In light of our results, this suggests that the im-
balance of m-AAA protease substrates, other than the ones re-
lated to respiratory chain function, is detrimental for the
myelin-producing cells of the central and PNS (11).
In summary, we provide strong in vivo evidence in support of
the hypothesis that Dars2 dysfunction, causing LBSL through
disturbances in the white matter of both central and PNS, arises
from a primary neuronal or axonal deficiency and not from a
defect of myelin-producing cells. Remarkably, our results also
highlighted neuroinflammatory processes, which coincide with
respiratory chain deficiency and precede neuronal cell loss as
possible yet unexplored targets of therapeutic interventions in
LBSL and potentially other mitochondrial diseases.
Experimental Procedures
Generation of Dars2mice
Forebrain-specific DARS2-deficient mice (NEKO) were generated
by mating Dars2loxP/loxP animals with transgenic mice express-
ing Cre recombinase under the control of CaMKIIa promoter (9).
MPC-specific DARS2-deficient mice (MYKO) were created also by
using Dars2loxP/loxP animals, mated with mice containing Plp1
driven CreER recombinase (10), whereas the activation of re-
combination was done by application of tamoxifen. Tamoxifen
(T5648, Sigma) was dissolved in a corn oil/ethanol (9:1) mixture
at a final concentration of 10mg/ml. A total of 1mg tamoxifen
was administrated by intraperitoneal injection once a day for
five consecutive days to 4weeks old mice. All genotypes were
acquired by PCR. Animal protocols were in accordance with
guidelines for humane treatment of animals and were reviewed
by the Animal Ethics Committee of the Nord-Rheine
Westphalia, Germany.
Histological analysis
Mice were anesthetized with the combination of ketamine/xyla-
zine, given intraperitoneally. Perfusion was performed intracar-
dially with phosphate buffered saline (PBS) followed by 4%
paraformaldehyde (PFA) in 0.1M PBS (pH 7.4). Isolated brains
were post-fixed in 4% PFA at 4 C (for transmission electron
microscopy analysis, post-fixed in 2% glutaraldehyde at 4 C)
overnight and then stored at 4 C in 0.05% sodium azide-PBS
(NaN3-PBS) until further analysis. After perfusion, coronal sec-
tions were cut on Leica VT1200S with a thickness of 30–40 mm.
Free floating sections were kept at 4 C in 0.05% NaN3-PBS.
For cryostat sections, freshly isolated brains were directly
embedded in Tissue-Tek (Sakura) and frozen using dry ice.
Figure 4. Neuroinflammatory processes in cortical and hippocampal areas of
control (Ctrl) and Dars2NEKO (NEKO) mice. (A and B) Representative immunofluo-
rescence merged Z-stack images of IBA1 positive microglia (A) and GFAP positive
astrocytes (B) in somatosensory cortex (SC) and the hippocampal CA1 region in
Ctrl and NEKOmice of the indicated age.
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Coronal sections were cut on a Leica CM1850 cryostat with a
thickness of 7 mm. Sections were directly mounted onto micro-
scope slides and stored at 20 C. Gallyas’ staining was per-
formed as previously described (28).
Nissl staining was performed on vibratome sections, which
were mounted on microscope slides using cromalin solution.
The sections were incubated for 45 s in Nissl solution and wash-
ing step was followed by dehydration with different ethanol
concentrations.
H&E staining was performed on cryosections using Mayer‘s
Hematoxylin solution (Sigma), and sections were mounted with
Entellan (Millipore).
TUNEL staining was performed on vibratome sections via
the ApopTag Plus Peroxidase In situ Apoptosis Detection Kit
(Millipore) according to the manufacturer’s protocol.
COX/SDH staining was performed on cryosections, with
40min of incubation in Cytochrome C solution (0.8ml 3, 3 dia-
minobenzidine tetrahydrochloride, 0.2ml 500 mM cytochrome c,
a few grains of catalase), and 40min Succinate solution (0.8ml
1.875mM nitroblue tetrazolium, 0.1ml 1.3M sodium succinate,
0.1ml 2mM phenazine methosulphate, 0.01ml 100mM sodium
azide) at 37 C in a humid chamber. Sections were washed in
PBS, dehydrated with increasing ethanol concentrations (75%
for 2min, 95% for 2min, 100% for 10min), air dried, and
mounted in D.P.X. Light microscopy images were acquired using
Leica SCN400 slidescanner. Cortical thickness and hippocampal
areas were measured in coronal brain sections of the same
rostro-caudal position in all animals. To quantify the number of
neurons in the hippocampal DG and CA1 regions, neurons were
counted in equally sized areas in the respective regions (n¼ 4
per mouse).
Immunostaining
Free-floating sections were washed extensively and pretreated
for 30min in 2% Triton X-100/PBS. Sections were permeabilized
and blocked in 0.4% Triton X-100, 10% goat serum in PBS for 1h
Figure 5. Characterization of mitochondrial function in control (Ctrl) and Dars2 MYKO (MYKO) mice. (A) Representative COX-SDH staining of brain striatum in Ctrl and
MYKO mice at 18weeks of age (Scale bars, 100 lm). (B) Representative COX-SDH staining of corpus callosum with the close-ups in NEKO and MYKO mice at 18weeks of
age. (C) Representative images of Gallyas’ myelin staining of the brain in 28-week-old Ctrl, MYKO and NEKO mice. (D) Representative immunofluorescence merged Z-
stack images of MBP positive cells in corpus callosum of Ctrl and NEKO mice at the indicated age. (E) Simple composite phenotype scoring system of NEKO and MYKO
mice compared with Ctrl at the indicated age. Bars represent mean6SD.
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at room temperature. Primary antibodies (APC 1:400, OP80,
Calbiochem), MBP (1:1000, SMI94, Covance), (GFAP 1:2000,
NeoMarkers), IBA1 (1:3000, WAKO Life Sciences) were incubated
overnight in 0.4% Triton X-100, 5% goat serum in PBS at 4 C.
After washing with PBS, secondary antibodies anti-mouse Alexa
Fluor 488 (1:2000, Invitrogen), anti-rabbit Alexa Fluor 546
(1:2000, Invitrogen) were applied in 5% goat serum in PBS for 2h.
Finally, the sections were washed in PBS and mounted using
FluorSave Reagent (Calbiochem).
Light microscopy images were acquired by Leica SCN400
slide scanner (Leica Microsystems). Evaluation and processing
was done with SlidePath Gateway Client software (version 2.0).
Fluorescent images were acquired by an Axio-Imager M2 micro-
scope, equipped with Apotome 2 (Zeiss). Images were processed
with AxioVision software (version 4.8.2).
Transmission electron microscopy
Coronal semi-thin sections (1 mm) were cut from hippocampus.
After treatment with osmium tetroxide, the tissue was embed-
ded in Epon (Fluka). For ultrastructural analyses, the tissue of
interest was selected for electron microscopy after examination
of semi-thin sections by light microscopy. Ultrathin sections
(70nm) were cut, collected on 200 mesh copper grids (Electron
Microscopy Sciences), and stained with uranium acetate (Plano
GMBH) and lead citrate (Electron Microscopy Sciences).
Western blot analysis
Protein lysates were obtained from either homogenized tissue
or isolated mitochondria, and subsequently subjected to west-
ern blot analysis as described previously (29). MEFs were lysed
with the RIPA buffer followed by sonication and lysate clear-
ance. Western blot analysis was performed using the following
primary antibodies at indicated concentrations: mtHSP70 and
LONP1 (1:1000, Abcam), Actin (1:5000, Santa Cruz), NDUFA9,
SDHA, UQCRC1, MTCO1 (1:1000, Invitrogen), ATP5A1 (1:1000,
MitoSciences). All secondary antibodies were purchased from
Sigma Aldrich and used in 1:2000 dilution. Western blot quanti-
fication was performed using the ImageJ software.
Blue native polyacrylamide gel electrophoresis (BN-
PAGE)
BN-PAGE was carried out using the NativePAGE Novex Bis-Tris
Mini Gel system (Invitrogen) according to themanufacturer’s spec-
ifications. Proteins were transferred onto a PVDF (polyvinylidene
fluoride) membrane, and immunodetection of mitochondrial
OXPHOS complexes was performed (CI: NDUFA9; CII: SDHA; CIII:
UQCRC1; CIV: MTCO1; CV: ATP5A1).
Analyses of de novo translation in isolated mitochondria
In organello translation was performed as previously described
in mitochondria from heart and liver (8). In organello proteins
synthesis was performed for 1h in presence of 35S-met at 37 C.
Mitochondria were lysed by incubation in SDS-PAGE loading
buffer. Translation products were separated by SDS-PAGE, the
gel was stained with Coomassie Brilliant Blue R-250; incubated
in Amplify solution (GE Healthcare) and newly synthesized
polypeptides were detected by autoradiography.
Respiratory chain enzyme activities
The measurements of respiratory chain enzyme complex activi-
ties and citrate synthase activity were performed as previously
described (30).
Phenotype scoring system
The protocol for simple composite scoring system was done ac-
cording to previously described protocol (24).
Statistical analysis
Two-tailed unpaired Student’s t test was used to determine sta-
tistical significance. Error bars represent standard deviation
(SD). Unless otherwise indicated, all experiments were per-
formed on three biological replicates.
Supplementary Material
Supplementary Material is available at HMG online.
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Abstract
Althoughmitochondria are ubiquitous, each mitochondrial disease has surprisingly distinctly different pattern of tissue and
organ involvement. Congruently, mutations in genes encoding for different mitochondrial tRNA synthetases result in the
development of a very flamboyant group of diseases. Mutations in some of these genes, including aspartyl-tRNA synthetase
(DARS2), lead to the onset of a white matter disease—leukoencephalopathy with brainstem and spinal cord involvement, and
lactate elevation (LBSL) characterized by progressive spastic ataxia and characteristic leukoencephalopathy signature with
multiple long-tract involvements. Puzzled by the white matter disease phenotypes caused by DARS2 deficiency when numer-
ous other mutations in the genes encoding proteins involved in mitochondrial translation have a detrimental effect predomi-
nantly on neurons, we generated transgenic mice in which DARS2 was specifically depleted in forebrain-hippocampal neu-
rons or myelin-producing cells. Our results now provide the first evidence that loss of DARS2 in adult neurons leads to strong
mitochondrial dysfunction and progressive loss of cells. In contrast, myelin-producing cells seem to be resistant to cell death
induced by DARS2 depletion despite robust respiratory chain deficiency arguing that LBSL might originate from the primary
neuronal and axonal defect. Remarkably, our results also suggest a role for early neuroinflammation in the disease progres-
sion, highlighting the possibility for therapeutic interventions of this process.
Introduction
Although mitochondrial diseases are often multisystemic, brain
and muscle are the most commonly affected tissues. Central ner-
vous system (CNS) involvement in mitochondrial disorders is clini-
cally heterogeneous, manifesting as epilepsy, stroke-like episodes,
migraine, ataxia, spasticity, extrapyramidal or hypophysial abnor-
malities, bulbar dysfunction, psychiatric abnormalities or neuropsy-
chological deficits. Leucoencephalopathy has also been added to
this long list of symptoms (1). Leucoencephalopathy with brain
stem and spinal cord involvement and high brain lactate (LBSL) is a
childhood or juvenile-onset disorder clinically characterized by
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slowly progressive cerebellar ataxia and spasticity with dorsal col-
umn dysfunction (2). LBSL is defined by a characteristic magnetic
resonance imaging showing signal abnormalities in the cerebral
white matter, specific brain stem and spinal cord tracts.
Additionally, there are spectroscopic findings of increased lactate in
the abnormal white matter in almost all affected individuals (1–3).
LBSL is caused by recessive mutations in the DARS2 gene,
which encodes the mitochondrial aspartyl-tRNA synthetase (1).
DARS2 belongs to the group of mitochondrial tRNA synthases
(mtARSs), which differ from their cytoplasmic counterparts (4).
These enzymes are responsible for the first step in mitochondrial
protein synthesis that involves covalently attaching an amino
acid to its cognate tRNA in a process referred to as tRNA charging
or loading (4). Howmutations in this ubiquitously expressed gene
cause a disorder in which tracts of the central and peripheral ner-
vous systems (PNS) are selectively affected is unexplained. An in-
creased number of patients with DARS2 mutations indicates that
the phenotypic spectrum in LBSL is much wider than originally
assumed. Adult-onset oligosymptomatic cases were described as
well as patients with infantile onset, rapid neurological deteriora-
tion and early demise (5). Almost all patients are compound het-
erozygous for different DARS2 mutations of which one is almost
invariably a splice site mutation in intron 2, upstream of exon 3
(1). As a consequence, exon 3 is not included in the messenger
RNA, leading to a frameshift, premature stop and absence of a
functional protein (6). Other mutations in DARS2 include dele-
tions, non-sense, missense and splice site mutations, for which
very little, if any, molecular data are available. More recently, an-
other white matter disease characterized by hypomyelination
(HBSL—hypomyelination with brain stem and spinal cord in-
volvement) has been associated with the mutations in DARS2
gene (7). Intriguingly, a majority of other mitochondrial diseases
caused by mutations that disrupt mitochondrial protein synthe-
sis usually lead to syndromes with devastating consequences in
neurons, while DARS2mutations leading to LBSL or HBSL suggest
a primary defect in white matter (1,7). To shed more light on this
important question, we generated transgenic mice in which
DARS2 was specifically depleted in forebrain-hippocampal neu-
rons ormyelin-producing cells.
Our analysis revealed that loss of DARS2 in adult neurons
leads to strong mitochondrial dysfunction accompanied by an
early inflammation response and progressive loss of cells.
Remarkably, DARS2 deficiency in adult myelin-producing cells,
despite clear signs of high level of mitochondrial dysfunction,
had no effect on survival, inflammatory response ormyelination.
Results and Discussion
We recently demonstrated that DARS2 is an essential protein
needed for early mammalian development, as depletion of
DARS2 in the whole body leads to lethality around the time of
organogenesis (8). To analyse the role of DARS2 in diverse neu-
ral cell types, we generated two different models where condi-
tional Dars2 mice (Dars2fl/fl) were bred with mice that
postnatally express the Cre recombinase specifically in neurons
or in myelin producing cells. Neuron-specific DARS2-deficient
mice were obtained by mating Dars2fl/fl to mice expressing Cre
recombinase under the calcium/calmodulin-dependent kinase
II alpha promoter (CaMKIIa-Cre) resulting in Dars2fl/fl; CaMKIIa-
Cre mice (referred to as Dars2NEKO mice). In this model, Cre
recombinase is active in forebrain, hippocampus and striatum
neurons from postnatal Day 14, with maximal recombination at
postnatal Day 29 (9). To deplete DARS2 in myelin-producing
cells, we used mice that express Cre recombinase under the
control of the tamoxifen-inducible proteolipid 1 promoter (Plp1-
CreERT), which allows temporal control of the recombination
(10). The resulting Dars2fl/fl; Plp-CreERT animals (referred to as
Dars2MYKO mice) were injected intraperitoneally with tamoxifen
for five consecutive days at 4weeks of age. Recently, we demon-
strated high sensitivity and specificity of the Cre expression in
oligodendrocytes using this protocol, after crossing Plp1-CreERT
mice with a reporter transgenic line expressing a floxed, mito-
chondrially targeted YFP (ROSA26þ/SmY) (11). Using this specific
timing for the activation of Cre-mediated recombination in PLP
positive cells, we ensured that DARS2 depletion occurs at about
the same time in both models.
Progressive degeneration of cortex and hippocampus
owing to massive cell loss observed in DARS2NEKOmice
Initially, we followed the development of phenotypes by moni-
toring the growth curves in both transgenic lines. We did not
observe any change in the growth curves of Dars2MYKO mice,
while Dars2NEKO animals had a lower weight gain already at the
time of weaning, and this became more prominent around
15weeks of age (Supplementary Material, Fig. S1A). The gross
morphology and weight of Dars2NEKO brains did not change until
around 24-26weeks of age when obvious loss of brain mass oc-
curred, with a strong atrophy of the forebrain (Fig. 1A). Early on,
most mice showed no obvious behavioral abnormalities, but
around 27-28weeks of age some mice started scratching their
necks and faces, resulting in self-inflicted wounds, at which
point mice had to be sacrificed (Supplementary Material, Fig.
S1B). In the rest of Dars2NEKO cohort, progressive nature of the
phenotype led to a shorter lifespan of up to 32-34weeks of age.
In contrast, neither changes in gross appearance, body weight
nor behavior in Dars2MYKO mice were observed (up until
80weeks of age when the mice were terminated).
In agreement with previous results, no clear change in struc-
ture, morphology and size of Dars2NEKO cortex and hippocampus
was observed at 20weeks of age. However, a significant decrease
of the cortical thickness was detected at 28weeks of age, accom-
panied by an apparent decrease in mean hippocampal area (Fig.
1B and C). Curiously, the number of cells within cortical and hip-
pocampal area seemed increased (Fig. 1B), suggesting that a pro-
gressive atrophy is accompanied by cellular infiltration, most
likely caused by an immune response. Conversely, a number of
neurons within the stratum granulosum of the dentate gyrus
(DG) or parts of the stratum pyramidale of the cornu ammonis
(primarily CA1 and CA2) was prominently reduced in 28-week-
old Dars2NEKO mice (Supplementary Material, Fig. S1C and D). An
increasing level of pyknotic cells with clear signs of chromatin
condensation suggested an irreversible state of heading into cell
death (Supplementary Material, Fig. S1C and E). Vacuolar lesions
in the same brain regions of the 28-week-old Dars2NEKO mice fur-
ther implied cell loss (Supplementary Material, Fig. S1C–E).
Transmission electron microscopy of the hippocampus area in
the 28-week-old Dars2NEKO brain revealed less dense mitochon-
dria that presented an apparent loss of lamellar-shaped cristae as
a clear sign of mitochondrial dysfunction in these cells (Fig. 1D).
Next, we used the TUNEL assay to detect nuclear DNA frag-
mentation, a hallmark of cells undergoing apoptosis. A massive
increase in apoptosis occurred at 20weeks of age (Fig. 2A and B;
Supplementary Material, Fig. S2), although at this time no ap-
parent morphological changes were detected in the same brain
regions (Fig. 1B). Remarkably, apoptotic cells in distinct brain re-
gions seem to appear at different dynamics; neurons in the
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second and third cortical layer of retrosplenial area (RS) undergo
considerable apoptosis only around 20weeks of age, while in
the rest of the cortex massive apoptotic cell death is observed
until 26weeks of age (Fig. 2A and B; Supplementary Material,
Fig. S2). At 28weeks of age, almost no TUNEL-positive nuclei
could be observed, suggesting that the majority of them had al-
ready been lost (Fig. 2A and B; Supplementary Material, Fig. S2).
In general, cortical neurons seem to be more vulnerable to
the loss of DARS2 and mitochondrial translation than hippo-
campal neurons (Fig. 2A and 2C). The hippocampal CA1 region
displayed a high occurrence of progressive apoptotic cells with
increased age, while in the DG region, despite having a large
number of COX deficient cells, only a few neurons seemed to
undergo apoptosis. The variances in the cell death dynamics
might be a result of differences in neuronal types and physiol-
ogy, and therefore their reliance on mitochondrial respiratory
function. Indeed, selective neuronal vulnerability to oxidative
stress (12), Parkinson’s disease (13) or Alzheimer’s disease (14)
was previously described suggesting distinctive metabolic pro-
files in different brain regions.
Strong mitochondrial deficiency and neuroinflammation
precede loss of DARS2-deficient neurons
Severe respiratory chain deficiency was observed already at
15weeks of age, and reached its peak in 20weeks old Dars2NEKO
brains (Fig. 3A). The number of COX deficient cells markedly de-
creased from 24weeks on, likely owing to the massive apoptosis
of DARS2-deficient cells (Fig. 2A). As a result, 28-week-old brains
had almost no COX()SDH(þ) (Complex IV deficient/Complex II
positive cells), but a severely reduced cortex. It also became ap-
parent that, instead of cell bodies, Dars2NEKO mice had holes
throughout the hippocampus and cortex area (Fig. 3A). Analysis
of mitochondrial respiratory chain (MRC) enzyme activities in
neocortical samples demonstrated decreased activities of com-
plexes containing critical mitochondrial DNA (mtDNA)-encoded
subunits, in 28-week-old Dars2NEKO mice (Fig. 3B). The observed
alterations in the MRC levels and enzyme activities matched
the reduction in the amount of fully assembled complex I (C I)
and IV (C IV—COX) in Dars2NEKO mice (Fig. 3C). The F1 subcom-
plex of complex V (C V) was also detected in Dars2NEKO mito-
chondria, implying a defect in mitochondrial protein synthesis,
as previously reported (8,15,16). Remarkably, at 28weeks of age,
mitochondrial de novo protein synthesis in Dars2NEKO cortex ap-
peared better than at 22weeks of age (Fig. 3D). This is likely ow-
ing to vast loss of DARS2-deficient cells at 28weeks, hence the
majority of mitochondria in these samples stems from other
cell types, unaffected by Cre-mediated deletion of Dars2.
The essential role of the OXPHOS function in neurons has
been previously demonstrated in other mouse models. Tissue-
specific depletion of Tfam in forebrain and hippocampus neurons
(TfamL/L; CamKIIa-Cre) guided the reduction of mtDNA levels and
Figure 1. Analyses of cortex and hippocampus degeneration in control (Ctrl) and Dars2NEKO (NEKO) mice. (A) Brain weights of Ctrl and NEKO mice at the indicated age;
representative photographs of isolated brains from both knockout and control mice at the indicated age. Bars present mean levels6SD. Statistical difference was calcu-
lated by Student’s t-test; **P<0.005, ***P<0.001 (n¼35). (B) Representative Nissl staining (Scale bars: 500 lm) of hippocampal regions of Ctrl and NEKOmice at indicated
age. Close-ups are for the indicated areas. (C) Quantification of brain cortical thickness [mm] at the indicated age in Ctrl and NEKO mice; bars represent mean levels
6SD. Statistical difference was calculated by Student’s t-test; **P<0.005, ***P<0.001 (n¼3–5). (D) Representative transmission electron micrographs (Scale bar: 0.5 lm) of
Ctrl and NEKO 29-week-old mice.
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strong respiratory chain deficiency from four months of age, re-
sulting in a severe, progressive neurodegeneration and massive
apoptosis (17). A complete loss of the complex I (C I) NDUFS4 sub-
unit (Ndufs4/) resulted primarily in a CNS defect and rapid de-
velopment of a Leigh-like phenotype characterized by ataxia,
blindness, retarded growth rate, lethargy and increased serum
lactate, leading to premature death at about 7weeks of age (18).
Similarly, depletion of Cox10 in neurons (Cox10L/L; CaMKIIa-Cre)
rendered them respiratory-deficient already at 2months of age in
both the cortex and hippocampus areas, while the neurodegener-
ative phenotype progressed slowly until the ages of 8 and
12months when the mice die (19,20). Typically, there is a time lag
between the occurrence of OXPHOS deficiency and onset of neu-
rodegeneration (17,20), during which neurons seems to compen-
sate for the disruption of oxidative phosphorylation. Increased
glycolysis and support from other cell types have been proposed
to account for this (21). However, here we show that DARS2 de-
pletion in neurons leads to a respiratory chain deficiency around
15weeks of age that quickly culminates in the occurrence of mas-
sive cell death at 20weeks, resulting in a severe brain atrophy
(30% loss) within the next four weeks. Therefore, if existing, com-
pensatory ATP supplementation by other cell types seems to be
insufficient to maintain neuronal function for prolonged time pe-
riods in Dars2NEKOmice.
In agreement with a strong OXPHOS defect and disturbed
mitochondrial protein synthesis, increased levels of mitochon-
drial HSP70 chaperone and LONP1 protease were detected, sug-
gesting higher activation of mitochondrial stress responses,
possibly mitochondrial unfolded protein response (UPRmt), in
20-week-old Dars2NEKO animals (Supplementary Material, Fig.
S3A). Increased mitochondrial biogenesis might also contribute
to the observed change, as suggested by higher SDH levels
(Fig. 3C). Remarkably, the increase was statistically significant
only in the hippocampus, possibly owing to a higher number of
cells other than neurons in the isolated cortex samples
(Supplementary Material, Fig. S3B and C).
Neuronal degeneration frequently leads to a local change in
physiological conditions that in turn promotes an inflammatory
response and activation of microglia, which are the resident im-
mune cells of the nervous system. Indeed, we detected high lev-
els of activated microglia in the cortical and hippocampal regions
of Dars2NEKO mice, starting from 15weeks of age (Fig. 4A). The
number of infiltrated microglia in the hippocampal CA1 and DG
regions dramatically increased with age, with an almost com-
plete loss of recognizable structure at 32weeks (Fig. 4A and
Supplementary Material, Fig. S4A). On the contrary, the level of
activated microglia in the cortex (SC and RS) peaked at 20weeks
(Fig. 4A and Supplementary Material, Fig. S4A), coinciding with
the highest levels of OXPHOS deficiency observed in these
Dars2NEKO brains. The decline of reactive microgliosis over time
coincides with a more robust, apoptotic neuronal loss in the cor-
tex layers than observed in the hippocampus (Fig. 4A and 2A).
Reactive astrocytes were increasingly detected from 15weeks of
age in both, cortex and hippocampal region of Dars2NEKO mice,
further emphasizing the presence of a neuroinflammatory re-
sponse (Fig. 4B and Supplementary Material, Fig. S4B). The high-
est level of GFAP positive cells was observed around 20weeks,
and was persistently present until the end of the lifespan at
around 32weeks (Fig. 4B and Supplementary Material, Fig. S4B).
Certainly, neuroinflammation is increasingly recognized as a
contribution to processes underlying neurodegeneration.
Primarily activated in response to diseases, toxins or mechani-
cal injury, neuroinflammation is strongly associated with de-
myelinating diseases (22). It is now clear that the microgliosis
and astrogliosis primarily intended to clear up debris and sup-
port neurons in distress, when chronically activated, can con-
vert from a beneficial program into a cytotoxic insult promoting
neuronal death (22). This might be one of the mechanisms to
explain the abrupt worsening of the Dars2NEKO phenotype after
20weeks of age when we could observe massive micro- and
astrogliosis.
Remarkably, activated microglia were detected in both the
cortex and hippocampus already at 15weeks of age before any
cell death could be observed, suggesting that respiratory-
deficient cells emit specific signals leading to activation of neu-
roinflammatory processes. We previously showed that DARS2
depletion in heart and skeletal muscle leads to accumulation of
unfolded/misfolded proteins that serve as the first signal caus-
ing activation of stress signals and systemic changes in metabo-
lism (8). It is tempting to speculate that the buildup of unfolded
and/or unassembled respiratory chain subunits owing to the
DARS2 depletion, and therefore imbalanced mitochondrial de
novo protein synthesis acts as an early signal for the cell autono-
mous activation of stress responses, which might also trigger
neuroinflammatory response. This would be in agreement with
previous studies where the activation of microglia coincided
with the accumulation of misfolded proteins in Alzheimer’s dis-
ease, amyloid lateral sclerosis or Huntington’s disease (23).
DARS2 depletion in myelin-producing cells does not
affect the number of oligodendrocytes nor myelin pro-
duction, despite strong OXPHOS deficiency
In agreement with our initial observation, DARS2 depletion in
adult myelin producing cells (Dars2MYKO mice) did not affect cell
Figure 2. Apoptotic cell death in cortical and hippocampal regions in control
(Ctrl) and Dars2NEKO (NEKO) mice. (A) Representative TUNEL staining of brain
hemispheres (cortex and hippocampus regions) in Ctrl and NEKO mice at the in-
dicated age. (B, C) Quantification of TUNEL positive cells per hemisphere in the
region of cortex (B) and hippocampus (C) at the indicated age in Ctrl and NEKO
mice. Bars present mean levels 6SD. Statistical difference was calculated by
Student’s t-test; *P<0.05, ***P<0.001 (n¼3).
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survival and therefore cell numbers at either 18 or 28weeks
(Supplementary Material, Fig. S5A). Moreover, the level of mye-
lin basic protein, which is one of the most abundant proteins in
myelin sheaths, was unchanged in Dars2MYKO mice
(Supplementary Material, Fig. S5B). We also analyzed myelina-
tion in the PNS and found no difference in the thickness of mye-
lin sheaths or appearance of Schwann cells (myelin producing
cells in PNS) on both sciatic nerve and spinal cord
(Supplementary Material, Fig. S5C).
Puzzled by the initial results, we wondered if DARS2 deple-
tion causes respiratory chain deficiency in myelin producing
cells as observed in neurons. Therefore, we analyzed OXPHOS
function, again turning to COX-SDH staining. A large number of
COX-deficient cells were detected in the striatum of Dars2MYKO
mice, indicating the presence of strong OXPHOS deficiency (Fig.
5A). In the corpus callosum, the largest white matter structure
in the brain, we detected COX-deficient oligodendrocytes in
Dars2MYKO mice, and in agreement with results on PNS, no
changes in the myelination (Fig. 5C). Furthermore, a very promi-
nent stream of OXPHOS deficient axons could be detected in 15-
week-old Dars2NEKO mice (Fig. 5B), which, remarkably, also did
not affect the myelination of the corpus callosum (Fig. 5C
and D).
DARS2 deficiency in forebrain and hippocampal neurons in-
duced strong OXPHOS deficiency and neuroinflammatory re-
sponse (Fig. 4 and Supplementary Material, Fig. S4). Despite
clear evidence of strong OXPHOS deficiency in oligodendrocytes,
no signs of neuroinflammatory response were detected in
Dars2MYKO mice (Supplementary Material, Fig. S6).
Finally, using simple composite phenotype scoring system
we tested to what extent DARS2 depletion affects motor skills in
our two models (24). In accordance with previous results,
Dars2MYKO mice did not show any signs of motor dysfunction
(Fig. 5E). In contrast, DARS2 deficiency in neurons led to progres-
sive loss of motor skills characterized by tremor, ataxia and
age-dependent kyphosis (Fig. 5E).
Our results demonstrate that DARS2 deficiency in forebrain
and hippocampal neurons leads to devastating cell death and
severe neurodegeneration preceded by an early neuroinflam-
matory response (Supplementary Material, Fig. S7). The loss of
DARS2 in oligodendrocytes, despite leading to strong respiratory
deficiency, does not trigger any of these responses on either a
Figure 3. Characterization of mitochondrial function in control (Ctrl) and Dars2NEKO (NEKO) mice. (A) COX-SDH staining of brain hemispheres (cortex and hippocampus
region) in Ctrl and NEKO mice at the indicated age. (B) Relative MRC complex activities in isolated cortex mitochondria of Ctrl and NEKO mice at 28weeks of age. Bars
present mean levels 6SD. Statistical difference was calculated by Student’s t-test; *P<0.05 (n¼3). (C) Western blots for OXPHOS complexes (with indicated position of
specific complexes) and representative Coomassie Brilliant Blue (CBB) stained BN-PAGE gel in cortex mitochondria from 28-week-old Ctrl and NEKO mice.
(D) Representative gel of in organello translation of 22- and 28-week-old Ctrl and NEKOmice cortex mitochondria. CBB stained gel used as loading control.
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cellular or physiological level (Supplementary Material, Fig. S7).
Remarkably, a recent study showed that the most common
DARS2 patient mutation, located in a splice-site of intron 2, has
the strongest effect causing exon 3 exclusion in neuronal cell
lines (6). Therefore, it is tempting to conclude that LBSL in
DARS2 patients is a consequence of a primary neuronal defi-
ciency, as neurons seems to be more affected with the splice-
site mutation and here we show that they are also much more
sensitive to a Dars2 depletion than myelin producing cells.
However, one has to keep in mind that our models induce the
post-natal ablation of DARS2, whereas LBSL is typically owing to
a hypomorphic allele which partially impairs the function of
DARS2 throughout the embryonic and brain development.
Therefore, a detrimental role of the mutation during
oligodendrocyte-mediated myelinization of the developing
brain cannot be excluded in the pathogenesis of the disease.
This is in agreement with a study showing that the most
common DARS2 patient mutation located in a splice-site of in-
tron 2, has the strongest effect causing exon 3 exclusion in neu-
ronal cell lines (6).
Why would these two cell types react so differently to the
loss of respiratory chain function? A different metabolic profile
of adult oligodendrocytes and Schwann cells, enabling them to
survive primarily using glycolysis for energy production when
mitochondrial respiration is impaired, might be the main
reason. In support of this hypothesis, Schwann-cell-specific de-
pletion of Tfam (TfamL/L, P0-Cre), the mitochondrial transcription
factor A gene, which is essential for mtDNA transcription and
maintenance, did not affect cell proliferation or survival, despite
severe mtDNA depletion and respiratory chain abnormalities
(25). Oligodendrocyte-specific deletion of Cox10 (Cox10L/L; Cnp1-
Cre), an essential assembly factor for complex IV, also did not
lead to axonal degeneration, demyelination or cell death (26). In
fact, recent data suggest that oligodendrocytes’ mitochondria
may be essential for specialized functions relevant for myelin
maintenance, such as lipid synthesis or fatty acid oxidation,
rather than for ATP production (27). In agreement with this
idea, a complete ablation of the m-AAA protease using the
same promoter and Cre-induction paradigm as in this study
(Afg3l1/; Afg3l2L/L; Plp1-Cre) resulted in progressive motor dys-
function and demyelination, owing to rapid oligodendrocyte
cell death (11). In light of our results, this suggests that the im-
balance of m-AAA protease substrates, other than the ones re-
lated to respiratory chain function, is detrimental for the
myelin-producing cells of the central and PNS (11).
In summary, we provide strong in vivo evidence in support of
the hypothesis that Dars2 dysfunction, causing LBSL through
disturbances in the white matter of both central and PNS, arises
from a primary neuronal or axonal deficiency and not from a
defect of myelin-producing cells. Remarkably, our results also
highlighted neuroinflammatory processes, which coincide with
respiratory chain deficiency and precede neuronal cell loss as
possible yet unexplored targets of therapeutic interventions in
LBSL and potentially other mitochondrial diseases.
Experimental Procedures
Generation of Dars2mice
Forebrain-specific DARS2-deficient mice (NEKO) were generated
by mating Dars2loxP/loxP animals with transgenic mice express-
ing Cre recombinase under the control of CaMKIIa promoter (9).
MPC-specific DARS2-deficient mice (MYKO) were created also by
using Dars2loxP/loxP animals, mated with mice containing Plp1
driven CreER recombinase (10), whereas the activation of re-
combination was done by application of tamoxifen. Tamoxifen
(T5648, Sigma) was dissolved in a corn oil/ethanol (9:1) mixture
at a final concentration of 10mg/ml. A total of 1mg tamoxifen
was administrated by intraperitoneal injection once a day for
five consecutive days to 4weeks old mice. All genotypes were
acquired by PCR. Animal protocols were in accordance with
guidelines for humane treatment of animals and were reviewed
by the Animal Ethics Committee of the Nord-Rheine
Westphalia, Germany.
Histological analysis
Mice were anesthetized with the combination of ketamine/xyla-
zine, given intraperitoneally. Perfusion was performed intracar-
dially with phosphate buffered saline (PBS) followed by 4%
paraformaldehyde (PFA) in 0.1M PBS (pH 7.4). Isolated brains
were post-fixed in 4% PFA at 4 C (for transmission electron
microscopy analysis, post-fixed in 2% glutaraldehyde at 4 C)
overnight and then stored at 4 C in 0.05% sodium azide-PBS
(NaN3-PBS) until further analysis. After perfusion, coronal sec-
tions were cut on Leica VT1200S with a thickness of 30–40 mm.
Free floating sections were kept at 4 C in 0.05% NaN3-PBS.
For cryostat sections, freshly isolated brains were directly
embedded in Tissue-Tek (Sakura) and frozen using dry ice.
Figure 4. Neuroinflammatory processes in cortical and hippocampal areas of
control (Ctrl) and Dars2NEKO (NEKO) mice. (A and B) Representative immunofluo-
rescence merged Z-stack images of IBA1 positive microglia (A) and GFAP positive
astrocytes (B) in somatosensory cortex (SC) and the hippocampal CA1 region in
Ctrl and NEKOmice of the indicated age.
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Coronal sections were cut on a Leica CM1850 cryostat with a
thickness of 7 mm. Sections were directly mounted onto micro-
scope slides and stored at 20 C. Gallyas’ staining was per-
formed as previously described (28).
Nissl staining was performed on vibratome sections, which
were mounted on microscope slides using cromalin solution.
The sections were incubated for 45 s in Nissl solution and wash-
ing step was followed by dehydration with different ethanol
concentrations.
H&E staining was performed on cryosections using Mayer‘s
Hematoxylin solution (Sigma), and sections were mounted with
Entellan (Millipore).
TUNEL staining was performed on vibratome sections via
the ApopTag Plus Peroxidase In situ Apoptosis Detection Kit
(Millipore) according to the manufacturer’s protocol.
COX/SDH staining was performed on cryosections, with
40min of incubation in Cytochrome C solution (0.8ml 3, 3 dia-
minobenzidine tetrahydrochloride, 0.2ml 500 mM cytochrome c,
a few grains of catalase), and 40min Succinate solution (0.8ml
1.875mM nitroblue tetrazolium, 0.1ml 1.3M sodium succinate,
0.1ml 2mM phenazine methosulphate, 0.01ml 100mM sodium
azide) at 37 C in a humid chamber. Sections were washed in
PBS, dehydrated with increasing ethanol concentrations (75%
for 2min, 95% for 2min, 100% for 10min), air dried, and
mounted in D.P.X. Light microscopy images were acquired using
Leica SCN400 slidescanner. Cortical thickness and hippocampal
areas were measured in coronal brain sections of the same
rostro-caudal position in all animals. To quantify the number of
neurons in the hippocampal DG and CA1 regions, neurons were
counted in equally sized areas in the respective regions (n¼ 4
per mouse).
Immunostaining
Free-floating sections were washed extensively and pretreated
for 30min in 2% Triton X-100/PBS. Sections were permeabilized
and blocked in 0.4% Triton X-100, 10% goat serum in PBS for 1h
Figure 5. Characterization of mitochondrial function in control (Ctrl) and Dars2 MYKO (MYKO) mice. (A) Representative COX-SDH staining of brain striatum in Ctrl and
MYKO mice at 18weeks of age (Scale bars, 100 lm). (B) Representative COX-SDH staining of corpus callosum with the close-ups in NEKO and MYKO mice at 18weeks of
age. (C) Representative images of Gallyas’ myelin staining of the brain in 28-week-old Ctrl, MYKO and NEKO mice. (D) Representative immunofluorescence merged Z-
stack images of MBP positive cells in corpus callosum of Ctrl and NEKO mice at the indicated age. (E) Simple composite phenotype scoring system of NEKO and MYKO
mice compared with Ctrl at the indicated age. Bars represent mean6SD.
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at room temperature. Primary antibodies (APC 1:400, OP80,
Calbiochem), MBP (1:1000, SMI94, Covance), (GFAP 1:2000,
NeoMarkers), IBA1 (1:3000, WAKO Life Sciences) were incubated
overnight in 0.4% Triton X-100, 5% goat serum in PBS at 4 C.
After washing with PBS, secondary antibodies anti-mouse Alexa
Fluor 488 (1:2000, Invitrogen), anti-rabbit Alexa Fluor 546
(1:2000, Invitrogen) were applied in 5% goat serum in PBS for 2h.
Finally, the sections were washed in PBS and mounted using
FluorSave Reagent (Calbiochem).
Light microscopy images were acquired by Leica SCN400
slide scanner (Leica Microsystems). Evaluation and processing
was done with SlidePath Gateway Client software (version 2.0).
Fluorescent images were acquired by an Axio-Imager M2 micro-
scope, equipped with Apotome 2 (Zeiss). Images were processed
with AxioVision software (version 4.8.2).
Transmission electron microscopy
Coronal semi-thin sections (1 mm) were cut from hippocampus.
After treatment with osmium tetroxide, the tissue was embed-
ded in Epon (Fluka). For ultrastructural analyses, the tissue of
interest was selected for electron microscopy after examination
of semi-thin sections by light microscopy. Ultrathin sections
(70nm) were cut, collected on 200 mesh copper grids (Electron
Microscopy Sciences), and stained with uranium acetate (Plano
GMBH) and lead citrate (Electron Microscopy Sciences).
Western blot analysis
Protein lysates were obtained from either homogenized tissue
or isolated mitochondria, and subsequently subjected to west-
ern blot analysis as described previously (29). MEFs were lysed
with the RIPA buffer followed by sonication and lysate clear-
ance. Western blot analysis was performed using the following
primary antibodies at indicated concentrations: mtHSP70 and
LONP1 (1:1000, Abcam), Actin (1:5000, Santa Cruz), NDUFA9,
SDHA, UQCRC1, MTCO1 (1:1000, Invitrogen), ATP5A1 (1:1000,
MitoSciences). All secondary antibodies were purchased from
Sigma Aldrich and used in 1:2000 dilution. Western blot quanti-
fication was performed using the ImageJ software.
Blue native polyacrylamide gel electrophoresis (BN-
PAGE)
BN-PAGE was carried out using the NativePAGE Novex Bis-Tris
Mini Gel system (Invitrogen) according to themanufacturer’s spec-
ifications. Proteins were transferred onto a PVDF (polyvinylidene
fluoride) membrane, and immunodetection of mitochondrial
OXPHOS complexes was performed (CI: NDUFA9; CII: SDHA; CIII:
UQCRC1; CIV: MTCO1; CV: ATP5A1).
Analyses of de novo translation in isolated mitochondria
In organello translation was performed as previously described
in mitochondria from heart and liver (8). In organello proteins
synthesis was performed for 1h in presence of 35S-met at 37 C.
Mitochondria were lysed by incubation in SDS-PAGE loading
buffer. Translation products were separated by SDS-PAGE, the
gel was stained with Coomassie Brilliant Blue R-250; incubated
in Amplify solution (GE Healthcare) and newly synthesized
polypeptides were detected by autoradiography.
Respiratory chain enzyme activities
The measurements of respiratory chain enzyme complex activi-
ties and citrate synthase activity were performed as previously
described (30).
Phenotype scoring system
The protocol for simple composite scoring system was done ac-
cording to previously described protocol (24).
Statistical analysis
Two-tailed unpaired Student’s t test was used to determine sta-
tistical significance. Error bars represent standard deviation
(SD). Unless otherwise indicated, all experiments were per-
formed on three biological replicates.
Supplementary Material
Supplementary Material is available at HMG online.
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